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ABSTRACT 
The overall goal of this study was to develop practical, natural, and efficient 
antimicrobials from egg. To accomplish the goal, novel protocols for large-scale production 
of egg yolk immunoglobulin and ovotransferrin were developed. Also antibacterial activity 
of ovotransferrin against Escherichia coli O157:H7 and Listeria monocytogenes was 
investigated and the antimicrobial activity of ovotransferrin was improved by combinations 
with other antimicrobials. The developed protocol for large-scale production of egg yolk 
immunoglobulin (IgY) consisted of several steps such as using 0.01 % charcoal to remove 
lipoproteins from IgY extract, ultrafiltration to concentrate IgY solution, and 40% 
ammonium sulfate to precipitate IgY following dialysis. Morevoer, apo-ovotransferrin was 
isolated from 2 time-diluted egg white by following steps: as iron saturation of egg white,  
extraction of iron-bound (holo) ovotransferrin using 43% ethanol, precipitation of holo-
bound ovotransferrin by 59% ethanol, dissolving the precipitate with distilled water, and 
removal iron from holo-ovotransferrin using AG ®1-X2 ion exchange resin. After separating 
apo-ovotransferrin, the effects of citric acid, Zn- and Fe- binding, and sodium bicarbonate 
(NaHCO3) on the antibacterial activity of ovotransferrin against E. coli O157:H7 and L. 
monocytogenes in model systems using BHI broth were investigated. Synergistic effects of 
EDTA and lysozyme on the antimicrobial activities of ovotransferrin were investigated 
toward E. coli O157 and L. monocytogenes on model systems using BHI broth and pork 
chops and hams. 
          According to this study, IgY obtained by developed protocol was approximately 70 ~ 
80% recovery and approximately 80% purity. The new procedure seems to be economical 
and practical for a large-scale purification of IgY from egg yolk since ammonium sulfate 
precipitation could accommodate of large volume of egg yolk. Also, the recovery rate and 
purity of ovotransferrin produced by the newly developed protocol was around 94% and 80% 
respectively. As the procedure is consisted of only a few steps, it is suitable to a large-scale 
production of ovotransferrin. Also becasuse ethanol and AG ®1-X2 ion exchange resins can 
be regenerated, it seems to be economical and efficient. In study related to antibacterial 
activity of ovotransferrin, 100 mM-NaHCO3 significantly increased the antibacterial activity 
of ovotransferrin against both E. coliO157:H7 and L. monocytogenes. 0.5% citric acid 
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enhanced the antibacterial activities of ovotransferrin against E. coli O157:H7, Zn-bound 
ovotransferrin appeared to inhibit the growth of L. monocytogenes. So, this study suggests 
that the iron binding capacity of ovotransferrin was not the major mechanism of 
antimicrobial actions of ovotransferrin because acidic pH or Zn2+ promotes antibacterial 
activity of ovotransferrin toward E. coliO157:H7 or L. monocytogenes respectively. Also, 2 
mg/ml EDTA improved antibacterial activity of ovotransferrin containing 100 mM-NaHCO3 
against E. coli O157:H7. Also when lysozyme was combined with OS, the antibacterial 
activity of OS against L. monocytogenes increased slightly in vitro test. However, synergistic 
effect of lysozyme on antimicrobial activity of OS against L. monocytogenes did not show 
significantly in this study. Contrary to the model system results using BHI broth, 
ovotransferrin plus EDTA or/and lysozyme did not show any antimicrobial activities toward 
E. coli O157:H7 and L. monocytogenes in pork chops and hams.  
          Developing preservatives such as IgY and ovotransferrin are significant not only for 
the food industry but also for consumers because they are derived from natural sources and 
generally regarded as safe. Use of these products will significantly increase the value of eggs, 
which is important for egg industry. Furthermore, this study claims that ovotransferrins 
combined with NaHCO3, EDTA, or lysozyme have high potential as natural antimicrobial 
agents to control E. coli O157:H7 and L. monocytogenes. Also, further studies are required to 
elucidate the antibacterial mechanisms of ovotransferrin and to overcome the limitations of 
applying ovotransferrin in food products in the future.  
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CHAPTER 1. GENERAL INTRODUCTION 
 
The extension of shelf-life and control of pathogenic microorganisms in meat during 
refrigerated storage is a great concern to the meat industry. Meat processors strive to produce 
raw products that have low levels of spoilage bacteria and no pathogens on the surface of 
meat. Meat processing, however, is not done in a sterile environment and contamination is 
unavoidable, and occasionally pathogenic microorganisms may come in contact with meat. 
Bacterial food-borne illnesses account for an estimated 5 million cases, 60,000 
hospitalizations and 1,800 deaths in the U.S. annually, and about half of the food-borne 
outbreaks are linked to contaminated meat (Huffman, 2002). Major pathogenic bacteria in 
meat or meat products include Escherichia coli O157:H7, Salmonella spp., Listeria 
monocytogenes, Campylobacter, Clostridium botulinum, Clostridium perfringenes, 
Staphylococcus aureus, Aeromonas hydrophila, and Bacillus cereus (Kotula and Kotula, 
2000; Lillard, 1990; Clouser et al., 1995). Listeria monocytogenes is commonly isolated from 
fresh and cooked meat and 70% of the ground beef in the United States is contaminated with 
L. monocytogenes (Brackett, 1988). The eradication of L. monocytogenes that exist in 
processing lines, machines and ready-to-eat meat products is difficult because of its ability to 
form biofilms, which has a strong adhering ability on all kinds of surfaces. The fimbria of E. 
coli O157: H7 also promotes bacterial adhesion and colonization of E. coli on the mucosal 
surface of meat (Naidu, 2002). 
       The reduction of the initial number of contaminated microorganisms in meat is critical 
for controlling propagation of pathogens. Therefore, pre-harvest decomtamination techniques 
of livestock as well as post-harvest decontamination of carcass and meat are considered as 
the major strategies to prevent or reduce the incidence of food borne diseases. Post-harvest 
intervention methods include chemical dehairing, hot water rinse, steam pasteurization, 
steam vacuum, chemical rinses, spraying lactoferrin, adding antimicrobial additives such as 
nicin, acids or acid salts, and irradiation (Huffman, 2002). Also, a  variety of methods such as 
pasteurization, vacuum packaging, high pressure processing, UV radiation, irradiation, 
antibiotics, lactic acid, or lactoferrin addition etc. have been used as decontamination means 
of meat products to control pathogenic and nonpathogenic microorganisms.  
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   Numerous methods have been introduced to prevent the growth of pathogens in meat. 
In recent years, however, the food industry has shown considerable interest about using 
natural antimicrobial agents which originate from natural sources such as plant, animal, and 
bacteria instead of using chemical sanitizers and additives. Due to these trends, many 
researchers have screened antibacterial materials from various natural sources. Natural 
antimicrobial materials, which are non-toxic to humans, but have inhibitory activity against 
undesirable microorganisms, provide great satisfaction to consumers sensitive to safety 
issues. 
         Egg contains high levels of proteins such as lysozyme, egg yolk antibody (IgY) and 
ovotransferrin that have strong antimicrobial activities. Especially, IgY has been considered 
as an interesting antibacterial source that can be used to cure or prevent diseases in animals, 
fish, and human. IgY can easily be isolated in large scale from egg yolk without using 
organic solvents, and there is practically no risk or negative side effect other than egg allergy 
from using IgY. Ovotransferrin is a major egg white protein (12% of total egg white protein) 
that can be used as a natural antimicrobial agent (Valenti et al., 1983a; Banks et al., 1986; 
Giansanti et al., 2005; Wang and Shelef, 1991). Lactoferrin, an ovotransferrin equivalent 
from milk, has been given GRAS (Generally recognized as safe) status by the US FDA and is 
approved to use in meat processing to control pathogens, but is very expensive. Although, the 
antimicrobial activity of ovotransferrin against a variety of pathogenic and nonpathogenic 
microorganisms has been discussed, no attempt has been made to separate ovotransferrin on 
a commercial scale and use it in processing meat or other foods. If ovotransferrin can be 
separated from egg white economically on a large scale, many meat processing plants may 
prefer to use ovotransferrin instead of lactoferrin. Furthermore, when ovotransferrin can be 
separated from egg white without using hazardous chemicals, it should easily get the status 
of GRAS, like lactoferrin. In spite of several potential benefits of using ovotransferrin, 
however, little work has been done to separate ovotransferrin from egg white on a 
commercial scales and to use in meat processing to prevent the growth of pathogens. 
         The first objective of this study was to develop economical, large-scale separation 
methods for IgY from egg yolk and ovotransferrin from egg white. The second objective was 
finding conditions for activating ovotransferrin separated from egg white and determining the 
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effects of activated ovotransferrin on the survival of food borne pathogens in model systems 
and ready-to-eat meat products. The central hypothesis of the study was that ovotransferrin 
and IgY can be purified in large quantities using simple procedures instead of expensive ion-
exchange chromatography or HPLC. Also, like activated lactoferrin, the activated 
ovotransferrin may become a natural antimicrobial agent that can be used to control 
pathogens in poultry carcasses.   
         This study developed rapid and simple protocols for large-scale production of IgY and 
ovotransferrin from egg. The separation protocols developed do not require sophisticated 
equipment or complicated steps for easy adaptation by industry. However, the results 
indicated that there are some weaknesses and problems to overcome for the practical 
application of ovotransferrin to control pathogens in meat products even though the 
antimicrobial efficacy of ovotransferrin in model systems was excellent.   
 
Dissertation organization 
The dissertation is composed of a general introduction (Chapter 1), literature review 
(Chapter 2), 5 research papers (Chapter 3-7) and a general conclusion (Chapter 10). The 
literature review includes an overview of Escherichia coliO157:H7 and Listeria 
monocytogenes, chemical and physical characteristics, purification methods, and passive 
immunization of animals using egg yolk antibody and antibacterial properties of lysozyme 
and chemical and physical characteristics, iron uptake and release mechanism, purification 
methods, and antimicrobial activity of ovotransferrin. Chapter 3 contains preparation of IgY 
from egg yolk using ammonium sulfate precipitation and ion exchange chromatography. 
Chapter 4 describes an economic and simple purification procedure for the large-scale 
production of ovotransferrin from egg white. Chapter 5 elucidates the effects of Zn2+, sodium 
bicarbonate, and citric acid on the antibacterial activity of ovotransferrin against E. coli 
O157:H7 and L. monocytogenes in vitro and in hams. Chapter 6 reports enhancement of the 
antimicrobial activity of ovotransferrin solution containing NaHCO3 against E. coli O157:H7 
by EDTA and lysozyme. Chapter 7 demonstrates the effect of EDTA and lysozyme on the 
antimicrobial activity of ovotransferrin against L. monocytogenes. Finally Chapter 8 is a 
discussion with general conclusions of this dissertation.  
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CHAPTER 2. LITERATURE REVIEW 
 
I. Escherichia coli O157:H7 and Listeria monocytogenes 
          Escherichia coli O157:H7 is one of emerging strains due to frequent disease outbreaks 
and meat product recalls. Also, due to risks of listeriosis caused by L. monocytogenes, the 
U.S. Department of Agriculture currently established a “zero tolerance” policy for L. 
monocytogenes in ready-to-eat (RTE) meat products. Therefore prevention or minimizing the 
contamination of E. coli O157:H7 and L. monocytogenes during meat processing or meat 
products is critical for meat industry. 
 
I-1. Escherichia coli O157:H7  
Escherichia coliO157:H7 has been used as an indicator organism to estimate if meat or 
meat products are contaminated by feces or digestive organs during slaughtering or 
processing.  Illness caused by E. coli O157:H7 are frequently linked with cattle and their 
products, undercooked ground beef and raw milk (Firstenberg-Eden, 1997; Weeranta and 
Doyle, 1991). In most of E. coli O157:H7 outbreaks, the vehicle of transmission were 
identified as ground raw beef. E. coli O157:H7 contamination on beef carcasses were from 
contamination by feces or soil during the slaughtering process (Dorn, 1993). In 1982, E. coli 
O157:H7 was known as a human pathogen after outbreaks of hemolytic colitis caused by 
contaminated ground beef patties in Oregon and Michigan (Abdul-Raouf et al., 1993; 
Buchanan and Doyle, 1997; Foulke, 1994). However, the public was not aware of the 
seriousness of E. coli O157:H7 as an emerging pathogenic strain until an outbreak linked 
with the consumption of undercooked hamburger happened in Washington State (USDA, 
1994). The outbreaks occurred in fast-food restaurants in Washington State indicated that 
improper cooking of patties could be responsible for the outbreak (Bell et al., 1994). Other 
foods associated with the outbreaks of illness caused by E. coli O157:H7 include roast beef, 
turkey roll, lettuce, radish sprouts, and alfalfa sprouts (Buchanan and Doyle, 1997; 
Semanchek and Golden, 1997). USDA-FSIS indicated that 1.8% of carcass samples taken 
post-processing were found to be positive for E. coli O157:H7 (Huffaman, 2002). 
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Generally, diarrheagenic Escherichia coli known as pathogenic strains can be 
classified based on virulence properties, clinical syndromes, differences in epidemiology and 
distinct O:H serogroups as enterotoxigenic (ETEC), enteroinvasive (EIEC), 
enteroaggregative (EAEC), enteropathogenic (EPEC), diffusely adherent (DAEC) and 
enterohemorrhagic (EHEC) (Bell, 1998b; Buchanan and Doyle, 1997; Gyles, 1994; Padhye 
and Doyle, 1992). E. coli O157,  known as Shiga-like toxin-producing E. coli or vero 
cytotoxin-producing E. coli, belongs to enterohemorrhagic (EHEC) group and it sometimes 
produces a variety of clinical syndromes including bloody and non-bloody diarrhea, 
hemorrhagic colitis (HC), severe abdominal pain, cramps, hemolytic uremic syndrome 
(HUS) incurring severe renal failure, and thrombotic thrombocytopenic purpura (TTP) 
causing an impairment of the central nervous system (Bell 1998b; Fistenberg-Eden, 1997; 
Hathcox et al., 1995; MacDonald et al., 1998; Martin et al., 1990; Padhye and Doyle, 1992; 
Raghubeer et al., 1995; Doyle, 1991). EHEC strains exist naturally in cattle, other animals, 
and soil, and have a very low infectious dose to cause severe clinical syndromes (Bell, 2002).  
E. coli O157:H7 possesses specific cell-surface appendages such as fimbria or 
colonization factor antigens that facilitate their adhesion and anchor them to the host-tissue-
matrix components such as fibronectin, collagen, elastin and mucin. Thus, they can tightly 
attach to beef tissues (Naidu, 2002). Furthermore, E. coli O157:H7 is quite tolerant to several 
harsh environments such as acid, sodium chloride, nitrite, alkali, and modified atmosphere 
even though the organism can be destroyed by cooking or pasteurization (Abdul-Raouf et al, 
1993; Semanchek and Golden, 1997; USDA,1994; Williams and Ingham, 1997). Also, it can 
survive in water, beef, and chicken stored at subfreezing temperatures as well as outside the 
host for extended periods of time (Semantic and Golden, 1997; Wang and Doyle, 1998; Bell, 
1998a). Even though E. coli O157:H7 has an optimal pH near 7.0 (Tsai and Ingham, 1997), it 
has higher tolerance to acidic pH than any other food borne pathogens (Brackett et al. 1994; 
Benjamin and Data 1995; Conner and Kostroma, 1995; Layer et al., 1995; Jordan et al., 
1999). Due to high resistance to acidic pH,  a variety of  acidic foods such as apple cider, 
apple juice, fermented meat products, mayonnaise and yogurt are implicated in food-borne 
illness by E. coli O157:H7 (Semanchek and Golden, 1997; Tsai and Ingham, 1997). 
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Furthermore, Farrell et al. (1997) reported that E. coli O157:H7 survived on meat grinders, 
which was sanitized with peroxyacetic acid and chlorine.  
        E. coli O157:H7 is considered as an emerging pathogenic strain due to frequent disease 
outbreaks and meat product recalls. So prevention or minimizing the contamination of E. coli 
O157:H7 during meat processing is very important for meat industry.  
 
II-2. Listeria monocytogenes 
Listera monocytoenes is one of the most frequent pathogens causing food born diseases. 
According to the report of the Center for Disease Control and Prevention, 2,500 people suffer 
from listeriosis annually in the United States, indicating that infection caused by L. 
monocytogenes is a serious problem (CDC, 2002). Moreover, Food Safety and Inspection 
Service reported that one in five died from the disease (USDA-FSIS). Due to these risks, the 
U.S. Department of Agriculture currently established a “zero tolerance” policy for L. 
monocytogenes in ready-to-eat (RTE) meat products.    
          The safety concern of L. monocytogenes is further highlighted by multistate outbreaks 
of listeriosis related to RTE meat products such as frankfurters and deli meats. As this 
organism can proliferate in the presence of curing salt at refrigerated temperature (Lou and 
Yousef, 1999), RTE cooked meat products have high incidence rates of contamination by L. 
monocytogenes due to multiple handling and processing steps performed after cooking 
(Uyttendaele et al., 1999). Many cases of listeriosis in humans are epidemiologically linked 
to the consumption of poultry products (Rorvik et al., 2003; Schwartz et al., 1988). The 
Nationwide Young Turkey Microbiological Baseline Data Collection Program reported that 
5.9% of turkey carcass rinses and 31% of ground turkey meat in United States were 
contaminated by L. monocytogenes (USDA-FSIS, 1998). In Berlin, L. monocytogenes were 
found on 85 carcasses among 100 chickens, which are consisted of 95 broilers and 5 layers 
(Schonberg et al., 1989), whereas in Northern Ireland, 38 of 80 retail packs of raw chicken 
purchased from supermarkets were contaminated by Listeria spp. and 62% (38 of 61) of raw 
broiler pieces chosen from retail stores were contaminated by L. monocyotogenes (Miettinen 
et al., 2001).  
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      Also, according to a report in Japan, contamination by L. monocytogenes was 
significantly higher in retail sliced beef (34.2%) and pork (36.4%) than on carcasses of cattle 
(4.9%) and swine (7.4%) (Iida et al., 1998). In Finland, six out of 50 carcasses (12%) were 
contaminated with L. monocytogenes (Autio et al., 2000). In the United States, ground meat 
products were found to be contaminated more frequently L. monocytogenes (Duffy et al., 
2001). According to a survey performed at retail markets of Maryland Northern California, 
577 of 31,705 samples were found to be contaminated by L. monocytogenes (Gombak et al., 
2003). 
     Generally, L. monocytogenes are found widely in plant, soil, silage, sewage, 
slaughterhouse waste, milk, human and animal feces, plant environments, and catering 
facilities (Farber and Petering, 1991; Beresford et al., 2001). L. monocytogenes is a gram-
positive, highly motile, rod with rounded ends. It is a facultatively anaerobic bacterium and 
does not produce spores or form a capsule (Farber and Petering, 1991). L. monocytogenes 
can grow at temperature from 0oC to 42o C. At refrigeration temperature its growth is slow 
with generation times of 30 ~ 40 h at 4o C in skim milk (Malevich, 1992; Rosenow and Mirth, 
1986). Usually, Listeria can grow at pH 4.5 ~ 9.6, optimally at pH 7.0 (Buchanan and Loiter, 
1990; George and Lund, 1992; Parish and Higgins, 1989; Petron and Portola, 1989; Seelinger 
and Jones, 1986). Some Listeria require various nutrient components such as leucine, 
isoleucine, arginin, methionine, valine, cysteine, riboflavin, biotin, thiamine, and thioctic acid 
for growing (Premaratne et al., 1991; Welshimer, 1963) and they grow faster in the presence 
of Fe3+ and phenylalanine (Premaratne et al., 1991). Also, they commonly proliferate well in 
meats near or above pH 6 and poorly on meat products near or below pH 5.0 (Glass and 
Doyle, 1989). The organisms tolerate salt and nitrite (McClure et al., 1997) and can grow at 
an water activity (aw) value below 0.93 (Farber et al., 1992; Petran and Zottola, 1989).  
        As they can colonize, multiply and persist on processing equipment or plant substances, 
which may be natural habitats of the organism, they form bio-films (Rocourt and Seeliger, 
1985). Low levels of L. monocytogenes in the intestines of infected animals may enter 
processing environments or facilities and then survive in bio-films. Therefore, these 
processing facilities play an important role in contamination by L. monocytogenes in some 
products. The contamination by L. monocytogenes in RTE meats occurs mainly during 
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packaging and after cooking because L. monocytogenes is sensitive to heat treatments and 
can be easily inactivated by cooking (Giovannacci et al., 1999; Lunden et al., 2003). Also, 
dust contaminated with L. monocytogenes may be a source of contamination since they can 
adhere to stainless steel even though the organisms show significant differences in their 
ability to attach to surfaces (De Ruin et al., 2003). Decayed vegetation is known as a source 
of many cases of listeriosis which occurred in farm animals. Due to these attributes, L. 
monocytogenes have been considered as one of the major food borne pathogens threatening 
the food industry (Rayer and Marth, 1999).  
          For prevention or minimizing the contamination of E. coli O157:H7 and L. 
monocytogenes, a variety of methods including pre- and post-harvest decontamination 
techniques have been employed.  However, due to consumers’ desire for natural 
antimicrobials that are environmentally, medically acceptable and safe, natural antimicrobial 
proteins have gained attention as a great source of antimicrobials.  
 
II. Natural antimicrobial proteins in chicken eggs 
      An egg is comprised of 9.5% eggshell including shell membrane, 63% egg white 
(albumen), and 27.5% egg yolk. An egg is composed of 75% water, 12% protein, 12% lipids, 
and 1% carbohydrate and minerals (Burley and Vadehra, 1989; Sugino et al., 1997). Egg 
whites contain a variety of chemical defenses such as lysozyme, ovotransferrin, avidin, cystic 
and ovomacroglobulin (called ovostatin) to protect them from microbial attack (Korpela et 
al., 1984; Molla et al., 1987; Miyagawa et al., 1991a, b, 1994; Blankenvoorde et al., 1998; 
Nakai, 2000; Ahlborn et al., 2006). Furthermore, ovomucin (Watanabe et al., 1998) and 
ovoinhibitor (Yolken et al., 1987) in egg albumin are reported to have antiviral properties. 
Egg yolk also contains antibacterial materials such as sialyloligosaccharides (Sugita-Konishi 
et al., 2002) and egg yolk antibodies called IgY. Eggshell membrane plays an important role 
as a barrier to bacterial penetration into the egg and contains active antibacterial substances 
(Ahlborn et al., 2006). The antibacterial activities of eggshell membrane are derived from 
lysozyme, ovotransferrin, and ß- N-acetylglucosaminidase, which a lysozomal enzyme 
associated with the hydrolytic degradation of peptidoglycan layer such as glycoproteins, 
mucopolysaccharides, and glycolipids in outer membranes of microorganisms (Ahlborn et al., 
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2006; Vadehra et al., 1972; Winn and Ball, 1975; Schockman and Höltje, 1994). These 
proteins and other eggshell membrane components seem to prevent the growth of bacteria by 
interacting with bacterial outer membrane (Ahlborn et al., 2006). 
          Among these egg proteins or components, egg yolk immunoglobulins that have a 
variety of advatages have gained attention as an antimicrobial agent for inhibition of bacterial 
growth in fish and human.     
 
II-1. Egg yolk immunoglobulin (IgY) 
Egg yolk antibodies have great potential as a natural antibacterial source due to their 
binding properties to bacteria. Even though IgY is not currently recognized as a GRAS 
material, egg yolk antibody can be used as a secondary food additive (FSIS), which is not 
required to be declared in the ingredients statement nor provide any standards for 
identification.   
 
II-1.1 Characteristics of IgY 
      Chicken egg yolk is an abundant, inexpensive source of antibodies called 
immunoglobulin Y (IgY), which originates from serum immunoglobulins (IgG) of chicken 
and accumulates in yolk (Gregory, 1995).  In the hen, egg yolk immunoglobulins (IgY) are 
actively transported from serum to yolk, and protect chicks from various infectious diseases. 
A large chicken egg (60 g) contains approximately 200 mg IgY, and antibodies recovered 
from an egg are equivalent to the amount of antibodies obtained from a rabbit every 2-3 
weeks. A layer hen produces more than 300 eggs per year, and thus the production cost of 
chicken antibodies is much lower than that of a rabbit (Larsson et al., 1993; Schade et al., 
1994). Generally, immunoglobulins protect animals or humans from bacterial, viral, and 
parasitic infections by inhibiting binding or colonization of bacteria, agglutinating bacteria, 
and neutralizing toxins (Williams and Gibbons, 1972; Kubo et al., 1973). Due to such 
attributes, egg yolk antibodies can inhibit the growth or propagation of some strains.  
Chicken antibodies have many advantages compared with the conventional 
mammalian antibodies. Chicken IgY reacts with more epitopes against mammalian antigens 
due to phylogenetic distance between birds and mammals, resulting in an amplification of 
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signals (Carlander et al., 1999; Larsson et al., 1993; Svensden et al., 1995; Schade et al., 
1994). Poultry, having lower phylogenetic status, thus are an excellent source of varied 
antibody production. Mammalian IgG often binds to the rheumatoid factors that are a marker 
of inflammatory response in immunoassays, but chicken egg yolk antibodies do not react 
with rheumatoid factors. Thus, if IgY is used in immunoassays, more accurate results can be 
obtained (Larsson, 1988; Davalos-Pantoja et al., 2000; Carlander et al., 1999). Also, chicken 
egg yolk antibodies do not interfere with the immune reactions of mammalian IgG and do not 
activate mammalian complement (Carlander et al, 2000; Larsson et al., 1991, 1992; Akita 
and Nakai, 1993). Also, chicken antibodies do not bind protein A and G, which are 
commonly used for the isolation of IgG because of the difference in the Fc-region of chicken 
antibody (Akerstrom et al., 1985; Schwarzkopf and Thiele, 1996). Due to these specific 
properties of egg yolk antibodies, IgY has been applied in many medical fields such as 
xenotransplantation (Fryer et al., 1999), diagnostics (Erhard et al., 2000) and antibiotic-
alternative therapy (Carlander et al., 2000).  
     Traditionally, polyclonal antibodies have been obtained from the serum of immunized 
mammals such as rabbits, sheep, goat and pigs. Using chicken for the production of 
polyclonal antibodies seems to provide great economical benefit because of low maintenance 
costs for animals and the non-invasive, simple, and fast technique for IgY separation (Wu et 
al., 2003; Tini et al., 2002). From an animal welfare standpoint, immunoglobulin (IgY) 
isolated from eggs obtained from immunized chicken is also a good alternative to traditional 
polyclonal antibody production with mammals (Svendsen et al., 1995). 
 
II-1.2. Passive immunizations of animal using IgY   
      Chicken egg antibodies can prevent the growth of pathogens as IgY can block or 
impair the function of bacterial components related to growth. Due to many advantages of 
IgY in inhibition of bacteria, many researchers have reported passive immunization using 
IgY. Also, oral administration of egg yolk antibodies produced from immunized chickens 
showed promising results as prevention or therapeutic treatment for specific diseases in 
infants, fish, small animals, and adult humans. 
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       Specific antibodies derived from eggs of immunized hens might be an inexpensive 
alternative for orally administered passive immunization against enteric infections in animals. 
In fact, IgY has been demonstrated to play a positive role in preventing or controlling enteric 
infections caused by enterotoxigenic E. coli, Salmonella typhimurium, rotavirus, and 
Helicobacter pylori (Sarker and Hammarstrom, 2004). Adhesion of enterotoxigenic E. coli 
(ETEC) to intestinal epithelium causes most of the gastrointestinal disorders in neonatal and 
weaned piglets (Nagy and Fekete, 1999). Egg yolk antibodies inhibited the adhesion of 
hemolytic E. coli K88 to piglet small intestinal mucosa (Jin et al., 1998) and showed 
therapeutic effects in piglet diets by inhibiting enetrotoxigenic E. coli infections which cause 
post weaning diarrhea (Owusu-Asiedu et al., 2002; Imberechts et al., 1997). Rabbits orally 
given egg yolk immunoglobulin obtained from hens immunized with enterotoxigenic E. coli 
were protected from diarrheal illness. In addition, specific egg yolk immunoglobulins 
inhibited the binding of E. coli to rabbit small bowel mucin glycoprotein in vitro (O’Farrelly, 
et al., 1992).  
Arasteh et al. (2004) reported that when IgY derived from chickens immunized with 
Vibrio anguillarum, an important pathogen of marine and fresh water fish, was administered 
orally and intraperitoneally to fish, anti V. anguilarum IgY showed protective effects against 
vibriosis and enhanced disease resistance. In fish, Yersinia ruckeri is a predominant bacteria 
isolated from rainbow trout with enteric redmouth disease. It has long periods of persistence 
in carrier fish and is shed in feces, leading to a continued source of infection. Feeding IgY 
specific for Y. ruckeri to fish decreased the mortality compared to the groups receiving 
normal feed. The oral feeding of specific IgY derived from immunized chickens with fish 
pathogens seems to be an alternative to antibiotics and chemotherapy for prevention of fish 
diseases (Lee et al., 2000).  
        Recently some reports show that egg yolk antibodies can be used as therapeutic 
materials in human diseases. H. pylori bind several receptors on the surface of gastric 
epithelial cells and are often resistant to antibiotics. Egg yolk antibodies obtained from hens 
immunized with H. pylori whole cell lysate showed cross-reactivity with normal human flora 
(Shin et al., 2002), and thus the antibodies may cause difficulties by inhibiting normal flora. 
However, urease-specific IgY (IgY-HpU) produced by immunizing hens with urease,  the 
 
 12
immunodominant H. pylori protein and a well-known critical virulence factor, has a 
significant inhibitory effect on H. pylori urease activity compared to control IgY (Shin et al., 
2004). Kim (2004) reported that H. pylori-specific IgY had a property to inhibit adhesion of 
the bacteria to gastric epithelial cells and had powerful urease-inhibiting activity both in 
human and animals.  
       Streptococcus mutans, which is the main bacterial species associated with dental caries, 
accumulate in the dental boil where multiple binding sites for their glucan proteins are 
present. Egg yolk antibodies obtained from chicken immunized with glucan-binding protein 
B inhibited accumulation of S. mutans within oral biofilms and protected against dental 
caries in a mammer similar to salivary antibodies (Smith et al., 2001).  
         Shimizu et al. (1993) reported that encapsulation of IgY with egg lecithin/ cholesterol 
liposomes reduced the loss of IgY activities in gastric juices. So, these immunoglobulins 
could be used to prevent gastro-intestinal infections in individuals lacking an active gut 
immune response. Purified egg yolk antibodies can also be used for the fortification of food 
products, especially in infant formula since they can be purified and their activity is relatively 
stable at pH above 4.0, heating up to 60o C, freezing, freeze-drying, and tryptic and 
chymotryptic digestions (Shimizu et al., 1988). Deignan et al. (2001) reported that hen egg 
yolk significantly inhibited the adherence of S. typhimurium to intestinal epithelial cells in 
vitro and assumed that egg yolk possesses novel anti-adhesive factors. Also, Salmonella-
specific IgY resulted in structural alterations of bacterial surface by binding the antigens 
expressed on Salmonella surface (Lee et al., 2002; Beal et al., 2004). In addition, E. coli 
O157:H7-specific antibodies had inhibitory effect on the growth of E. coli O157:H7 in a 
liquid medium (Sunwoo et al., 2002). 
 
II-1.3. Separation and purification methods of IgY 
          In spite of various advantages of using IgY in research and diagnostics, limitations of 
IgY purification protocols inhibit its practical use (Akerstrom et al., 1985; Camenisch et al., 
1999; Amersham Pharmacia Biotech, 2000). The classical protocols for purifying egg yolk 
antibodies are normally complex and time-consuming, and are associated with a combination 
of precipitation and chromatographic steps because of the peculiar composition of egg yolk 
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and lack of specific affinity ligands (Verdoliva et al., 2000). The IgY separation methods 
developed so far are expensive and impractical for large scale production of antibodies. 
Moreover, due to the high lipid content in egg yolk and low solubility of egg yolk proteins, 
chromatographic techniques are considered to be less suitable for the separation of egg yolk 
proteins.  
          The first step of antibody isolation from egg yolk usually is associated with the 
removal of lipids and lipoproteins because they are the major obstacles in isolating chicken 
antibodies from egg yolk (Hasen et al., 1998; Verdoliva et al., 2000). As removing lipids is a 
laborious and tedious task during the purification step, various methods have been tested to 
remove lipids or lipoproteins from egg yolk. The methods include using detergents such as 
cetrimide, sodium dodecyl sulfate (Sriram and Ygeeswaran, 1999), carrageenan (Chang et al., 
2000; Hatta et al., 1990), sodium alginate or xantham gum (Hatta et al., 1990), solvents such 
as acetone (Sriram and Ygeeswaran, 1999) and chloroform (Ntakarutimana et al., 1992), and  
ethanol precipitation (Bade and Stegemann, 1984), and cold propane-2-ol extraction, and 
precipitation with polyethylene glycol (Polson et al., 1985, Akita and Nakai, 1993; Gee et al., 
2003), dextran sulfate (Jensenius et al., 1981), caprylic acid (McLaren et al., 1994), or pectin 
(Chang et al., 2000). Also, aqueous two–phase system with phosphate and triton X-100 
(Stalberg and Larsson, 2001),  simple freeze and thaw method (Svendsen et al., 1995), and 
water dilution method under acidic conditions (Ruan et al., 2005; Akita and Nakai, 1992 ) 
were used for separating lipids and water soluble proteins.  
          After removal of lipids and lipoproteins from egg yolk, egg yolk antibodies were 
precipitated by ammonium sulfate (Akita and Nakai, 1992, 1993; Hansen et al, 1998), 
sodium sulfate (Wooley and Landon, 1995) or caprylic acid-ammounium sulfate (Ruan et al 
2005; McLaren et al., 1994). From the precipitated egg yolk proteins, antibodies were further 
purified by affinity column chromatography (Greene and Holt, 1997; Yokoyama et al., 1993), 
gel filtration (Devi et al., 2002), cation exchange chromatography (Fichtali et al., 1992, 1993) 
or DEAE-sephacel anion exchange chromatography (Akita and Nakai, 1992).  
         Akita and Nakai (1992) suggested that a protocol using ammonium sulfate 
precipitation followed by ultrafiltration and gel filtration was the most efficient for IgY 
purification. Among various methods suggested for the removal of lipids, a water dilution 
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method under acidic conditions was the most efficient and economical procedure for large-
scale production of egg yolk antibodies (Akita and Nakai, 1993). Svendsen et al. (1995) 
reported that two-times precipitation of IgY by using 25% ammonium sulfate following 40% 
ammonium sulfate was the most efficient and practical purification method for a large-scale 
production of IgY. The changes of pH values in egg yolk solution influenced the extent of 
interactions between polysaccharides and proteins, and the degree of precipitation of 
polysaccharide-lipoprotein complexes and the immunoactivity of IgY (Chang et al., 2000; 
Samant et al., 1993; Gurov et al., 1983). At pH higher than the pI of proteins, 
polysaccharides containing sulfate groups form precipitants by reacting with globulin 
(Samant et al., 1993).  
          Also, 0.1% of carrageenan at pH 5.0 was excellent in removing lipoproteins from 
diluted egg yolk solution (Chang et al., 2000). Kim and Nakai (1996) suggested that λ-
carrageenan was the most effective in precipitating lipoproteins, whereas Chang et al. (2000) 
reported that pectin was better than any gums. According to Akita and Nakai (1992), 
adjusting the pH of diluted egg yolk between 5.0-5.2 and incubating it for 6 h at 4oC reduced 
the amount of lipoproteins and improved the recovery of immunoglobulin in the water-
soluble fraction. They reported that even though addition of salt to the diluted egg yolk 
increased the amount of proteins, it demonstrated an inhibitory effect on the removal of 
lipoprotein from the water-soluble fraction. As a lower ionic strength supports the 
aggregation of lipoproteins in egg yolk, increasing the dilution ratio facilitated the 
precipitation of lipoproteins in egg yolk. However, the increased volume made it difficult to 
handle the subsequent processing of IgY purification. Thus, it was necessary to reduce 
volume by concentrating the supernatant with ultrafiltration (Kim and Nakai, 1996, 1998) or 
precipitation of proteins using ammonium sulfate (Hansen et al., 1998; Cook et al., 2001).    
          Developing a simple and large-scale production protocol for IgY production is 
required for the application of egg yolk antibodies in various fields. However, various 
methods developed for isolation and purification of egg yolk antibodies until now are not 
applicable for large-scale production. Most of these methods have drawbacks such as low 
recovery rates of IgY, complexity of procedures, or impracticality for routine separation. 
Among the various reviewed methods for IgY purification, a separation technique consisting 
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of ammonium sulfate precipitation and ultrafiltration after delipidation by water dilution 
method under acidic conditions have high potentials for use in large scale production of IgY. 
Also, pH conditions and the amount of ammonium sulfate were critical factors in antibody 
purification from egg yolk. As egg yolk antibodies can be lost by fouling of the membrane 
during the ultrafiltration process, some steps to make the water-soluble egg yolk solution free 
of lipoproteins or other material is absolutely required. To overcome such a problem, 
carrageenan or charcoal were used to remove lipid or lipoproteins completely. 
 
II-2. Lysozyme 
Egg white also has several antimicrobial proteins. Lysozyme is one of the major egg 
white proteins involved in defense of egg from microbial invasion. It is a natural, 
bacteriolytic enzyme that inhibits the growth of bacteria, especially gram-positive 
microorganisms (Rayer and Marth, 1999). It catalyzes the hydrolysis of ß-1.4-glycosidic 
bond between N-acetylglucosamine (NAG) and the N-acetylmuramic acid (NAM) in the 
polysaccharides of certain bacterial cell wall. Also, it catalyzes the hydrolysis of 1.4-
glycosidic bond in chitin, which is a polymer of N-acetyl-D-glucosamine (Jolles and Jolles, 
1984; Phillips, 1966; Davis and Reeves, 2002). Lysozyme comprises 3.5% of hen egg white 
proteins and laying hen possesses 10-fold higher lysozyme than mammals (Osuga and 
Feeney, 1977). The molecular weight of egg white lysozyme is 14 kDa, and is composed of 
129 amino acid residues. Lysozyme binds to ovomucin, transferrin, and ovoalbumin in egg 
white (Davis and Reeves, 2002). Although not yet approved as a food additive in the United 
States, it has a great potential to be a natural food preservative due to its properties: it is a 
very stable protein over a wide range of pH and heating at 100o C for 1~2 minutes, and does 
not cause harm to humans since lysozyme is specific for only bacterial cell walls (Davis and 
Reeves, 2002; Rayer and Marth, 1999). 
As gram-positive bacteria do not possess any outer membrane, lysozyme can 
hydrolyze easily the peptidoglycan layer, resulting in the lysis of bacteria (Salton and Pavlik, 
1960). The antimicrobial activities of lysozyme are derived from its lytic action on certain 
gram-positive bacteria, but not on gram-negative bacteria possessing an outer membrane 
(Davis and Reeves, 2002; Davies et al., 1980). Hughey and Johnson (1987) reported that 70~ 
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80% of L. monocytogenes in stationary phase were lysed by 10 mg/L lysozyme while cells of 
L. monocytogenes in the logarithmic growth phase were not lyzed by 100 mg /L of lysozyme 
after 12 h of incubation. Listeria can grow in nutrient-rich media such as BHI broth 
containing lysozyme (20 ~ 200 mg/L) unlike the listericidal effect of lysozyme in nutrient-
poor media (Hughey and Johnson, 1987; Rayer and Marth, 1999).  
Gram-negative bacteria are less susceptible to the bacteriolytic action of lysozyme 
because the outer membrane prevents the access of lysozyme to the target site (Salton and 
Pavlik, 1960). Bacterial lipopolysaccharides induce reversible inactivation of bacteriolytic 
activity of lysozyme (Ohno and Morrison, 1989a, b). Among gram-negative bacteria, some 
genera such as Salmonella and Shigella are the most sensitive, whereas E. coli, Vibrio and 
Proteus are relatively resistant to lysozyme (Peterson and Hartsell, 1955). Considering these 
results, the antimicrobial actions of lysozyme may be attributed to the direct and indirect 
interaction as well as bacteriolytic actions that destroy cell wall of microorganisms.  
      Antimicrobial activity of lysozyme against microorganisms is affected by the pH of 
media, lysozyme concentration, incubation temperature, growth state before treatment, and 
various growth modifiers or chemical treatments (Johansen et al., 1994; Rayer and Marth, 
1999). Smith et al. (1991) reported that L. monocytogenes grown at low temperature was less 
resistant to bacteriolytic action by lysozyme than those grown at 37o C. Low pH promoted 
cell lysis by lysozyme, but the bacteriolytic activity of lysozyme was relatively stable at the 
range from pH 5.5 to 7.0 (Johansen et al., 1994). Heating (62.5o C for 15 s) L. monocytogenes 
in a phosphate buffer prior to treatments increased the antilisterial activities of lysozyme 
(Kihm et al., 1994). Carminati and Carini (1989) reported that 25 ppm and 1,000 ppm of 
lysozyme induced 22% and 57% reduction in L monocytogenes, respectively, and Listeria 
could grow in heat-treated skim milk containing lysozyme. Lysozyme at 100 mg/L did not 
show antibacterial activity against L. monocytogens in whole milk, but showed some 
antilisterial activities in mineral-free milk at 4o C. Listeria in demineralized milk containing 
lysozyme and heated at 55oC resulted in much larger antilisterial activity than that in 
mineralized milk. Combination of lysozyme and EDTA did not display antibacterial effect 
against L. monocytogenes in ultrahigh-temperature (UHT) milk (Payne et al. 1994). This 
indicated that minerals in milk protected L. monocytogenes from the lytic action of lysozyme 
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(Kihm et al.,1994) and the components of media influenced the antibacterial acitivity of 
lysozyme. 
          The antibacterial action of lysozyme against bacteria and fungi could be improved by 
various chemicals such as EDTA, butylparaben, and tripolyphosphate as well as by some 
other naturally occurring antimicrobial agents (Johnson, 1994). Lactic acid promotes the 
bacteriolytic activity of lysozyme against L. monocytogenes. Also, EDTA showed a strong 
synergistic effect on lytic action of lysozyme against L. monocytogenes grown in BHI agar. 
Lysozyme (0.1 mg/ml) or 1 mM-EDTA could not inhibit the growth of some strains of L. 
monocytogenes, but the combination of EDTA and lysozyme inhibited their growth (Hughey 
and Johnson, 1987). L. monocytogenes (at 104 CFU/g) in fresh green beans, fresh corn, 
shredded cabbage, shredded lettuce, and carrots were inactivated by the treatment of 
combined lysozyme and EDTA, while Listeria in control groups grew to 106 ~ 107 levels 
during storage at 5o C (Hughey et al., 1989).  Also, lysozyme (3 mg/ml) alone or a 
combination of lysozyme (3 mg/mL) and EDTA (25 mM) retarded the growth of 103 levels 
of L. monocytogenes in raw cod fish fillets (Wang and Shelef, 1992). The release of 
lipopolysaccharides from outer membrane or disruption of outer membrane by EDTA, 
proteinases or antibody made them more susceptible to the lytic actions of lysozyme (Salton 
and Pavlik, 1960; Gill and Holley, 2000; Wilson and Spitznagel, 1968; Feingold et al., 1968). 
Antimicrobial activity of lysozyme against gram-negative bacteria can be promoted by 
chemical modification such as lipophilization and/or glycosylation (Liu et al., 2000a, b) and 
heating, which induced partial unfolding of lysozyme (Ibrahim et al., 1996a, b) 
        The antilisterial activity of lysozyme in foods is much lower than that in laboratory 
media. Also, controlling L. monocytogenes in vegetables using lysozyme is more effective 
than that in meat products. Even though listeriostatic property of lysozyme lasted for 2-3 
weeks in fresh pork sausages, lysozyme showed no effects on the growth of L. 
monocytogenes during extended storage (Hughey et al., 1989).  
 
II-3. Ovotransferrin  
Ovotransferrin, also known as conalbumin, is another major contributor to the egg’s 
defense against microbial infection and rotting, and has potential to be used as a natural 
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antimicrobial agent in foods. However, few studies on the antimicrobial activities of 
ovotrasnferrin in meat or meat products are available.  
 
II-3.1. Chemical and physical characteristics of ovotrasnferrin 
          Ovotransferrin known as the major iron-binding protein in egg white constitutes 12% 
of total egg white proteins. Ovotransferrin is a monomeric glycoprotein consisting of 686 
amino acids with 78 kDa of molecular weight, has no free sulfhydryl groups or phosphorus, 
and binds reversibly with two Fe2+ ions per molecule and concomitantly with two CO2- ions 
(Abola et al., 1982; Stadelman and Cotterill, 1986; Aisen and Listowsky, 1980; Ibrahim, 
1997). Ovotransferrin is composed of one N- and one C-terminal domain and one atom of 
transition metals such as Fe(III), Cu(III), or Al(III) can bind tightly within the interdomain 
cleft of each domain of ovotransferrin. Iron is bound by three phenolic hydroxyl groups of 
protein and one carbonate ion (Warner and Weber, 1953; Wishnia and Warner, 1961). Two 
lobes in Fe3+-free ovotransferrin is considered to have a conformation with an opening of the 
interdomain cleft (Rawas et al., 1997; Jeffrey et al., 1998; Kurokawa et al., 1999). 
        The sequence homology between human serum transferrin and hen ovotransferrin is 
51%, but a greater intimate homology is shown at C-terminal regions of these proteins 
(Metz-Boutigue et al., 1984). Ovotransferrin also has significant structural similarities to 
lactoferrin. In addition, both ovotransferrin and lactoferrin have the same iron-binding sites 
consisting of two phenolate oxygens from two tyrosines, a carboxylate oxygen from aspartic 
acid, and one imidazole nitrogen from single histidine (Metz-Bovtigue et al., 1984; Williams 
et al., 1982; Baker et al., 1987). Ovotransferrin has a significant similarity to lactoferrin in 
amino acid sequence and the global folding of the molecules, but its disulfide cross-linking 
patterns and the number of carbohydrate chains in the molecule is different from that of 
lactoferrin. Also, lactoferrin is implicated in defense function against infections, whereas 
ovotransferrin is mainly related to the transport of iron to target cells (Davis and Reeves, 
2002; Giansanti et al., 2002). The protein moieties of transferrin in egg and chicken blood 
serum are identical, but the carbohydrate prosthetic groups are different (Williams, 1962a, b) 
          A metal-free ovotransferrin is easily destroyed by physical and chemical treatments, 
whereas iron-bound ovotransferrin, the holo-form, is relatively stable to proteolytic 
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hydrolysis, chemical and thermal denaturations (Azari and Feeney, 1958). Generally, most 
chemical reagents and denaturing conditions reduce the affinity of ovotransferrin for iron 
because they change particular spatial configurations of native ovotransferrin, which is 
required for the formation of colored iron-bound ovotransferrin (Fraenkel-Conrat, 1950). 
Like most heat labile proteins in egg white, ovotransferrin forms aggregates by heating at 60o 
C, resulting in a milky white gel (Matsudomi et al., 1991). Preheating at 60o C induces partial 
unfolding and aggregation of proteins and forms soluble aggregates, which is attributed to 
disulfide bond and hydrophobic interactions during heating (Xu et al., 1997). Cunningham 
and Lineweaver (1965) reported that heating at pH 9.0 did not produce significant changes in 
ovotransferrin. A variety of factors such as pH, ionic strength, heating conditions, and protein 
concentration influenced the formation of heat-induced protein-a transparent gel or a turbid 
gel (Kitabatake et al., 1988). Understanding the chemical and physical properties or 
mechanism of iron uptake and release of ovotrasnferrin is essential for the application of 
ovotransferrin as a natural antimicrobiological agent to meat or meat products.  
 
II-3.2. Iron uptake and release of ovotransferrin 
 
II-3.2.1 Iron uptake of ovotransferrin 
      Ovotransferrin transports and scavenges Fe (III) in eggs of poultry (Kurokawa et al., 
1995). Ovotransferrin has two iron binding sites, which are located within the interdomain 
cleft of each lobe (Butterworth et al., 1975) and requires anions to bind specifically with 
Fe(III) (Bate and Schlabach, 1975). Like transferrin or lactoferrin that requires bicarbonate to 
overcome the effect of citrate, which may bind iron (Masson and Heremams, 1968), 
ovotransferrin also requires 1 molecule of CO2 as CO32- or HCO3- per atom of Fe3+  to bind 
iron (Warner and Weber, 1953). Some anions such as sulfate and phosphate did not induce 
stable tertiary complexes with Fe(III), but they resulted in similar effects to that of 
bicarbonate by occupying anion-binding sites in ovotransferrin (Woodworth, 1975). 
Warner and Weber (1953) reported that the first and second iron atoms that bind to 
ovotransferrin have different association constants. In transferrin, Fe3+ binding properties are 
markedly different for the N- and C-lobes even though they have similar overall 
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conformation (Miautani et al., 2001). Abdallah and El Hage Chahine (1998) suggested that 
iron uptake from nitrilotriacetatoFe (III) occurred first at C-domain of ovotransferrin after 
interacting with bicarbonate and then the protein conformation was changed by the loss of 3 
~ 5 protons. Such a modification allows the protein to capture another Fe(III) from 
nitrilotriacetatoFe (III) at the N-domain. In the final step, the monoferric or diferric state of 
ovotransferrin lasted for about four hours to attain their equilibrium. Recently, however, 
Okamoto et al. (2004) suggested that iron uptake of monoferric ovotransferrin occurs mainly 
at N-lobe as shown at Fig. 1. 
 
 
 
 
 
Figure 1. The scheme of iron uptake of ovotransferrin: The circle represents the N-lobe of 
ovotransferrin, while the square represents the C-lobe. When a lobe is loaded with iron, an  
“F” appears the respective circle or square. The solid and slashed arrows represent the major 
and minor iron uptake processes, respectively” (adapted from Okamoto et al., 2004). Apo-
OTF means apo-ovotransferrin, FeC-OTF represents iron-bound monoferric ovotransferrin at 
C-terminal, FeN-OTF indicates iron-bound monoferric ovotransferrin at N-terminal, and 
Differic-OTF stands for iron-saturated ovotransferrin. 
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The monoferric N-terminal of ovotransferrin shows a special interdomain interaction 
between the two lysines on the side chain of N-domain, and is assumed to be a hydrogen-
bonding interaction with the aromatic ring of a tyrosine residue. Positive charges of two 
lysine residues play a role to open the N-lobe domain, whereas the interaction of Fe3+ and the 
aspartate ligand results in the closure of the domain. Subsequently, an interdomain 
interaction from lysine - lysine couple plays a role to close the protein domain at pH > 6.0, 
indicating that a dilysine trigger sensitive to pH is considered to be responsible for the second  
Fe3+ uptake and subsequent domain closure, not permitting Fe3+  to release (Dewan et al., 
1993). The iron uptake rate of ovotransferrin is similar to that of lactoferrin. However, the 
affinity of ovotransferrin to iron is the lowest among transferrin family proteins such as 
transferrin, lactoferrin, and ovotransferrin. (Pakdaman and El Hage Chahine, 1996; 
Pakdaman et al., 1998; Abdallah and EL Hage Chahine, 1998). 
         The iron bound to transferrin is relatively stable between pH 6 and 11, but the color 
formed by iron binding decreases at pH < 5.5 and disappears at pH < 4 (Warner and Weber, 
1953). The iron binding capacity of ovotransferrin increased as the pH of the solution 
increased from 6.5 to 9.5. Above pH 9.5, however, part of the ovotransferrin is irreversibly 
denatured (Abdallah and EL Hage Chahine, 1998). At alkaline pH, iron preferentially 
occupies the N-terminal binding site. However, in acidic pH, the monoferric complex is 
formed due to partial release of iron from N-terminal site and the Fe3+ found is mainly at C-
terminal binding site (Williams et al., 1978; Butterworth et al., 1975). Also, in the mild acidic 
conditions, the iron-ovotransferrin complex releases Fe3+ preferentially from N-terminal 
binding site of ovotransferrin (Williams, 1975). 
 
II-3.2.2. Iron release of ovotransferrin 
The in vitro release of Fe3+ from ferric transferrin requires the presence of a simple 
anion such as pyrophosphate, sulfate, or chloride. These anions in Fe3+ release are closely 
related to the opening of the domain in the N- or C-lobe (Baldwin and MR de Sousa, 1981; 
Cheuk et al., 1987; Bailey et al., 1997). The Fe3+ release of ovotranferrin is similar but not 
identical to that of transferrin: iron release of ovotransferrin is slower and occurs at lower pH 
than transferrin (Abdallah and El Hage Chahine, 1999). In apo-ovotrasnferrin, two lobes 
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display a conformation with an opening interdomain cleft (Jeffrey et al., 1998). In iron 
release, decarbonation is a prerequisite (El Hage Chahine and Pakadaman, 1995; Pakadaman 
and El Hage Chahine, 1996). Also, the influences of anions on the Fe3+ release are 
significantly different in the two lobes. The rate of anion-mediated Fe3+ release is much 
faster from the N-lobe than the C-lobe (Kretchmar and Raymond, 1986; Bail and Harris, 
1989). The anion binding to the N-lobe of ovotransferrin follows a dual-pathway, which 
includes the occupation of an iron ligand residue, the opening of the domains, and the release 
of the synergistic carbonate anion (Muralidhara and Hirose, 2000). Unlike N-lobe, C-lobe 
possesses only one anion-binding site in the interdomain cleft and displays a simple 
monophasic pathway in Fe3+ release. Moreover, it does not facilitate Fe3+ release so that the 
rate of Fe3+ release from C-lobe is slower than that of the N-lobe (Kurokawa et al., 1995). 
The anion effect is associated with pH-dependent conformational changes in the N-lobe of 
ovotransferrin. Addition of chloride slows down iron release at high pH, while at low pH 
chloride accelerates it (Rawas et al., 1995).  
Iron release from ovotransferrin occurs at wide ranges of pH (pH 3.0 to 6.0). At acidic 
pH, the N-lobes of serum transferrin and ovotransferrin show weaker binding stability and 
accelerated Fe3+ release than the C-lobe (Griffiths and Humphreys, 1977; Mizutani et al., 
2001). After decarbonation of the iron-loaded protein, the release of Fe3+ occurs first at the 
N-lobe and then at C-lobe (Abdallah and El Hage Chahine, 1999). Even though iron bound in 
holo-ovotransferrin or holo-transferrin is released rapidly at pH 4.0, it is released slowly in 
neutral media (El Hage Hanhine and Pakdaman, 1995). With transferrin, iron release is faster 
in the presence of citrate than formate or acetate because citrate interacts with decarbonated 
monoferric protein with high affinity. However, in the absence of citrate, iron release occurs 
at a lower pH and the intermediate complex is not formed (Abdallah and El Hage Chahine, 
1999). pH itself affects the efficiency of citrate-mediated release of Fe3+ from lactoferrin in 
the absence of NaHCO3 (Griffiths and Humphreys, 1977). Iron can be removed from iron-
transport proteins at low pH (pH 4.5) in the presence of a large excess of citrate (Guo, 2003). 
Citrate-mediated Fe3+ release is slightly more efficient at pH 6.8 than at pH 7.4 (Griffiths and 
Humphreys, 1977). 
 
 
 23
   II-3.2.3. Effect of sodium bicarbonate on iron uptake and release of ovotransferrin 
         Bicarbonate is known as a synergistic anion (Schalabach and Bates, 1975), and is a 
prerequisite for the iron uptake of transferrin and lactoferrin (Aisen, 1989; Pakdaman and El 
Hage Chahine, 1996; Pakdaman et al., 1998) because it prevents citrate from binding iron 
(Griffiths and Humphereys, 1977; Peaker and Linzell, 1975). The anion serves as a bridging 
ligand between protein and metal ion (Aisen, 1980). With increasing bicarbonate 
concentrations, Fe3+-specific binding capacity of transferrin is promoted at a constant pH 
(Abdallah and El Hage Chahine, 1998; Workman et al., 1975 Aisen, 1989; Pakdaman and El 
Hage Chahine, 1997). Bicarbonate or carbonate (CO32- or HCO3-) occupies one of 
Fe3+coordination sites consisting of four lateral chains of two tyrosines, one histidine, one 
aspartate, and a carbonate of bicarbonate (Bailey et al, 1988; Andeson et al., 1989; Zuccola, 
1993; Kurokawa et al., 1995; Rawas et al., 1996).  
         Apotransferrin interacts with two HCO3- but not CO32-. Also, each lobe of apo-
transferrin shows a different affinity constant to HCO3-. Such an affinity difference between 
protein and bicarbonate is not affected by the state of protonation of ovotransferrin or proton 
transfer, while the difference is attributed to ionic interactions associated with the side chain 
of arginine residues in binding sites of each lobe (Bellounis et al., 1996; Pakdaman et al, 
1998). Bicarbonate may be weakly bound to apo-transferrin in the absence of a metal ion 
(Woodworth, 1975), but it is not clear that the binding is specific. The affinity of 
ovotransferrin for bicarbonate in each lobe is about three-fold weaker than that of serum 
transferrin (Bellounis et al., 1996; Pakdaman and El Hage Chahine, 1997).  
 
II-3.3 Purification methods of ovotransferrin  
       Bain and Deutsch (1948) separated essentially pure ovotransferrin from egg white 
using aqueous and ethanol fractionation procedures. They judged the purity and yield of the 
protein by electrophoretic and sedimentation behavior. Warner and Weber (1951) also 
fractionated ovotransferrin from egg white using NaCl and ethanol at pH 6 to 9. 
Ovotransferrin was also separated by fractional precipitation with ammonium sulfate or by 
shaking the protein solution to help precipitate ovalbumin by coagulation (Fraenkel-Conrat 
and Feeney, 1950; Warner, 1954; Azari and Baugh, 1967). However, the drawback of 
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ammonium sulfate precipitation at acidic condition is that the electrophoretic behavior of the 
ovotransferrin differs from native ovotransferrin (Fraenkel-Conrat and Feeney, 1950). 
Vachier et al. (1995) reported that using salt or ethanol precipitation, for the separation of 
ovotransferrin from egg white, denatures the protein and the purity of the protein was 
relatively low.  
In addition to salt or ethanol precipitation, several chromatographic methods such as 
gel permeation, ion-exchange, reverse-phase, hydrophobic interaction, and immobilized-
ligand-affinity chromatography have been employed for the separation or purification of 
ovotransferrin. Ion-exchange chromatography is the most frequently used method for protein 
purification and isolation, and is a commonly practiced method due to its ease of use and 
scale-up possibilities (Larive et al., 1999; Awade, 1996). Because ovotransferrin has 
relatively high pI value (pH 6.1) among the egg white proteins except for lysozyme and 
avidin, the separation of ovotransferrin by ion exchange chromatography was mainly based 
on the exchange of a cation. CM-cellulose was used to separate two conalbumin fractions 
from egg albumin and ovotransferrin contaminated by globulins was then obtained (Rhodes 
et al., 1958). To obtain a purer protein, Azari and Baugh (1967) precipitated and crystallized 
ovotransferrin eluted from a cation column. Anion exchange chromatography using DEAE-
cellulose (Mandeles, 1960) or using a Q-Sepharose Fast Flow column was also carried out to 
separate egg white proteins (Vachier et al., 1995).  
Ovotransferrin separated from anion exchange chromatography using Q-Sepharose 
Fast Flow column is further purified using the Q-Sepharose column a second time. The final 
protein obtained appeared to be homogenous on electrophoresis and its purity was around 
97.5% and the amino acid composition was close to that of the nucleotide sequence of 
ovotransferrin (Croguennec et al., 2001). Awade et al. (1994) used a two-step 
chromatographic procedure involving gel permeation on a Superose 6 Prep Grade column 
and an anion exchange chromatography on a Q-Sepharose Fast Flow for the purification of 
major hen egg white proteins. The purity and yield of ovotransferrin obtained by two-step 
chromatographic procedure were 80% and 60%, respectively. Guerin and Brule (1992) 
developed an industrial-scale procedure for the separation of ovotransferrin from egg white 
devoid of lysozyme using a cation exchange chromatography on DUOLITE C464 and C476. 
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The yield and purity of the isolated ovotransferrin were 54% and 97%, respectively. The 
drawback of the study was, however, more than 7 hours was required for the equilibration of 
resins due to pH adjustment to attach ovotransferrin to resin. Ahlborn et al. (2006) separated 
ovotransferrin from prepared egg white solution and supernatant obtained from 
centrifugation after dilution of egg white solution with sodium phosphate buffer (pH 5.0) 
containing 2M Urea by employing Econo-Pac® High-S Cation or High-Q Anion Exchange 
Cartridge (5 ml). The purity and recovery of ovotransferrin separated on cation exchange 
chromatography was higher than that of anion exchange chromatography. However, the 
recovery rate of ovotransferrin obtained by cation exchange chromatography was around 
37%. 
Owing to the metal binding property of ovotransferrin, immobilized-metal affinity 
chromatography has been considered as an efficient method for the isolation and purification 
of specific protein that has binding property with metal ion (Porath et al., 1975). Lonnerdal 
and Keen (1982) reported that the binding ability of ovotransferrin on metal-chelate gel is 
ascribed to electron-rich groups such as histidine and tryptophan, which can replace water or 
buffer bonded weakly to the metal complex (Lonnerdal and Keen, 1982). Immobilized metal 
affinity chromatography with a copper-loaded Sepharose 6B column was employed by Al-
Mashikhi and Nakai (1987) who separated ovotransferrin from undiluted, blended egg white 
by a single chromatographic step. They obtained two fractions of ovotransferrin possessing 
purity of 98% and 94%. However, a part of the ovotransferrin was not bound at the loading 
step and was lost in the washing step, resulting in a low recovery rate. They indicated that 
ovotransferrin without modification of histidine strongly bound to the Cu-chelate gel, while 
histidine-modified ovotransferrin did not bind to Cu-chelate matrix at alkaline pH (Al-
Mashikhi and Nakai, 1987). Chung et al. (1991) used a bifunctional dye-ligand 
chromatography using DEAE Affi-Gel Blue, as a preliminary first step, to fractionate egg 
white proteins. The fraction containing ovotransferrin obtained from DEAE Affi-Gel Blue 
was further purified by Fast Protein liquid chromatography. 
Based on the review of ovotransferrin purification methods reported, affinity 
chromatography and ion-exchange chromatography seem to be attractive choices for the 
isolation of ovotransferrin. However, many protocols using ion-exchange chromatography or 
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immobilized metal affinity chromatography are developed only on a laboratory scale, and 
thus are not likely to be practical for pilot-scale production of ovotransferrin. Furthermore, 
they require expensive resins and facilities, intensive technique for performance, and more 
expensive maintenance costs (Awade, 1996). Even though, a variety of protocols for a 
laboratory-scale separation of ovotransferrin have been developed (Azari and Baugh, 1967; 
Al-Mashiki and Nakai, 1987; Guerin and Brule, 1992; Shibusawa et al., 2001), no successful 
attempt for commercial-scale productions of ovotransferrin is available. Thus, developing an 
economical, simple, large-scale production method for separating ovotransferrin is very 
important for the commercial use of ovotransferrin as a natural antimicrobial agent in meat or 
meat products.   
 
II-3.4. Activated lactoferrin 
As ovotransferrin has significant structural and functional similarities to lactoferrin, the 
knowledge about antimicrobial actions of activated lactoferrin will be helpful in 
understanding the mechanism of antibacterial activity of ovotransferrin.  
Lactoferrin, an ovotransferrin equivalent from milk, is a member of transferrin family 
and an iron-binding protein with 80 kDa of molecular weight. It transports iron from plasma 
to target cells and binds iron with high affinity (Meta-Boutigue et al., 1984). Lactoferrin is 
synthesized at glandular epithelial cells and secreted into mucosal fluids in response to 
inflammatory stimuli. It is very rich in colostrum and milk, and small amounts of lactoferrin 
also exist in tears, saliva, nasal fluids, pancreatic juice, gastrointestinal fluids, neutrophils, 
and reproductive tissue secretions (Masson et al., 1966; Levay and Viljoen, 1995). 
Lactoferrin has a variety of biological functions: it is involved in iron homeostasis, cellular 
growth and differentiation, host defense against microbial infections, anti-inflammatory 
activities, and protection from cancer (Levay and Viljoen, 1995; Ward et al., 2002; Brock, 
2002; Harmsen et al, 1996).  
Activated lactoferrin is known as a microbial blocking agent and binds to the same 
anchor sites as bacteria on tissue surfaces with a greater affinity, and thus it can block tissue 
interactions with bacteria by competitive binding (Naidu, 2002). Deprivation of iron from 
their environment is assumed to be a central property in a variety of biological functions of 
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lactoferrin and results in suppression of microbial growth (Finkelstein et al., 1983). Some 
researchers reported that activated lactoferrin had direct bactericidal rather than bacteriostatic 
effect against several bacteria, including E. coli, Vibrio cholerae, S. mutans, S. pneumoniae, 
and Legionella pneumophila (Arnold et al., 1980, 1981, 1982; Bortner et al., 1986). 
Lactoferrin also possesses diverse physiological functions and interacts with various 
molecules including lipopolysaccharides (Elass-Rochard et al., 1995; Appelmelk et al, 1994), 
glycosaminoglycans (Mann et al., 1994) and cell-type-specific receptors on epithelial and 
immune cells (Ward et al., 2002; Brock, 2002, Suzuki et al., 2002; Baveye et al., 1999). The 
specific binding of activated lactoferrin against outer membrane proteins of gram-negative 
bacteria leads to inhibition of various cellular functions, deregulation of adhesion/ fibril 
synthesis, increases the permeability of bacterial outer membrane, increases the susceptibility 
of bacteria to hydrophobic antibiotics and lysozyme, and facilitates the release of 
lipopolysaccharide molecules from the cell membrane (Naidu, 2002; Ellison et al., 1988, 
1991).  
Activated lactoferrin is recognized as GRAS material by the FDA and used in meat 
processing to control pathogens (Naidu et al., 2003; Kruger, 2004). Like activated lactoferrin, 
ovotransferrin is also expected to have similar bactericidal functions, and thus has a great 
potential as a natural antimicrobial compound in the future.  
 
II-3.5. Antimicrobial activity of ovotransferrin 
As ovotransferrin has high affinities to di- or tri-valent metallic ions (Valenti et al., 
1983b; Tranter and Board, 1982; Feeney, 1964), irons are naturally sequestered and rendered 
unavailable for the growth of microorganisms. Generally, lactoferrin in mammals functions 
mainly to defend against infections, but ovotransferrin is reported to be related mainly to iron 
transport like transferrin in mammals (Giansanti et al., 2002). Valenti et al. (1983b) reported 
that ovotransferrin possesses structurally-dependent antibacterial activity rather than iron 
deprivation, which is considered to be the major cause of antibacterial activity of lactoferrin 
in spite of  remarkable structural similarities with lactoferrin. 
Many studies have been conducted to determine the antimicrobial effects of 
ovotransferrin against various bacterial species. Ovotransferrin has demonstrated strong 
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antibacterial activity against a wide spectrum of bacteria, including Escherichia coli (Shade 
and Carolin, 1944; Valenti et al., 1983a), Pseudomonas spp., Streptococcus mutans (Valenti 
et al., 1983a), Staphylococcus aureus and Bacillus cereus (Ibrahim, 1996; 1997), and 
Salmonella enteritidis (Baron et al., 1997; 2000). Valenti et al. (1985) reported that 99 among 
100 species of Candida were sensitive to the antimicrobial action of ovotransferrin. 
Also, ovotransferrin is reported to have antiviral activity against herpes virus of 
Marek’s disease. Ovotransferrin is more potent against avian herpes virus than bovine 
lactoferrin and human lactoferrin. Even though ovotransferrin has lower activities against 
herpes simplex virus (HSV) than human transferrin and bovine lactoferrin, it is capable of 
inhibiting viral infections in the egg white of birds (Giansanti et al., 2002). Such a 
phenomenon may be attributed to different features of the binding sites. Lactoferrin 
possesses specific binding sites consisting of a cluster of positive charges at the N-terminus 
lobe, which are responsible for binding to glycosaminglycans (Mann et al., 1994; Wu et al., 
1995) of some viruses including HSV (WuDunn and Spear 1989; Roderiquez et al., 1995), 
whereas ovotransferrin does not exhibit such a cluster of positive charges at N-terminus 
region (Williams et al., 1982, Metz-Boutigue et al., 1984, Jeltsch et al., 1987). Therefore, 
ovotransferrin is lacking in antiviral activity against HSV.  
 
II-3.5.1. Mechanism of antibacterial action of ovotransferrin 
 Although many researchers are interested in biological functions of ovotransferrin, its 
antimicrobial action and roles in physiological systems have not been defined clearly. 
Ovotransferrin plays a role in chelating iron and possibly minerals into stable complexes so 
that essential minerals required for microbial growth become deficient. Based on this theory, 
many researchers assumed that the antibacterial activity of ovotransferrin is attributed mainly 
to iron deprivation (Alderton et al., 1946; Fraenkel-Conrat and Feeney, 1950), which will 
inhibit the growth of bacteria (Arnold et al., 1980; Bullen et al., 1972; Valenti, 1983a; Mayes 
and Takeballi, 1983). Recently, however, several conflicting studies show the mechanisms of 
antibacterial action of ovotransferrin are ascribed not only to iron deprivation but also from 
direct interactions between ovotransferrin and microorganisms (Valenti et al., 1985). 
Considering that ovotransferrin has remarkable structural similarity to that of human 
 
 29
lactoferrin, it is postulated that the antimicrobial action could be related to direct reactions of 
ovotransferrin with bacterial membrane in a mamer similar to human lactoferrin (Valenti et 
al., 1983a; 1987). Ovotransferrin may permeate bacterial outer membranes, reach the inner 
membrane, and lead to permeability of other ions and dissipation of electrical potential. Thus, 
ovotransferrin can exert antibacterial action against gram-negative bacteria (Aguilera et al., 
2003; Ibrahim, 1997).  
 Many studies supporting direct reactions between ovotransferrin and microorganisms 
have been reported (Arnold et al., 1977, 1980, 1981, Valenti et al., 1982, 1985). 
Ovotransferrin saturated with iron displayed antifungal activity toward Candida spp. (Valenti 
et al., 1985), and ovotransferrin saturated with iron has more powerful bactericidal activity 
against E. coli than apo-ovotransferrin regardless of the amount of iron available. Ibrahim et 
al. (2000) suggested that the N-terminal lobe of ovotransferrin had more potent bactericidal 
activity against S. aureus than the C-terminal lobe regardless of the degree of iron saturation. 
Also, Davis and Reeves (2002) reported that the antimicrobial activity of ovotransferrin was 
attributed to the bactericidal domain, which is located in the N-terminal of ovotransferrin 
molecule rather than its iron binding capacity. 
          In conclusion, the causes of antibacterial effect of ovotransferrin are not fully 
understood, and further studies related to the mechanisms of antibacterial activity of 
ovotransferrin are needed.  
 
II-3.5.2. Factors affecting antibacterial activity of ovotransferrin 
The antimicrobial activity of ovotransferrin can be influenced by several factors such 
as bicarbonate and citrate concentrations, pH, composition of medium, exposure time, and 
bacterial species or strains (Valenti et al., 1981, 1983a; Brock, 1985). The bicarbonate in a 
medium can increase bacteriostatic effect, but does not affect antifungal activity of 
ovotransferrin (Valenti et al., 1985). The antimicrobial effect of ovotransferrin against E. coli 
is the highest at pH 8.0 (Valenti et al., 1983a). An excess of citrate can annul the 
antimicrobial activity of ovotransferrin by chelating iron, indicating that the iron binding 
capacity of ovotransferrin is affected by metal chelaters such as citrate (Valenti et al., 1983a; 
Phelpa and Antonini, 1975). However, it is also well known that the effect of citrate on 
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antibacterial activities of ovotransferrin depends on the species of microorganism. For 
example, E. coli have iron transport system mediated by citrate (Frost and Rosemberg, 1973), 
and thus can annul the antibacterial activity of ovotransferrin. However, addition of excess 
citrate does not influence the antimicrobial activity of ovotransferrin against S. aureus and 
Candida spp, which do not have iron citrate transport systems (Valenti et al., 1980; Valenti et 
al., 1985). 
The anitibacterial effect of ovotransferrin is variable among strains of microorganisms. 
Some species such as E. coli, Pseudomonas spp, and S. mutans are the most sensitive to 
ovotransferrin, whereas other species such as S. aureues. Proteus spp and Klebsiella spp are 
the most resistant species (Valenti et al., 1983a). Valenti et al. (1980) reported that some 
species of Staphylococci were resistant to ovotransferrin, while others were sensitive to the 
action of ovotransferrin. The different behavior of bacterial strains against ovotransferrin is 
attributed to the differences in iron transport systems in genus Staphylococcus. Some 
bacterial species lacking in iron transport system are much more sensitive to ovotransferrin 
when exposed to an iron-deficient environment. Also, the antimicrobial activity of 
ovotransferrin is affected by media components or matrix. Valenti et al. (1982) reported that 
the antibacterial activity increased as the amount of free or Sepharose-bound ovotransferrin 
increased. In addition, Sepharose-bound ovotransferrin showed higher antimicrobial activity 
than free ovotransferrin, which could be attributed to the higher stability of matrix-bound 
proteins.  
As ovotransferrin can bind metal ions such as Cu, Al, Zn, and Fe, the antimicrobial 
effect of ovotransferrin is decreased if it binds other metal ions besides iron. However, 
ovotransferrin saturated with metals as such zinc and iron still is reported to display 
antimicrobial activities (Ibrahim, 1997; Valenti et al., 1985; 1987). For example, Zn2+-loaded 
ovotransferrin was found to have more bactericidal activity than apo-ovotransferrin and other 
metal bound ovotransferrin. According to their explanation, the antimicrobial effect of Zn2+-
ovotransferrin is attributed to the direct interaction of Zn2+-ovotransferrin molecule against 
the surface of bacteria rather than iron deprivation from medium (Valenti et al, 1987), and its 
bactericidal activity is not affected by the degree of iron saturation. In addition, the iron-
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saturated N-lobe has almost two-fold greater antimicrobial activity than iron-saturated 
ovotransferrin (Ibrahim et al., 1998).  
  
II-3.6. Bactericidal peptides of ovotransferrin 
Besides reports about antibacterial activity of intact ovotransferrin, certain peptides of 
ovotransferrin obtained after protein hydrolysis have been reported to have strong 
antimicrobial activity against some microorganisms.  
OTAP-92 is a cationic fragment consisting of 92 amino acid residues located within 
109-200 sequence of N-lobe of ovotransferrin and contains six cysteines engaged in three 
intra-domain disulfide bridges. The unique structural motif of OTAP-92 plays an important 
role in the biological function of ovotransferrin (Ibrahim et al., 1998; Navasota et al., 1988). 
The bactericidal peptide is isolated by diluted-acid hydrolysis, which cleaves specifically at 
Asp-X sequence of ovotransferrin and produces a mixture of large disulfide-containing 
peptides (Ibram et al., 1998; Ingres, 1983). After proteolysis of ovotransferrin, the 
bactericidal domain was isolated from the hydrolysate of ovotransferrin using gel filtration 
and reversed-phase HPLC (Ibrahim et al., 1998). The cationic peptide corresponds to the 
sequence of ovotransferrin located at the lip of the N2-domain of the N-lobe of  
ovotransferrin. The cationic peptide of ovotransferrin exhibited potent bactericidal activity 
against gram-positive bacteria such as S. aureus, Bacillus subtilis, and B. cereus as well as 
gram-negative bacteria such as E. coli and P. aeruginosa. OTAP-92 is reported to display 
antibacterial activity against gram negative bacteria by crossing the bacterial outer membrane 
and damaging the cytoplasmic membrane (Ibrahim et al., 2000). 
According to analysis of computer-assisted multiple alignment, OTAP-92 has a 
significant structural similarity with insect defensins and bovine lactoferrin at some regions 
(Ibrahim et al., 1998). As the cationic antimicrobial peptide can cross the outer membrane by 
a self promoted uptake and dissipate the transmembrane electrochemical potential, it exhibits 
bactericidal properties against gram-negative bacteria (Ibrahim et al., 2000). However, when 
disulfide bonds of OTAP-92 were reduced, the bactericidal property was lost. Therefore, the 
maintenance of unique tertiary structure of OTAP-92 was essential for the accomplishment 
of antimicrobial activity (Ibrahim et al., 1998). Although the peptides of ovotransferrin with 
 
 32
antivirial effects have significant sequence homology with bovine lactoferrin peptides that 
show antiviral activity against MDV, intact hen ovotransferrin and bovine lactoferrin show 
stronger antiviral activity than the peptides. Therefore, maintaining native conformation is 
important for bovine lactoferrin and hen ovotransferrin to have antiviral capabilities 
(Giansanti et al., 2005). 
 
III. Summary  
E. coli O157:H7 is considered as an emerging strain due to frequent disease outbreaks 
and meat product recalls. Also, the U.S. Department of Agriculture currently established a 
“zero tolerance” policy for L. monocytogenes in ready-to-eat (RTE) meat products due to 
risks of listeriosis. So prevention or minimizing the contamination of E. coli O157:H7 and L. 
monocytogenes during meat processing or meat product is very important for meat industry.        
          Egg has potential as a natural antibacterial source because it contains antimicrobial 
proteins such as ovotransferrin, egg yolk immunoglobulins (IgY), and lysozyme. As IgY has 
a variety of advantages compared to traditional antibodies, many studies of passive 
immunization using IgY in fish and human have been reported. But some limitations in 
purification of IgY from egg yolk seems to inhibit its practical use. Therefore, for broad 
application of IgY as a antimicrobial agent, a simple and efficient protocol for IgY separation 
should be developed.  
Ovotransferrin transports and scavenges Fe (III) in poultry and has a significant 
similarity to lactoferrin, which has been currently recongnized as safe material (GRAS) and 
is permitted to use as an antimicrobial at meat processing or meat products. Also, a variety of 
methods including HPLC or ion exchange chromatography, gel chromatography, and affinity 
chromatography have been developed to separate ovotransferrin from egg white. Also, 
studies related to antibacterial activity of ovotransferrin have been reported, however, no 
application of ovotransferrin toward real products has been reported until now inspite of the 
attributes of ovotransferrin, which has structural and functional similiarties to lactoferrin. 
Ovotransferrin has two iron binding sites and requires anions, which serve as a bridging 
ligand between protein and metal ion, to bind specifically with Fe(III). Some anions in Fe3+ 
release are closely related to the opening of the domain in the N- or C-lobe.  
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          The mechanism of antimicrobial activity of ovotransferrin is still controversial. 
Initially, iron binding capacity of ovotransferrin has been believed to be major mechanism of 
antimicrobial action of ovotransferrin. As ovotransferrin has high affinities to di- or tri-valent 
metallic ions, irons are naturally sequestered and rendered unavailable for the growth of 
microorganisms. However, subsequent studies claim that ovotransferrin reacts directly with 
microorganisms. Ovotransferrin has demonstrated antibacterial activity against a wide 
spectrum of bacteria, including E. coli, Pseudomonas spp., S. mutans, S. aureus, B. cereus, S. 
enteritidis, and Candida. Also, antibacterial activity of ovotransferrin has been reported to be 
affected by several factors such as sodium bicarbonate, citrate, pH, media, bacterial species, 
stability of ovotransferrin, and Zn2+ among others.  
          In conclusion, through this review, it seemed to be necessary first to develop simple 
and efficient protocols for large-scale production of natural antimcriobials from eggs to use 
them with real products or meat processing. Also, to incresase the antimicrobial effectiveness 
of ovotransferrin, the understanig of precise mechanism of its antimicrobial action is 
considered to be essential work prior to ovotransferrin application into real products or meat 
processing. Furthermore, it seems to be a valuable work to apply ovotransferrin to real 
products.    
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CHAPTER 3. PREPARATION OF EGG YOLK IMMUNOGLOBULIN (IgY) FROM 
CHICKEN EGGS USING AMMONIUM SULFATE PRECIPITATION AND ION 
EXCHANGE CHROMATOGRAPHY 
 
A paper published in the Poultry Science * 
K. Y. Ko1 and D. U. Ahn2  
 
Abstract 
The objective of this study was developing an economical, simple, and large-scale 
separation method for egg yolk immunoglobulin from chicken eggs. Egg yolk diluted with 9 
volumes of cold water was centrifuged after adjusting the pH to 5.0. The supernatant was 
added with 0.01% charcoal or 0.01% carrageenan and centrifuged at 2,800 x g for 30 min. 
The supernatant was filtered through a Whatman No. 1 filter paper and then the filtrate was 
concentrated to 20% original volume using ultrafiltration. The concentrated solution was 
further purified using either cation exchange chromatography or ammonium sulfate 
precipitation. For the cation exchange chromatography method, the concentrated sample was 
loaded onto a column equilibrated with 20 mM citrate-phosphate buffer at pH 4.8 and eluted 
with 200 mM citrate-phosphate buffer at pH 6.4. For the ammonium sulfate precipitation 
method, the concentrated sample was twice precipitated with 40% ammonium sulfate 
solution at pH 9.0. The recovery and purity of IgY were determined by ELISA and 
electrophoresis. The yield of IgY from the cation exchange chromatography method was 30-
40%, whereas that of the ammonium precipitation was 70 ~ 80%. The purity of IgY from 
ammonium sulfate method was higher than that of the cation exchange chromatography. The 
cation exchange chromatography could handle only a small amount of samples, whereas the 
ammonium sulfate precipitation could handle large volume of samples. This study suggests  
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that ammonium sulfate precipitation was a more efficient and useful purification method than  
cation exchange chromatography for the large-scale preparation of IgY from egg yolk.  
 
Introduction 
The production of antibodies from immunized chicken eggs is an excellent alternative 
to that from the serum of mammals (Svendsen et al., 1995). Chicken antibodies have many 
advantages to the traditional mammalian antibodies and have several important differences 
against mammalian IgG in regard to their functions. First, chicken immunoglobulin Y (IgY) 
can react with many epitopes of mammalian antigens due to phylogenic distance between 
birds and mammals, resulting in amplification of signals. Second, chicken antibodies do not 
react with rheumatoid factors, mammalian IgG, and bacterial Fc-receptors; they do not 
induce false positive results in immunoassays because they do not activate mammalian 
complement (Larsson et al., 1991, 1992; Davalos-Pantoja, 2000; Stalberg and Larsson, 2001), 
and do not bind protein A and G, which are commonly used for the isolation of IgG, due to 
differences in the Fc-regions (Akerstrom, 1985; Schwarzkopf and Thiele, 1996). Therefore, 
IgY can be applied in many medical fields such as xenotransplantation (Fryer et al., 1999), 
diagnostics (Erhard et al., 2000) and antibiotic-alternative therapies (Carlander et al., 1999). 
Furthermore, the amount of antibodies obtained from an egg is equivalent to that from 200 to 
300 mL of mammalian blood and the costs for animal care per unit production of antibodies 
are much lower in chicken than in mammals (Larsson et al., 1993; Schade and Hlinak, 1996). 
However, the practical use of IgY in research and diagnostics is limited due to complex and 
time-consuming purification steps associated with the further purification of IgY (Akita and 
Nakai, 1992; Camenisch et al., 1999). 
        The first step of IgY separation from egg yolk usually involves with the extraction of 
IgY from yolk. One of the major obstacles in isolating IgY from egg yolk is high 
concentrations of lipids and lipoproteins (Hasen et al., 1998; Verdoliva et al., 2000). 
Various strategies including the use of detergents such as sodium dodecylsulfate (Sriram 
and Ygeeswaran, 1999), carrageenan (Hatta and Kim, 1990), sodium alginate or xantham 
gum (Hatta et al., 1988); solvents such as acetone (Sriram and Ygeeswaran, 1999), 
chloroform (Ntakarutimana et al., 1992) or ethanol (Bade and Stegemann, 1984);  
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polyethylene glycol (Polson et al., 1985, Akita and Nakai, 1993) or dextran sulfate 
(Jensenius et al., 1981); aqueous two-phase system with phosphate and triton X-100 
(Stalberg and Larsson, 2001); simple freeze and thaw cycling (Svendsen et al., 1995); and 
water dilution under acidic conditions (Akita and Nakai, 1993) have been used to remove 
lipids and lipoproteins from egg yolk extract. Most of these methods, however, have 
drawbacks such as low IgY recovery rates, complexity of procedures, or compatibility for 
human use.  
          Among the methods, Akita and Nakai (1993) suggested that water dilution method 
under acidic conditions were suggested to be the most efficient and economical procedure for 
large-scale production of IgY from egg yolk. Upon removal of lipids and lipoproteins from 
egg yolk using acidified water, IgY can be precipitated by ammonium sulfate (Akita and 
Nakai, 1993), sodium sulfate (Wooley and Landon, 1995) or caprylic acid-ammonium sulfate 
(McLaren et al., 1994; Ruan et al., 2005). However, the water dilution (10x) method results 
in an extreme volume increase, which makes it difficult to use salt precipitation on a large-
scale. Ultrafiltration is one of the best methods of reducing the volume of egg yolk extract, 
but the efficacy of ultrafiltration is greatly influenced by the presence of lipids or lipoproteins 
in the solution. Therefore, complete removal of lipids or lipoproteins from the water-extract 
of egg yolk is necessary. The changes of pH value in egg yolk solution influence the extent 
of interactions between polysaccharides and proteins, the precipitation of polysaccharide-
lipoprotein complexes, and the recovery of immune-activity in IgY (Gurov et al., 1983; 
Samant et al., 1993). Chang et al. (2000) reported that addition of 0.1% of λ-carrageenan was 
effective in removing lipoproteins from the water-extract of egg yolk at pH 5.0. 
          After precipitation of IgY by salts, column chromatography (Jensenius et al., 1981) is 
frequently used as a final step for IgY purification. However, column chromatography is 
expensive and impractical for the large-scale production of antibodies. Therefore, appropriate 
strategies for the large-scale production of antibodies with high purity and recovery are 
needed. The objective of this work was to develop an efficient and simple protocol for large-
scale production of antibodies with high purity and recovery rates. In this study carrageenan 
or charcoal was added to the water-soluble fraction obtained by water dilution method to 
remove lipoproteins, which tend to clog membrane filter during ultrafiltration. 
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Materials and Methods 
 
Preparation of egg yolk extract 
          Fresh eggs (less than 2-day-old) were obtained from a local farm and yolk was 
separated from white using yolk separators. Egg yolk (4o C) was diluted with 9 volumes of 
cold (4o C) distilled water and homogenized for 1 min using a Waring blender at high speed. 
The pH of egg yolk solution was adjusted to pH 5.0 with 1 N-HCl. To determine the effect of 
NaCl on the extraction of IgY from egg yolk, various amounts of NaCl was added to the egg 
yolk before homogenization. To investigate the effect of storage temperature on the 
extraction of water-soluble proteins, homogenized egg yolk solutions were kept in room 
temperature (control), freezer, or refrigerator for 24 hrs before centrifugation at 2,800 x g for 
40 min at 4oC. The turbidity and IgY yield of the supernatant were measured. 
After centrifugation, various concentrations of carrageen or  charcoal was added to the 
supernatant collected and centrifuged again at 2,800 x g for 30 min at 4oC to remove residual 
lipoproteins in the supernatant. The supernatant was filtered through a Whitman No.1 filter 
paper and then concentrated to one-fifth of the original volume using a Pelican XL Biomax-
50 ultrafiltration membrane filter (cut-off size: 100 kD) installed to a Lab scale TM TFF 
System (Millipore, MA, USA). The concentrate was further purified for IgY either using a 
cation exchange chromatography or ammonium sulfate precipitation method. The turbidity 
and lipid content of the supernatant and filtrate were measured. The turbidity was determined 
by reading the absorbance of sample solutions using a Spectrophotometer (Cary 50 Bio, 
Varian, CA, USA) at 600 nm. Protein concentration was determined using the Bio-Rad 
protein assay method (Bio-Rad, Hercules, CA, USA) based on the Bradford method. Bovine 
Serum Albumin (1 mg protein/ml, Sigma, St. Louis, MO, USA) was used as a reference 
protein. The absorbance at 595 nm after 30 min of reaction with Bradford solution was 
measured using a spectrophotometer. Lipid content was measured using the Foch’s method 
(Folch et al., 1957).  
         The concentrated sample solution by ultrafiltration was further purified using either 
cation exchange chromatography or ammonium sulfate precipitation method. For cation 
exchange chromatography, an aliquot of sample was loaded onto a column (6 mL of bed 
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volume) packed with pre-swollen carboxymethyl (CM) cellulose (Sigma-Aldrich St. Louis, 
MO, U.S.A) and equilibrated with 200 mM citrate-phosphate buffer, pH 5.0. The column 
was washed two times with 9 mL of 20 mM citrate- phosphate buffer, pH 5.0 and eluted with 
200 mM citrate-phosphate buffer, pH 6.4. The elution profiles of samples were plotted and 
fractions that make a peak were pooled and analyzed for antibody activity and purity using 
enzyme-linked immunosorbent assay (ELISA) and sodium dodecylsulfate - polyacrylamide 
gel electrophoresis (SDS-PAGE), respectively. 
         For ammonium sulfate precipitation method, the concentrated sample by ultrafiltration 
was first precipitated by 40% ammonium sulfate at 4o C. Then, the pellet was resuspended in 
0.01M Tris-HCl (pH 8.0) to a volume equal to half of the supernatant. The sample was 
precipitated by 40% saturated ammonium sulfate again at 4o C, the pellet was dissolved in 
PBS, pH 7.4 and dialyzed against 10 mM phosphate buffer, pH 7.0 for 24 to 48 h to remove 
salt. The schematic diagram for the isolation of IgY from egg yolk is shown in Fig. 1. 
Antibody activity and purity were determined using ELISA and SDS-PAGE, respectively. 
All the sample preparation processes were replicated 4 times.        
 
SDS-polyacrylamide gel electrophoresis  
          SDS-PAGE was done under non-reducing conditions using Mini–PROTEAN II cell 
(Bio Rad, Richmond, CA) following instruction of the manufacturer. A 10% polyacrylamide 
separating gel (33% [vol/vol] acrylamide: N,N- bis-methylene acrylamide = 30% : 0.8% 
[wt/vol], 0.1% [wt/vol] SDS, 0.5% [vol/vol] TEMED, 0.05% [wt/vol] APS, and 0.38M Tris 
·HCl, pH 8.8) was used for determination of egg yolk proteins. A 4% polyacrylamide gel 
(13.4% [vol/vol] acrylamide: N,N-bis-methelyene acrylamide = 30% : 0.8% [wt/vol], 0.1% 
[wt/vol] SDS, 0.1% [vol/vol] TEMED, 0.05% [wt/vol] APS, and 0.125M Tris ·HCl, pH 6.8) 
was used for the stacking gel and coomassie brilliant blue R-250 staining was used. The 
purity of various IgY preparations was estimated using 10% SDA-PAGE, and coomassie 
brilliant blue R-250 (BioRad) was used to visualize the protein bands. Broad-range SDS-
PAGE molecular weight standards of 45 ~ 200 kDa (Bio-Rad) were used as markers. The 
purity of protein was estimated by densitometric measurements using the AlphaEaseFC 
software (FluorChem 8800, Alpha Innotech Corp.).  
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Enzyme-linked immunosorbent assay (ELISA) 
          Immulon I micro titer 96-well plates (Dynatec Laboratories, McLean, VA) were used 
as the solid support. Polystyrene 96-well plates (Nalge Nunc Inc., Rochester, NY) were 
coated with 100 µL of IgY samples dissolved in a coating solution (0.05M carbonate buffer, 
pH 9.6) and incubated overnight at 4°C. After washing the wells three times with phosphate 
buffered saline-tween (PBS-TW: 10 mM phosphate, 0.15 M NaCl, pH 7.2, 0.05% Tween 20), 
300 μL/well of blocking solution [(1% bovine serum albumin solution in PBS (10 mM 
phosphate, 0.15 M NaCl, pH 7.2) was added. After incubating for 1 h at room temperature, 
the plate was washed with PBS-TW. To each well of the plate, 100 μL primary anti-chicken 
IgG (1:10000 solution diluted with 1% bovine serum albumin (BSA)-conjugated alkaline 
phosphatase) was added and then incubated for l hr. After washing with phosphate buffered 
saline (PBS)-TW, each well was added with 50 μl of p-nitrophenyl phosphate solution as a 
substrate for color development and incubated for 30 min. The enzyme reaction was stopped 
by adding 50μL of 3N-NaOH and the color developed was read on an ELISA plate reader 
(Thermo max, Molecular Devices Corp., Sunnyvale, CA) with a 405 nm filter. For each plate, 
3 kinds of controls were prepared: positive controls with reagent-grade chicken IgG (Sigma-
Aldrich, St. Louis, MO, USA), non-specific antigen BSA as another control, and a negative 
control without antigen. All the procedures for ELISA were conducted at room temperature 
(about 25oC). 
Statistical analysis 
          Data were analyzed using SAS software (Release 6.11, SAS Institure Inc., Cary, NC) 
by the generalized linear model procedure. The Student-Newman-Keuls' multiple range test 
was used to compare differences among means. Mean values and standard deviation of mean 
(STD) were reported. Significance was defined at P < 0.05. 
 
Results and Discussion 
pH adjustment on delipidation and IgY extraction  
  Lipid content of supernatant from egg yolk solution without pH adjustment (pH 6.0) 
was 1.0 %, whereas that adjusted to pH 5.0 was 0.08%. Also, there was a significant 
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difference in the turbidity of supernatant between pH adjusted and non-adjusted egg yolk 
solutions (Table 1). The low turbidity of supernatant from the pH-adjusted egg yolk solution 
was attributed to better delipidation at pH 5.0 than at pH 6.0. However, there was no 
significatnt difference in the amount of obtained IgY between pH-adjustment to 5.0 and 
control. Similar results were obtained by Chang et al. (2000) who reported that lowering pH 
value of water-soluble fraction of egg yolk from pH 6.0 to 5.0 resulted in a significant 
decrease in lipid content (from 6.0 ~ 7.5% to 1.6 ~ 7.5%). Akita and Nakai (1992) reported 
that the adjustment of pH to 5.0 and 10 time dilution of yolk was crucial in removing lipids 
or lipoproteins from the water-soluble fraction of egg yolk. They reported that 93 ~ 96% of 
IgY was recovered after pH adjustment of water-soluble fraction to 5.0 ~5.2 and lowering pH 
value of diluted egg yolk solution resulted in a water-soluble fraction with low turbidity.   
          Sugano and Watanabe (1961) reported that the solubility of lipoproteins at low ionic 
strengths decreased as the pH of water-soluble fraction was adjusted to pH 4.3. The pH of 
water-soluble fraction was the most important factor for IgY recovery because pH influenced 
the interactions between polysaccharides and proteins and the precipitation of 
polysaccharide-lipoprotein complexes (Gurov et al., 1983; Akita and Nakai, 1992; Samant et 
al., 1993). The protein contents of water-soluble fraction in both pH-adjusted and control  
were substantially underestimated because the Bradford’s dye-binding assay resulted in 
significantly lower readings for IgY than other methods (Sedmak and Grossberg 1977; 
Hansen et al., 1998). However, no significant difference in protein contents between pH-
adjusted and pH non-adjusted treatments were observed. Akita and Nakai (1992) reported 
that the water-soluble fraction of egg yolk solution was free of lipids at pH 4.6 and 5.2 range, 
but lipid contents increased at pH below and above this range. The pH of diluted egg yolk 
was 5.8 ~6.3 and increased during storage. As it is difficult to separate lipids or lipoproteins 
at this pH, pH adjustment to 5.0 prior to centrifugation is important to eliminate lipids.      
 
Temperature effect on extraction of water-soluble proteins  
          Egg yolk antibodies were separated by centrifuging diluted egg yolk after pH 
adjustment to 5.0. The volume of supernatant obtained from frozen (24 hrs) egg yolk solution 
was lower than that of the control and refrigerated solution, but the turbidity of supernatants 
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was the lowest among the treatments (Table 2). The amounts of IgY in supernatant obtained 
after incubation at different temperature conditions was not significantly different. Also, 
there were no significant differences in total amount of IgY. Kim and Nakai (1996) and 
Yokoyama et al. (1993) reported that incubation of diluted egg yolk solution at freezing (-20 
oC) or refrigeration temperature (4o C) was helpful in removing lipoproteins from water-
soluble fraction. Larsson et al. (1993) reported that IgY was stable for 5 years of storage at 
cold temperature (4o C) without changes in antibody activities. However, according to our 
result that IgY yield obtained from freezing indicated to be lower (Table 2), some IgY 
seemed to be precipitated and lost during freezing, probably due to irreversible aggregation 
under these conditions.  
 
Effect of NaCl in IgY precipitation 
As the concentration of NaCl in egg yolk solution increased, the turbidity of 
supernatants after centrifugation increased (Table 3). The IgY contents was not increased by 
the added NaCl. Kim and Nakai (1998) reported that addition of NaCl facilitated the 
separation of IgY from other proteins by polymerizing IgY molecules. Aggregation of IgY 
had no effect on Fab fragments of chicken antibody, but Fc fragments were precipitated by 
high salt concentration (Kubo and Benedict, 1969). Akita and Nakai (1992), however, 
reported that 0.16 M of NaCl resulted in an inhibitory effect in separating egg yolk granules 
from plasma proteins in diluted egg yolk solution, and the adverse effect of NaCl increased 
as the concentration of NaCl increased. In addition, if NaCl is added during extraction of IgY, 
dialysis step to remove the NaCl is necessary. Therefore, addition of salt to the diluted egg 
yolk solution would not be beneficial.   
 
Carrageenan and charcoal effect on IgY isolation 
Ultrafiltration is an important tool for the large-scale preparation of IgY from egg yolk 
by concentrating supernatant of egg yolk solution that contains IgY. However, lipids or 
lipoproteins in water-soluble fraction (supernatant) should be minimized to prevent clogging 
of ultrafiltration membrane and improve filtration efficiency. Charcoal and carrageenan 
decreased the amount of lipids or lipoproteins in water-soluble fraction of egg yolk. The 
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optimal conditions for the highest yield of IgY from the water-soluble fraction of egg yolk 
was removing lipoproteins using 0.02% of λ-carrageenan at pH 4.0 (Figs. 2 and 3) or 0.01% 
charcoal at pH 4.0 (Figs. 4 and 5). Chang et al. (2000) reported that 0.1% λ-carrageenan at 
pH 5.0 was the optimal conditions for the removal of lipoproteins from 6-fold-diluted egg 
yolk solution. However, our result indicated that the yield of IgY at pH 5.0 was lower than 
that at pH 4.0. This should be caused by the differences in dilution of egg yolk. Even though 
some researchers suggest that addition of λ-carrageenan resulted in effective delipidation of 
egg yolk solution (Hatta and Kim, 1990; Kim and Nakai, 1996), some IgY should be 
precipitated by electrostatic forces that occur from interactions between proteins and 
polysaccharides (Imeson et al., 1978). Addition of 0.01% charcoal at pH 4.0 produced the 
highest IgY yield among the carrageenan and charcoal treatments (Fig. 6).  
 
Cation exchange chromatography  
The purity of IgY solution obtained by cation exchange chromatography was not high 
and contained many egg yolk proteins other than IgY (Fig.7). MacCannel and Nakai (1989) 
used DEAE-Sephacel anion exchange chromatography to separate IgY from water-soluble 
fraction of egg yolk and found that the purity of IgY was 50 ~ 60%. The antibody preparation 
recovered by cation-exchange chromatography had 60 ~ 69% of purity (Fichtali et al., 1992; 
1993). Therefore, we assumed that there are some limitations such as low purity and 
efficiency when ion exchange chromatography is used to purify IgY. 
 
Ammonium sulfate precipitation 
The precipitation of IgY using 40% ammonium sulfate was influenced by pH of the 
solution, and the optimal conditions for the highest yield of IgY was at pH 9.0 (Fig. 8). The 
purity of IgY obtained after the second precipitation with the first precipitant using 40% 
ammonium sulfate at pH 9.0 appeared to be significantly high (Fig.9). This study 
demonstrates that 2-time precipitation of IgY using 40% ammonium sulfate at pH 9.0 
produced IgY with much higher purity than cation exchange chromatography, and the 
efficiency of IgY purification was greater than the cation exchange chromatography methods. 
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Akita and Nakai (1992) reported that use of 60% ammonium sulfate produced a high IgY 
recovery and removed contaminating proteins, especially 38 kDa and 53 kDa proteins.  
 
Recovery of IgY   
The recovery rates of IgY at each purification step are shown in Table 4. The protocol 
using ammonium sulfate (40%) and 0.01% charcoal was used for the recovery study. 
Addition of charcoal lowered the turbidity of supernatant by removing lipoprotein or lipids 
existing in the supernatant of egg yolk solution. This step caused no loss of IgY but speeded 
up the flow of ultrafiltration. About 20% of IgY was lost at ultrafilteration step, which 
removes proteins smaller than 50 kDa from the supernatant. Kim and Nakai (1998) also 
observed 15-20% loss in IgY by ultrafiltration. However, the percent loss of IgY can be 
reduced if larger volumes of supernatant are used for ultrafiltration. Kim and Nakai (1996) 
suggested that direct application of water-soluble fraction to ultrafiltration resulted in loss of 
IgY due to clogging of mucous lipoproteins on the membrane.  
The first precipitation of water-soluble fraction with 40% ammonium sulfate showed 
75% IgY recovery (Table 3). After second precipitation of IgY using 40% ammonium sulfate, 
however, resulted in 69% yield of IgY (Table 3 and Fig. 9). Even though 6% of IgY was lost 
at the second precipitation step, the purity of IgY increased significantly. Akita and Nakai 
(1992) used 60% ammonium sulfate precipitation for purification of IgY, which resulted in 
89% of IgY yield with 30% purity. Svendsen et al. (1995) used 25 ~ 45% of ammonium 
sulfate precipitation, which resulted in 58% yield of IgY with high purity. Most of the studies 
for purification or separation of specific proteins used combination methods adopting ion-
exchange or gel filtration chromatography for further purification after precipitation with 
ammonium sulfate at first step. However the protocol developed in this study depends largely 
on ammonium sulfate precipitation at pH 9.0 after charcoal addition to water-soluble fraction 
to remove extra lipoproteins. Ammonium sulfate precipitation produced IgY with higher 
purity and yield than HPLC (Stec et al., 2004) or ion exchange chromatography, and was 
suitable for a large scale IgY preparation from egg yolk particularly with minimal steps.   
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Conclusion 
Egg yolk cooled was diluted to 10 times and adjusted to pH 5.0, and then centrifuged 
at 4,000 rpm for 40 min. The supernatant was filtered with filter paper, or was added with 
0.01% activated charcoal or 0.02% carrageenan and then filtered. 0.01% charcoal treatment 
to water soluble egg yolk solution facilitates to reduce lipoprotein or lipid and then the 
solution became to be much clearer solution than that of carageenan. The water soluble 
fraction of egg yolk solution obtained after addition of charcoal following infiltration was 5 
times concentrated with interfering proteins during ultrafiltration processing. The 
concentrated water soluble fraction was purified either using an action ion exchange column 
or precipitation with 40% ammonium sulfate solution at pH 9.0. The recovery of IgY from 
action exchange chromatography was 30 ~ 40%, whereas that of ammonium sulfate 
precipitation was around 70 ~ 80%. The purity of IgY from ammonium sulfate precipitation 
method was higher than that from anion exchange chromatography. As ammonium sulfate 
precipitation method could handle larger volume at once time than ion exchange 
chromatography, the new procedure developed at this study using precipitation of IgY using 
40% ammonium sulfate and 0.01% charcoal is an economical and practical method for large-
scale purification of IgY from egg yolk. 
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Table 1. Changes of diluted egg yolk solution by pH adjustment to 5.0 
               
                                         Lipid (%)     Turbidity       Protein (mg/ml)   IgY (mg/ml) 
                                                                                                                                        
                                               
Control (pH 6.0)           1.00 ± 0.12 a    2.97 ± 0.15 a    0.41 ± 0.07a          0.82 ± 0.25a 
pH adjustment to 5.0    0.08 ± 0.02 b    0.33 ± 0.01b       0.51 ± 0.05 a      1.09 ± 0.34a  
                                        
a, bMeans within a column with no common superscript differ (P < 0.05). n = 4                                                                 
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Table 2. Turbidity and the yields of IgY obtained from water soluble fraction after 
centrifugation  
                
  Yield (%)* Turbidity (600nm) IgY (mg/ml) Total IgY** 
    (yield x IgY) 
                                                                                      
Control 77.03a 0.065a 1.11a 86.73a 
Refrigerator 78.23a 0.040b 1.12a 88.78a 
Freezing 72.03b 0.014c 1.24a 90.05a 
                               
a-cMeans within a column with no common superscript differ (P<0.05). 
*The volume of supernatant gained after centrifugation. n = 4. 
**IgY concentration x the volume of supernatant gained after centrifugation 
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Table 3. Changes of turbidity, protein and IgY content in adding NaCl to egg yolk water 
soluble fraction  
     
 Salt (%) Turbidity IgY (mg/ml) 
                                                                 
 0 0.07d ± 0.005 2.02a ± 0.18 
0.1 0.06d ± 0.01  2.20a ±0.36 
0.2 0.09cd ± 0.03 2.04a ± 0.20 
0.3 0.14c  ± 0.01 2.70a ± 0.35 
0.4 0.21b ± 0.01 2.57a ± 0.11 
0.5 0.51a ± 0.06 2.70a ± 0.32 
                                                                                          
 a-dmeans within a column with no common superscript differ (P < 0.05). n = 4. 
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Table 4. The yields of IgY obtained through each processing 
                  
Purification step                   IgY (mg/ml)     Vol. (ml)        Conc. x Vol.   Yield (%)  
                                         
Water soluble fraction         0.33 ± 0.03     3970 ± 32.5     1310 ± 101.6       100 
Charcoal and diafiltration    0.38 ± 0.01     3590 ± 28.3     1353 ± 27.4       103.5  
Ultrafiltration                      1.79 ± 0.10        590 ± 21.2     1056 ± 20.4        80.6 
Ammonium sulfate (1st)      7.95 ± 0.06        122 ± 5.6a        970 ± 14.8        74.1 
Ammonium sulfate (2nd)     15.9 ± 0.07          57 ± 3.8b         906 ± 5.5         69.2  
                                         
aThe volume obtained after addition of 100ml of distilled water to the precipitate gained by 
first precipitation of 40% ammonium sulfate following dialysis. 
bThe volume gained from addition of 45ml of distilled water to the precipitate after second 
cipitation following dialysis. n = 4 pre
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Fig 1. Schematic diagram for the isolation of IgY from egg yolk 
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Fig. 2. IgY content in water soluble fraction by addition of carrageenan following 
centrifugation. Bars with different letters indicate significantly different values 
 (p < 0.05, S.E = 0.17, n = 4). 
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Fig. 3. Changes of IgY content after adding 0.02% carrageenan to water soluble fraction of 
egg yolk in different pH conditions. Bars with different letters indicate significantly different 
values (p < 0.05, S.E = 0.35, n = 4). 
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Fig. 4. IgY content on each pH conditions in the addition of 0.01% charcoal addition to water 
soluble egg yolk protein solution. Bars with different letters indicate significantly different 
values (p < 0.05, S.E = 0.48, n = 4). 
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Fig. 5. Comparison of IgY yields on charcoal amount added to water soluble egg yolk protein 
solution. Bars with different letters indicate significantly different values (p < 0.05, S.E = 
0.16, n = 4). 
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Fig. 6. Comparison of IgY yields on the addition of different concentration of carrnageenan 
and 0.01% charcoal (Char*) to water soluble egg yolk protein solution. Bars with different 
letters indicate significantly different values (p < 0.05, S.E = 0.02, n = 4). 
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Fig. 7. SDS-PAGE patterns of egg yolk solutions obtained by cation ion exchange 
chromatography. 8ml of concentrated water soluble egg yolk solution by ultrafiltration were 
loaded on CM cellulose chromatography and the column was washed 20mM citrate 
phosphate buffer with pH 4.8, IgY was eluted by 200 mM citrate phosphate buffer with pH 
6.4. Lane 1: marker, 2: after loading, 3 ~8: washing, 9: elution    
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Fig. 8. Changes of IgY yields on each pH condition in precipitation of 40% ammonium 
sulfate with concentrated water soluble egg yolk solution by ultrafiltration 
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Fig. 9. SDS-PAGE patterns of sample fractions obtained from each steps including chicken 
centrifugation, ultrafiltration and 40% Ammonium sulfate precipitaion. Lane 1: Marker, 2: 
IgG, 4: after centrifugation of WSF, 5: addition of 0.01% charcoal following diafilteration, 6: 
after ultrafiltration, 7: after first precipitation by 40% ammonium sulfate at pH 9.0, 8: 2nd 
precipitation with ammounium sulfate   
 
 
 
 
 
 
 
   1     2     3     4     5     6      7     8 
IgY 
 
 88
CHAPTER 4. AN ECONOMIC AND SIMPLE PURIFICATION PROCEDURE FOR 
THE LARGE-SCALE PRODUCTION OF OVOTRANSFERRIN FROM EGG 
WHITE 
 
                                   A paper which will be submitted to Poultry Science 
 
K. Y. Ko1 and D. U. Ahn2 
 
Abstract 
The objective of this study was to develop a simple and economical protocol for 
separating ovotransferrin from egg white. Egg white was separated from whole egg and 
diluted with the same volume of distilled water. To prevent denaturation during separation 
process, ovotransferrin in 2x-diluted egg white was converted to holo-form by adding 20 mM 
FeCl3.6 H2O solution (0.25-3 ml/100 ml). The pH of egg white solution was adjusted to pH 
7.0, 8.0 or 9.0, and 50 mM-NaHCO3 and 0.15M-NaCl were added to facilitate iron binding 
to ovotransferrin. The iron-bound ovotransferrin was separated from other egg white usin
different concentrations of ethanol (30-50%). Ethanol at 43% (final concentration) and pH at 
9.0 was the best condition for separating iron-bound ovotransferrin from 2x-diluted egg 
white solution. Almost all egg white proteins including ovoalbumin were precipitated easily 
at 43% ethanol, but most of the iron-bound ovotransferrin remained in the supernatant. Holo-
ovotransferrin in the 43% ethanol solution started to precipitate as the concentration of 
ethanol increased and the optimal conditions for precipitating ovotransferrin occurred when 
the ethanol concentration reached to 59% (final). Final holo-form ovotransferrin solution was 
prepared by dissolving the precipitate with distilled water. AG1-X
g 
2 ion exchange resin, at 2x 
theoretical content of ovotransferrin, was used to remove iron bound to ovotransferrin after 
pH adjustment to 4.7 using 200 mM-citric acids. The apo-ovotransferrin separated using the 
protocol was 80% in purity and 94% in yield. The protocol developed is simple, economical 
and appropriate for a large-scale production of ovotransferrin from egg white. Also, the  
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 isolated ovotransferrin can be applied to human foods because the only solvent used in this 
process is ethanol. Furthermore, the AG1-X2 ion exchange resin and ethanol used in this 
process can be regenerated and recovered. 
 
Introduction 
Ovotransferrin is a major avian egg white protein that constitutes 12% of total egg 
white protein. It is a monomeric glycoprotein consisting of 686 amino acids with 15 disulfide 
bridges and has molecular weight of 76 kDa and pI of 6.1 (Abola et al., 1982; Stadelman and 
Cotterill, 1986). Ovotransferrin is composed of an N- and a C-terminal domain and one atom 
of transition metals such as Fe(III), Cu(III) and Al(III) can bind tightly within the 
interdomain cleft of each domain.  
A metal-free ovotransferrin (apo-form) is colorless and easily destroyed by physical 
and chemical treatments, whereas iron-bound ovotransferrin (holo-form) shows a salmon-
pink color and is stable to proteolytic hydrolysis and thermal denaturation (Azeri and Feeney, 
1958). Because most chemical reagents and denaturing conditions decrease the affinity of 
ovotransferrin for iron, particular spatial configuration of native ovotransferrin is needed for 
the formation of colored iron-bound ovotransferrin (Fraenkel-Conrat, 1950). The binding of 
iron to ovotransferrin requires 1 molecule of CO2 as CO32- or HCO3- per atom of Fe3+ 
(Warner and Weber, 1953) to overcome the effect of citrate, which can bind iron (Masson 
and Heremams, 1968). Reiter et al. (1975), however, reported that bicarbonate rather than pH 
is a critical factor for bacteriostatic capability of lactoferrin. 
         To release Fe3+ from ferric transferrin, a simple anion, such as pyrophosphate, sulfate, 
and chloride is required in vitro. The anion-induced Fe3+ release are closely related to the 
opening of a domain in either lobe (Baldwin et al., 1981; Cheuk et al., 1987; Bailey et al., 
1997). At acidic pH, the N-lobe of ovotransferrin displays lower iron-binding capacity and 
faster release of Fe3+ than the C-lobe. In the absence of NaHCO3, pH affects the efficiency of 
citrate-mediated release of Fe3+ from lactoferrin. Citrate-mediated Fe3+ release is more 
efficient at pH 6.8 than at pH 7.4 (Griffiths and Humphreys, 1977). Iron could be removed 
from iron-transport proteins at low pH (pH 4.5) in the presence of a large excess of citrate 
(Guo et al., 2003). Cunningham and Lineweaver (1965) reported that when holo-
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ovotransferrin solution was heated at pH 9, the protein was not altered significantly. 
However, ovotransferrin was denatured when the protein was exposed to a pH below 4.2, but 
the influence of pH was reversible under certain experimental conditions (Phelps and Cann, 
1956). 
Also, ovotransferrin can be separated from the egg white by aqueous and ethanol 
fractionation procedures (Bain and Deutsch, 1948; Warner and Weber, 1951), fractional 
precipitation with ammonium sulfate, or coagulating ovoalbumin (Warner, 1954; Azari and 
Baugh, 1967). However, the drawback of these techniques such as ammonium sulfate 
precipitation at acidic conditions and ethanol precipitation for purification of ovotransferrin 
denature ovotransferrin and the purity of products is relatively low (Vachier et al., 1995). In 
order to overcome these drawbacks from ethanol or ammonium sulfate precipitation, cation 
exchange chromatography such as CM-Cellulose (Rhodes et al., 1958; Azari and Baugh, 
1967), DEAE-cellulose anion exchange chromatography (Mandeles, 1960), and Q-Sepharose 
Fast Flow column (Vachier et al., 1995) were employed for purification of ovotransferrin 
from egg albumin. Guerin and Brule (1992) used a cation exchange chromatography on 
DUOLITE C464 and C476 from egg white devoid of lysozyme for industrial-scale 
production of ovotransferrin. Al-Mashikhi and Nakai (1987) used a single step 
chromatographic method using an immobilized metal affinity chromatography (a copper-
loaded Sepharose 6B column) to separate ovotransferrin from undiluted, blended egg white. 
Chung et al. (1991) used a bi-functional dye-ligand chromatography using DEAE Affi-Gel 
Blue, as the first step to fractionate egg white proteins. The fraction containing ovotransferrin 
obtained from DEAE Affi-Gel Blue, then was further purified by Fast Protein liquid 
chromatography. A two-step chromatographic procedure involving gel permeation on a 
Superose-6 Prep Grade column and anion-exchange chromatography on a Q-Superose Fast 
Flow was also employed (Awade et al., 1994).  
Recently, Ahlborn et al. (2006) separated ovotransferrin from egg white using Econo-
Pac® High S-Cation and High Q-Anion Exchange Cartridges. Even though ion-exchange 
chromatography or immobilized metal affinity chromatography have been developed on a 
laboratory scale, the application of these techniques on pilot-scale is difficult because these 
methods are labor-intensive and very expensive (Awade, 1996). 
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The objective of this study was to develop a simple and rapid procedure for an 
economical, large-scale production of ovotransferrin from egg white.  
 
Materials and Methods 
 
Materials 
Chicken eggs were purchased from a local store. Egg white was separated from egg 
and diluted with the same volume of distilled water. Two-times diluted egg white solution 
was blended for 2 minutes using an electric blender (speed: level 6, Kichen Aid, St. Joseph. 
MI. USA) and used as a starting material for ovotransferrin separation.  
 
Determination of FeCl3 concentration for iron saturation of egg white solution  
Because iron-saturated, holo-ovotransferrin is more stable to chemicals such as ethanol 
than the apo-form, the iron-free ovotransferrin in egg white solution was converted to iron-
bound form using FeCl3 solution. The pH of 2x-diluted egg white solution was adjusted to 
pH 7.0, 8.0, or 9.0 first, and then NaHCO3 and NaCl were added to make their 
concentrations in the egg white solution 50 mM and 0.15 M, respectively to help iron bindin
In order to determine the optimal concentration of FeCl
g. 
e 
fugation 
n was 
3
.6H2O for iron saturation, 0.25, 0.5, 
1.0, 2.0 or 3.0 ml of 20 mM-FeCl3.6 H2O solution was added to 2x-diluted egg whit
solution. Sufficient mixing was conducted for 1 hr at room temperature for complete iron 
saturation of egg white solution. Cold ethanol (43%, final concentration) was added to the 
iron-saturated egg white solution to extract iron-bound ovotransferrin and then centri
was performed under 3,220 x g for 20 min. After filtering the supernatant including iron-
bound ovotransferrin with Wathman filter papter No. 1, the iron-saturated ovotransferri
precipitated by addition of ethanol following centrifugation. The precipitate (holo-
ovotransferrin) was dissolved with 10 volumes of distilled water. The degree of iron 
saturation of egg white solution was estimated by measuring the optical density of the 
prepared solution at 468 nm since iron-bound ovotransferrin forms salmon-pink color (Azari 
and Feeney, 1958). That is, when there was no change of absorbance value, the solution was 
assumed to reach complete iron saturation.   
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Ethanol concentration for extraction and precipitation of Fe-ovotransferrin   
The egg white solution was stirred for 30 min at room temperature and then varying 
amounts of 100% cold ethanol (20%, 33%, 43%, and 50%, final concentrations) was added 
to isolate iron-bound ovotransferrin from iron-saturated egg white solution by denaturating 
and precipitating other egg white proteins such as ovoalbumin in the ethanol treatment. Holo-
ovotransferrin was separated from the iron satured egg white solution by centrifugation at 
3,220 x g for 20 min. The supernatants collected were filtered through Whatman No.1 filter 
paper to remove floating materials. After filtering, cold ethanol (100%), which correspons to 
be 53%, 56%, 59%, or 62%, was slowly added to aliquots of supernatant to precipitate iron-
bound ovotransferrin. The optimal ethanol concentration for extraction and precipitation of 
iron-bound ovotransferrin was estimated using SDS-PAGE.   
 
SDS-polyacrylamide gel electrophoresis  
          A 10% polyacrylamide separating gel (33% [vol/vol] acrylamide:N,N- bis-methylene 
acrylamide = 30% : 0.8% [wt/vol], 0.1% [wt/vol] SDS, 0.5% [vol/vol] TEMED, 0.05% 
[wt/vol] APS, and 0.38M Tris ·HCl, pH 8.8) was used for determination of egg white 
proteins under non-reducing conditions using Mini–PROTEAN II cell (Bio Rad, Richmond, 
CA). A 4% polyacrylamide gel (13.4% [vol/vol] Acrylamide: N,N-bis-methelyene 
acrylamide = 30% : 0.8% [wt/vol], 0.1% [wt/vol] SDS, 0.1% [vol/vol] TEMED, 0.05% 
[wt/vol] APS, and 0.125M Tris ·HCl, pH 6.8) was used for the stacking gel and coomassie 
brilliant blue R-250 staining was used. Broad-range SDS-PAGE molecular weight standards 
of 45 ~ 200 kDa (Bio-Rad, Richmond, CA) were used as a marker. The purity of protein was 
estimated by densitometric measurements using the AlphaEaseFC software (FluorChem 
8800, Alpha Innotech Corp.).  
 
Iron binding capacity 
The quantity of ovotransferrin was determined using iron binding capacity, which was 
measured by the modified method of Williams (1974). The calibration curve was obtained 
using a commercial ovotransferrin (sigma, Sigma-Aldrich, Inc., St. Louis, USA). 50 mM- 
NaHCO3 and 0.15 M-NaCl solution was added to the final apo-ovotransferrin solution to 
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support its iron binding capability and then its pH was adjusted to 8.0. After pH adjustment, 
0.4 ml of 10 mM Fe-nitriloacetate in 50 mM Tris-HCl at pH 8.0 was added to 20 ml of 
prepared iron-free ovotransferrin and then the solution was kept at room temperature for 1 
hour to develop color. Finally, iron binding capacity of the solution was determined by 
measuring absorbance at 468 nm. In order to eliminate trace amounts of metal contaminants, 
water used in all the procedures was treated with Chelex (Chelex-100 sodium form, Sigma-
Aldrich Inc., St. Louis, USA) according to the method reported by Willard et al. (1969). To 
determine the effect of pH on iron binding capacity of ovotransferrin, the pH of apo-form 
ovotransferrin solution was adjusted to pH 4, 5, 6, 7, 8, or 9, and then the iron binding 
capacity of each solution was measured by the same method described above. 
      
Removal of iron using AG1-X2 resin  
After separation of iron-bound ovotransferrin, iron-free ovotransferrin was produced 
by removing iron from iron saturated ovotransferrin using AG ®1-X2 resin (chloride form, 
Bio-Rad, California, U.S.A). Firstly, to facilitate the release of iron from holo-ovotransferrin, 
the pH of iron saturated ovotransferrin solution was adjusted to pH 4.7 using 200 mM-citric 
acid based on the suggestion of Guo et al. (2003): a large excess of citrate can remove iron 
from iron bound transferrin family proteins forming ferric citrate. 0.1, 0.2, 0.3, 0.6, or 0.9 g 
of AG ®1-X2 resin was added to 100 ml iron-bound ovotransferrin solution (6mg/ml). The 
mixture was gently stirred for 1 hour until the yellow color of ferric citrate completely 
disappears and filtered through a Whatman No.1 filter paper. After releasing iron, the 
residual iron in the solution was estimated by the Ferrozine test (Carter, 1971).  
Most of citric acid added at this step was assumed to be removed as a ferric citrate 
form. However, as some of citrate might remain in solution, dialysis (12kD membrane cut-off 
size) was conducted to remove residual citrate in presence of 20 mM-phosphate buffer, pH 
6.5. In addition, to know if a dialysis step is necessary or not, ovotransferrin and protein 
concentration of the solution obtained after dialysis were compared to that of the solution 
parepared without perfoming dialysis. The ovotransferrin concentration was determined by 
iron binding capacity, whereas the protein contents were estimated by Lowry method (Lowry 
et al, 1951) using prepared reagents (DC Protein Assay, Bio-Rad, Hercules, CA) 
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Ferrozine test 
After iron removal from holo-ovotransferrin, the amount of residual iron in 
ovotransferrin was measured using the Ferrozine method (Carter, 1971). All reactions were 
performed with disposable polyethylene vessels, which are essentially free of metal 
contamination. Aqueous solutions were prepared with deionized distilled water. Fresh 0.1%- 
ascorbic acid in 0.2 N-HCl (1 ml) was added to 1 ml of iron-free ovotransferrin solution and 
then the mixture was stirred and allowed to stand at room temperature for 5 min. TCA 
(11.3% solution, 1 ml) was added to the mixture and centrifuged at 2,500 x g for 10 min. 
Each standard iron solution under certain concentrations was prepared by serial dilution from 
100 ppm of Fe(NH4)2SO4.6H2O solution containing 50 ppm concentrated sulfuric acid with
distilled water. Ferrzine color reagent (0.8 ml), which was prepared with 75 mg ferroine, 75 
mg neocuproin, and 1 drop HCl in 25 ml distilled water, was added to 2 ml sample and 
standard iron solution, and then the mixture was stirred gently. Finally, the optical density of 
the sample was measured at 562 nm after standing for 5 min at room temperature.      
 
 
Yield of ovotransferrin 
To determine the yield of ovotransferrin, iron-bound ovotransferrin was extracted 
twice from iron-saturated egg white solution using 43% ethanol. The iron bound-
ovotransferrin in the supernatant obtained from the first extraction by 43% ethanol was 
precipitated with 59% ethanol (final concentration), whereas that of the second extraction 
was precipitated with 64% ethanol. The precipitates were dissolved with distilled water and 
then the iron bound to ovotransferrin was removed using AG1-X2 resin. After iron removal, 
the concentration of apo-ovotransferrrin from each supernatant was determined by measuring 
iron binding capacity.  
Also, after combining the first and second supernatants, the holo-ovotransferrin was 
precipitated with 59% ethanol to determine the total yield of apo-ovotransferrin produced by 
the protocol. In calculating the yield of apo-ovotransferrin, total amount of ovotransferrin in 
2 x-diluted egg white solution was assumed to be 100%. Also, therorectical value of 
ovotransferrin in egg white is estimated to be 14 mg/ml since ovotransferrin comprises 12% 
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of total egg white proteins (Abola et al., 1982), which are reported to be around 12% by Ahn 
and his co-workers (1997).  
 
Statistical analysis 
All procedures were replicated three times and data were analyzed using the JMP 
software (version 5.1.1; SAS Institute., Cary, NC). Differences in the mean values were 
compared by Tukey HSD, and mean values and standard deviations were reported (Kuehl, 
2000) 
 
Results and Discussion 
 
Effects of FeCl3 addition in ethanol treatment  
The yield of ovotransferrin was calculated by multiplying the concentration and 
volume of ovotransferrin. The obtained content of ovotransferrin was significantly different 
depending upon the amount of added FeCl3: addition of 0.4 mM and 0.6 mM-FeCl3.6H2O 
for iron saturation of diluted egg white solution produced higher absorbance at 468 nm th
those of lower concentrations of FeCl
an 
of apo-
 
g 
 
3
.6H2O. There was no significant difference in 
absorbance values at 468 nm between 0.4 mM and 0.6 mM-FeCl3.6H2O, indicating that all 
the apo-ovotransferrin in egg white solution was saturated by addition of 0.4 mM 
FeCl3.6H2O (Fig. 1). The theoretical amount of FeCl3.6H2O required for saturation 
form ovotransferrin in 2x-diluted egg white is around 0.2 mM because an ovotransferrin 
molecule can bind two iron molecules (Azari and Feeney, 1958). Therefore, addition of 0.02,
0.1, 0.2, 0.4, or 0.6 mM-FeCl3.6H2O to 2 times diluted egg white solution corresponds to 
provide 1/4, 1/2, 1, 2, or 3 times the iron theoretically required. Fraenkel-Conrat (1950) 
reported that particular spatial configuration of native ovotransferrin is required for the 
formation of colored iron-bound ovotransferrin and most chemical reagents and denaturin
conditions reduced the affinity of ovotransferrin to iron. As suggested by Azeri and Feeney 
(1958), the formation of holo-transferrin prevented denaturation of ovotransferrin in ethanol.
The result indicated that addition of FeCl3 was a critical step for the purification of 
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ovotransferrin using ethanol. Also this study confirmed the suggestion of Vachier et al. 
(1995) who reported that apo-ovotransferrin is denatured easily by ethanol.  
Addition of ethanol to diluted egg white solution without adding FeCl3 denatured apo-
ovotransferrin and co-precipitated with other proteins in egg white (Fig. l). Also, addition of 
0.4mM-FeCl3.6H2O to 2x diluted egg white solution was shown to be the most appropriate 
for iron saturation of ovotransferrin to prevent the loss of ovotransferrin during ethanol 
extraction.  
 
pH effect on iron biniding capacity and stability of holo-ovotransferrin in ETOH  
The pH of egg white solution had a significant effect on the recovery of the apo-
ovotransferrin during ethanol extraction (Table 1). Among the different pH conditions, pH 
9.0 allowed the highest recovery rate for ovotransferrin, which was around 96%. Even 
though iron saturation stabilized ovotransferrin by converting apo-form to holo-form, pH 9.0 
conditions was found to be the most appropriate for the stabilization of holo-ovotransferrin in 
ethanol treatment. This indicated that pH was also a critical factor for the stability of iron 
bound to ovotransferrin.      
Also, the effect of pH conditions on iron binding capacity of apo-ovotransferrin 
indicated that iron binds well with ovotransferrin at pH > 6.0, but iron binding capacity of 
ovotransferrin appeared to be decreased at < pH 6.0 (Fig. 2). It is known that pH conditions 
influenced the iron binding property of ovotransferrin. Griffiths and Humphreys (1977) 
reported that the N-domain of ovotransferrin displays lower iron-binding stability and more 
accelerated release of Fe3+ than the C-domain at acidic pH. Also, they showed that pH itself 
affects the efficiency of citrate-mediated release of Fe3+ from lactoferrin in the absence of 
NaHCO3. Based on these reports, pH is a critical factor for iron binding to native 
ovotransferrin and for appropriate iron binding of ovotransferrin, higher than pH 6.0 is 
required. Warner and Weber (1951) reported that even though ovotransferrin can be 
separated from egg white at any pH condition using ethanol, the intensity of salmon-pink 
color of iron-bound ovotransferrin solution decreased at < pH 5.5. However the color did not 
disappear until the pH was lower than < pH 4.0. Also Williams (1975) described that iron 
was bound preferentially to the N-terminal site at pH 8.0, but released at pH 5.0. At alkaline 
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pH conditions, iron was bound specifically at the N-terminal binding site, whereas iron 
binding occurs preferentially at C-terminal site in acid pH conditions (Williams et al., 1978).  
 
Extraction and precipitation of iron-bound ovotransferrin by ethanol  
SDS-PAGE gel electrophoresis indicated that when ethanol was added to egg white 
solution at a final concentration of 33%, many proteins besides ovotransferrin were not 
precipitated and remained in the supernatant. However, at 43% ethanol, most other proteins 
were found to be precipitated and only a small amount of ovotransferrin was precipitated. 
Also, at 50% ethanol, slightly larger amount of ovotransferrin was found to be precipitated 
than that of 43% ethanol (Fig. 3). Therefore, 43% ethanol was chosen as the most suitable 
condition to extract holo-ovotransferrins possessing high purity and yield from iron-saturated 
egg white solution.  
Iron-bound ovotransferrin in the supernatant was precipitated by ethanol addition and 
the amount of ovotransferrin that remained in the supernatant decreased as the amount of 
ethanol increased (Fig. 4). When 2.5 ml of ethanol was added to 5 ml supernatant 
(corresponding to 62% ethanol), most all the ovotransferrin in the supernatant was 
precipitated. However, for the production of ovotransferrin both with high purity and yield, 
adding 2 ml of ethanol to 5 ml of the supernatant obtained from 43% ethanol extraction (59% 
ethanol, final) was the most appropriate conditions for precipitating iron-bound 
ovotransferrin. 
 
Iron release from holo-form ovotransferrin 
When 0.6, or 0.9 g of AG ®1-X2 resin was added to 100 ml iron-bound ovotransferrin 
solution, residual iron content was 1.8 and 1.6 ppm respectively. Free iron or iron bound to 
ovotransferrin was removed completely by first addition of 0.6 g or 0.9 g of AG ®1-X2 resin, 
and thus a second iron releasing step by addition of 0.6 or 0.9 g of AG1-X2  resin was 
conducted. The content of residual iron in the solution after second iron removal was less 
than 0.5 ppm (Fig. 5). Therefore, the optimal conditions for AG ®1-X2 resin to release and 
remove iron from ovotransferrin was 2 times addition of 0.6 g of AG1-X2  resin to 100 ml of 
holo-form ovotransferrin solution. Considering the concentration of ovotrasnferrin solution 
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used in this study was around 6 mg/ml, the optimal ratio of AG ®1-X2  required for removing 
iron from holo-ovotransferrin was 2:1.  
Citrate was added in the holo-ovotransferrin solution because the release of Fe3+ from 
ferric transferrin requires presence of a simple anion, which should be closely related to 
opening of a domain in either C or N-lobe of ovotransferrin (Baldwin et al., 1981; Cheuk et 
al., 1987; Bailey et al., 1997). However, it is known that citrate binds iron (Masson and 
Heremans, 1968), and thus any residual citrate may result in underestimation of 
ovotransferrin by iron binding capacity method. In this study, citric acid was added to adjust 
the pH of holo-ovotransferrin to 4.7 and the added citric acid formed ferric citrate with iron. 
This study investigated if the dialysis as a mean to remove residual citrate is necessary 
because a part of citrate might remain in the solution even though most ferric citrate could be 
filtered. As a result, there was no significant difference in the concentrations of 
ovotransferrin and other proteins in the ovotransferrin solution before and after dialysis 
(Table 2). Therfore, the ferric citrate was found to be easily removed by AG1-X2 resin and 
dialysis was not necessary.      
 
Recovery and purity of ovotransferrin  
Iron-bound ovotransferrin (holo-form) in supernatant is stable at alkaline pH. When the 
pH of the solution was changed to 4.7 by citric acid for iron removal, however, most of the 
holo-form of ovotransferrin was changed to the apo-form. The apo-ovotransferrin formed in 
acidic conditions was denatured easily by ethanol in the solution. Therefore, it was 
impossible to measure the concentration of ovotransferrin in the supernatant containing 
ethanol, so the yield was measured only at the final stage where iron-bound ovotransferrin 
was precipitated with ethanol. The ethanol precipitate was dissolved with distilled water and 
used to determine the yield of ovotransferrin by measuring iron binding capacity. The 
amount of apo-ovotransferrin obtained from the first extraction by 43% ethanol was around 
75.3% of total ovotransferrin in egg white solution, while the second extraction recovered 
18.4% of total amount (Table 3). Also, total yield of ovotransferrin using the protocol in Fig. 
7 was around 94% (Table 4), indicating that almost all ovotransferrin in egg white was 
recovered through the ethanol extraction and precipitation method.  
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Also, as shown at Fig. 6, the purity of the separated ovotransferrin appeared to be 
around 80%. Ovoalbumin comprising about 50% of total egg white proteins displayed the 
broadest band on SDS-PAGE (Lane 3). Almost all ovotransferrin was precipitated by 59% of 
ethanol (Lane 6), but some ovotransferrin still remained in the supernatant (Lane 5). The 
purity of apo-form ovotransferrin solution appeared to increase through re-addition of 
ethanol to final holo-ovotransferrin prepared before iron removal. 
   
Conclusion 
Most of the ovotransferrin in the natural egg white exists in the apo-form. Thus, the 
conversion of apo-ovotransferrin to iron-bound form was the most critical step to reduce the 
loss or denaturation of ovotransferrin by ethanol. The amount of iron required to saturate all 
the ovotransferrin in egg white was about 2 times the theoretical amount to bind all of the 
apo-form of ovotransferrin. The holo-ovotransferrin in the presence of excess iron was more 
stable to ethanol treatment. At pH 9.0, the stability of iron binding in holo-ovotransferrin was 
significantly higher than at pH 7.0 or 8.0 during ethanol extraction and precipitation steps. 
The holo-ovotransferrin could be easily separated from iron-saturated egg white with 43% 
ethanol and precipitated at 59% ethanol. AG ®1-X2 ion exchange resin was excellent for iron 
removal from holo-ovotransferrin and the citric acid added for pH adjustment seemed to play 
a critical role in iron releasing from holo-ovotransferrin. The protocol developed is 
appropriate for a large–scale production of ovotransferrin because the recovery rate is 
excellent (94%), the product has relatively high purity (> 80% purity), and the purification 
steps are simple and economical because ethanol can be recovered and AG ®1-X2 ion 
exchange resin can be regenerated. The ovotransferrin produced by this method is applicable 
for food products because only ethanol was used to separate ovotransferrin from egg white. 
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Table 1. Effect of pH on the yield ovotransferrin from 2x-diluted egg white solution.  
                                         
        First supernatant1                        Second supernatant2                        Vol. x Conc.  
pH   Conc. (mg/ml)3  Vol. (ml)   Conc. (mg/ml) Vol. (ml)      (mg)                 Yield (%)* 
                                                                                        
 7  9.40ab ± 0.15 61.3a ± 1.26  2.48b ± 0.62  14.0ab ± 0.25  610.7ab ± 25.9   87.2 ± 3.57        
 8   8.94b ± 0.82  61.7a ± 2.08  2.82b ±1.00  13.7b ± 0.14   581.4b ± 32.2    83.1 ± 4.50 
 9  9.69a ± 0.08 62.3a± 0.29   6.62a ± 0.62 14.3a ± 0.14   671.5a ± 0.58    95.8 ± 0.15  
                                         
1The solution obtained from the first extraction with 43% ethanol.  
2The solution obtained from the second extraction with 43% ethanol  
3Final apo-ovotransferrin solutions free of ethanol and irons were used for measuring iron 
binding capacity.  
*The yields were calculated based on theorectical value (7.5 mg) of ovotransferrin in 2 times 
diluted egg white solution.  
a ~ bMean values with different superscript letters are significantly different (p < 0.05). n=3. 
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Table 2. The influence of citric acid on iron binding capacity of ovotransferrin.    
                                                                 
Treatment                 Protein (mg/ml)    Ovotransferrin (mg/ml)   Residual iron (ppm)1        
                                                
Without dialysis         8.59a ± 0.14              8.00a ± 0.57                   0.52a ± 0.08                                         
 Dialysis                      8.57a ± 0.17              8.42a ± 0.67                   0.53a ± 0.06        
                                                  
1The amount of iron remained in the solution after iron removal was measured.  
a Mean values with different superscript letters are significantly different (p < 0.05, n=3).  
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Table 3. The yields of each supernatant obtained by adding 43% ethanol to egg white 
solution. 
                                                                 
 Extraction    Conc. (mg/ml)     Vol. (ml)      Vol. x Conc. (mg)     Yield*(%)    
                                                         
First1         11.99 ± 0.23       43.95 ± 0.13       527.3 ± 8.64          75.3 ± 1.23                                     
 Second2      6.65 ± 0.37        19.32 ± 0.36       128.49 ± 1.80        18.4 ± 0.26         
                                                          
1 Ethanol was added to 100 ml of 2x-diluted egg white to make 43% ethanol (final)  
    and then the holo-ovotransferrin was precipitated by 59% ethanol (final). The holo-
ovotransferrin in precipitate was dissolved with distilled water (a half volume of 
supernatant obtained from 43% ethanol extraction). 
2 In second extraction, the holo-form of ovotransferrin in supernatant was precipitated  
  by 64% ethanol. n=3. 
*The yields were calculated based on theorectical value (700 mg) of ovotransferrin in  
  100ml of 2 times diluted egg white solution. 
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Table 4. The yield of final ovotransferrin solution separated by the developed method.  
                                                           
Sample             Conc. (mg/ml)     Vol. (ml)       Vol. x Conc. (mg)     Yield (%)    
                                                          
Egg white1               7.50                    100                   750                       100                                   
Final solution2     6.36 ± 0.37       103 ± 2.10      655.1 ± 45.53        93.58 ± 0.6  
                                                           
1The theorectical concentration of ovotransferrin in 2x-diluted egg white solution  
  used was 7.0 mg/ml.         
2Apo-ovotransferrin solution produced after iron removal. n=3 
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 Fig. 1. Effect of addition iron on extraction and precipitation of ovotransferrin with ethanol. 
Egg white solution contained 50 mM-NaHCO3 and 0.15 M-NaCl. Bars with different letters are 
significantly different (p < 0.05, n = 4). 
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Fig 2. Changes of iron binding capacity by different pH condition. The concentrations of 
ovotransferrin were determined using iron binding capacity. Bars with different letters are 
significantly different (p < 0.05, n = 4). 
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Fig. 3. SDS-PAGE of ovotransferrin solution obtained after addition of various 
concentrations of ethanol. Lane 1: diluted egg white, Lanes 2~5: supernatants obtained by 
20%, 33%, 43% and 50% of ethanol extraction, lanes 6~9: precipitates of 20%, 33%, 43%, 
and 50% of ethanol extraction    
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Fig. 4. SDS-PAGE of ovotransferrin solution obtained after addition of different 
concentrations of ethanol for precipitating holo-ovotransferrin in supernatant produced by 
first extraction. Lane 1: 2x-diluted egg white solution, lanes 2~5 : precipitates obtained after 
addition of 1 ml (53%, lane 2), 1.5 ml (56%, lane 3), 2 ml (59%, lane 4) and 2.5 ml (62%, 
lane 5) of ethanol to 5 ml of supernatant obtained by 43% ethanol extraction followed by 
dissolution of the precipitant with distilled water, lane 6~9: supernatant gained after adding 1 
ml (53%, lane 6), 1.5 ml (56%, lane 7), 2 ml (59%, lane 8) and 2.5 ml (62%, lane 9) of 
ethanol to 5 ml of supernatant.  
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Fig. 5. Amounts of residual iron in ovotransferrin solution after first and second treatments 
with AG1-X2 resin. The ovotransferrin concentration of the solution used at this study  
ovotransferrin was around 6.5 mg/ml. Bars with different letters indicate significant different 
values (p < 0.05, n = 4). 
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Fig. 6. Ovotransferrin purified from 2x-diluted egg white solution. Lane 1: marker, lane 2: 
empty, lane 3: 2x-diluted egg white, lane 4: first supernatant obtained after ethanol extraction 
from iron-bound egg white solution, lane 5: supernatant obtained after precipitation of 
ovotransferrin with ethanol from first supernatant, lane 6: final purified ovotransferrin 
dissolved in the distilled water after precipitation with ethanol.   
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Fig. 7. Schematic diagram for the isolation of ovotransferrin from egg white 
 
                Dilution of egg white with 1 volume distilled water  
                            
               Add NaHCO3, NaCl, and FeCl3 and adjust pH to 9.0 
 
  Stir for 30 min, add ethanol (43%, final), and centrifuge at 3,220 x g for 20 min 
                  
      
    Supernatant (1st)                                                     Precipitant 
                                                                                                Re-extract with 43% ethanol  
                                                                       Centrifugation at 3,220 x g, 20min 
                         
                                                                                  Supernatant (2nd) 
 
 
   Add ethanol (Supernatant: ethanol = 5: 2) and centrifuge 
 
                            Dissolve precipitant with distilled water   
 
                         pH adjustment to 4.7 with 200 mM citric acid 
 
                        Add AG1-X2 resin and stir for 1 hr and filter 
  
                                Repeat AG1-X2 resin treatment 
 
                                           Apo-ovotransferrin                   
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CHAPTER 5. Effect of Zn2+, sodium bicarbonate, and citric acid on the antibacterial 
activity of ovotransferrin against Escherichia coli O157:H7 and Listeria monocytogenes 
in model systems and hams 
 
                 A paper which will be submitted to Journal of Food Protection 
                                     K. Y. Ko1, D. U. Ahn2, H. A. Ismail, and A. Mendonca 
 
Abstract 
The influence of bicarbonate (NaHCO3) and citric acid on the antibacterial activity of 
apo-ovotransferrin in model systems and hams were investigated. The antibacterial activities 
of 20 mg/ml ovotransferrin solution added with NaHCO3 (0, 25, 50, or 100 mM) or citric 
acid (0.25% or 0.5%) were estimated against five different E. coli O157:H7 an
monocytogenes strains in BHI broth media. The antimicrobial properties of ovotransferrin 
saturated with Fe
d L. 
2+ or Zn2+ against E. coli O157:H7 and L. monocytogenes were also 
measured in vitro. In addition, ovotransferrin solutions containing either 100 mM-NaHCO3 
or 0.5% citric acid were applied to commercial hams inoculated with E. coli O157:H7 or L. 
monocytogenes. The antibacterial activities of each treatment were analyzed during 
refrigerator storage for 4 weeks. Antimicrobial activity of ovotransferrin increased as the 
concentration of added sodium bicarbonate increased. 100 mM-NaHCO3 promoted the 
antibacterial activity of ovotransferrin against E. coli O157:H7 and L. monocytogenes 
significantly. L. monocytogenes was shown to be susceptible to 0.5% citric acid alone, 
whereas 0.5% citric acid enhanced the antibacterial activity of ovotransferrin against E. coli 
O157:H7. NaHCO3 addition annulled the strong antibacterial activity of ovotransferrin plus 
citric acid against E. coli O157:H7 and using sodium citrate instead of citric acid did not 
show any antibacterial activity against the two bacterial species. The antimicrobial activity of 
ovotransferrin increased significantly by acidic conditions. Unlike the model system, the  
 
1 Primary researcher and author 
2 Author of correspondence. 
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antibacterial activity of ovotransferrin added with either 100 mM-NaHCO3 or 0.5% citric 
acid was not detected on ham. Zn-bound ovotransferrin prevented the growth of L. 
monocytogenes but not E.coli O157:H7 as did apo-ovotransferrin combined with 100 mM-
NaHCO3. Also, Fe-bound ovotransferrin had little or no antibacterial activity against E. coli 
O157:H7 and L. monocytogenes in BHI broth culture. This study described that certain 
concentrations of bicarbonate and citric acid improved the antibacterial activity of 
ovotransferrin and Zn2+ improved the antibacterial capacity of natural ovotransferrin against 
certain pathogens. However, the study also suggested that there are many limitations for 
applying ovotransferrin directly to meat or meat products in contrast to model systems.     
 
Introduction 
          Ovotransferrin is a monomeric glycoprotein consisting of 686 amino acids with 78 kDa 
molecular weight, has no free sulfhydryl groups or phosphorus, and binds reversibly with 
two Fe2+ ions per molecule concomitantly with two CO2- ions (Abola et al., 1982; Stadelman 
and Cotterill, 1986; Aisen and Listowsky, 1980; Ibrahim, 1997). It is identified as the second 
major avian egg white protein constituting 12% of total egg white protein and contributes to 
the egg’s defense against microbial infection and rotting (Abola et al., 1982). Ovotransferrin 
has demonstrated antibacterial activity against a wide spectrum of bacteria, including, 
Escherichia coli (Shade and Carolin, 1944; Valenti et al., 1983a), Pseudomonas spp., 
Streptococcus mutans (Valenti et al., 1983a), Staphylococcus aureus, Bacillus cereus 
(Ibrahim, 1997), Salmonella enteritidis (Baron et al., 1997; 2000), and Candida (Valenti et al. 
1985). The antimicrobial activity of ovotransferrin is influenced by several factors such as 
bicarbonate and citrate concentrations, pH conditions, composition of medium or metal irons 
like Zn2+ as well as bacterial species or strains (Valenti et al., 1981, 1983a, 1987; Brock, 
1985). Bicarbonate known as a synergistic anion (Schalabach and Bates, 1975) is a 
prerequisite for the iron uptake of transferrin and lactoferrin (Aisen, 1989; Pakdaman and 
Elhage Chahine, 1996; Pakdaman et al., 1998) because it prevents iron binding by citrate 
(Griffiths and Humphereys, 1977; Peaker and Linzell, 1975). The anion may serve as a 
bridging ligand between proteins and metal ions (Aisen, 1980). Bicarbonate weakly binds to 
apo-transferrin in the absence of a metal ion (Woodworth, 1975), but it is not known if the 
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binding is specific. The affinity of ovotransferrin for bicarbonate in each lobe is about three-
fold weaker than that of serum transferrin (Bellounis et al., 1996; Pakdaman and El Hage 
Chahine, 1997). Also, bicarbonate or carbonate (CO32- or HCO3-) occupies one of 
Fe3+coordination sites consisting of four lateral chains with two tyrosines, one histidine, one 
aspartate, and a carbonate or bicarbonate (Bailey et al, 1988; Andeson et al., 1989; Zuccola, 
1992; Kurokawa et al., 1995: Rawas et al., 1996). 
An excess of citrate can annul the antimicrobial activity of ovotransferrin by chelating 
iron, and thus the iron binding capacity of ovotransferrin is affected by metal chelates such as 
citrate (Valenti et al., 1983a; Phelpa and Antonini, 1975). However, it is also well known that 
the effect of citrate on antibacterial activity of ovotransferrin depends on the species of 
microorganism. For example, E. coli possessing iron transport system mediated by citrate 
(Frost and Rosemberg, 1973) can annul the antibacterial activity, whereas the addition of 
excess citrate does not influence the antimicrobial activity of ovotransferrin against S. aureus 
and Candida, which do not have an iron citrate transport system (Valenti et al., 1980; Valenti 
et al., 1985). 
As ovotransferrin can bind metal ions such as Cu, Al, Zn, and Fe, the antimicrobial 
effect of ovotransferrin is expected to decrease by binding other metal ions. Generally, iron, 
copper, and zinc bind the same sites in the ovotransferrin molecules (Warner and Weber, 
1953). However, in some studies ovotransferrin saturated with metals such as zinc and iron 
still displayed antimicrobial activities (Ibrahim, 1997; Valenti et al., 1985, 1987). Valenti et 
al. (1987) reported that Zn2+-loaded ovotransferrin had more bactericidal activity than apo-
ovotransferrin and other metal complexes, and the antimicrobial effect of Zn2+-ovotransferrin 
was attributed to the direct interaction of Zn2+-ovotransferrin with the surface of bacteria 
rather than iron deprivation from medium. However, other researchers reported that the cause 
of antibacterial action of ovotransferrin is due to more complex mechanisms related to direct 
interaction between ovotransferrin and microorganisms in addition to iron deprivation 
(Valenti et al., 1985).  
Ovotransferrin has a great potential as a natural antimicrobial agent like lactoferrin. 
However, no attempt has been used to study the control of pathogenic and nonpathogenic 
microorganisms in meat or other food processings using ovotransferrin. To identify the 
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possibility of ovotransferrin utilization as an antibacterial agent in meat, methods to activate 
or improve antimicrobial capability of natural apo-ovotransferrin against E. coli O157:H7 
and L. monocytogenes are required. In this study, the influences of bicarbonate and citric acid 
as synergistic anions on the antibacterial activity of apo-ovotransferrin were investigated. 
Also, ovotransferrin combined with bicarbonate and citric acid was applied to ham to 
determine the possibility of using ovotransferrin as a natural antimicrobial agent in meat 
processing.   
            
Materials and Methods 
 
Ovotransferrin 
Apo-ovotransferrin used in this study was produced by the method of Ko and Ahn 
(2007, not published). After iron saturation of 2x-diluted egg white solution, holo-
ovotransferrin (iron-free form) was separated from the egg white solution. Apo-
ovotransferrin was obtained by removing iron bound to holo-ovotransferrin using AG ®1-X2 
resin (chloride form, Bio-Rad, California, U.S.A). The apo-ovotransferrin was freeze-dried 
and used for microbial experiments. The dried apo-ovotransferrin was dissolved in distilled 
water, the pH adjusted to 7.4, and NaCl added to 0.15 M. The purity of prepared 
ovotransferrin was around 80% and the content of residual iron in the prepared apo-
ovotransferrin solution was less than 0.5 ppm. Prior to using it in microbial study, it was 
sterilized by 0.22 μm syringe filter (Whatman Inc. Florbam Park, NJ. USA)  
 
Bacterial strains and growth conditions 
Five strains of E. coli O157:H7 (ATCC 43890, C467, FRIK 125, ATCC 43895, and 
93-062) and five strains of L. monocytogenes (NADC 2045, H7962, H7969, H7762, H7596) 
were used. The pathogens were obtained from the microbiology laboratory of Food Science 
Department at Iowa State University. To activate inocula, E. coli O157: H7 and L. 
monocytogenes strains were individually cultured two times in brain heart infusion broths 
(BHI, Remel Inc., Lenexa, KS, USA) for 24 hours at 35oC. The bacteria were grown to 
stationary or mid-log phase and harvested. Each culture solution (5 ml) was collected in a 
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sterilized centrifuge tube and centrifuged (100,000 x g for 10 min) at 4o C. The pellets for all 
E. coli strains were combined, washed with saline, and re-suspended in 25 ml saline to have 
approximately the same number of each strain in the cocktail. The pellets for all L. 
monocytogenes strains were treated the same. The following method was used to determine 
the number of bacteria used in each experiment: after serial dilution with a 1-ml aliquot of 
the suspension into 0.1% peptone water (Difco Laboratories, Detroit, MI), 0.1 ml of 
appropriate diluted solution was distributed on the BHI agar media. After incubating at 35oC 
for 24 ~ 48 hr, the numbers of E. coil O157:H7 and L. monocytogenes colonies appearing on 
the BHI agar plates were counted. 
 
Sodium bicarbonate effect  
Preliminary disc diffusion experiment (Bauer et al, 1966) was performed using 
ovotransferrin (5, 10, 15, or 20 mg/ml) and NaHCO3 (30, 40, or 50 mM) combinations to 
determine a minimum concentration of ovotransferrin showing antibacterial activity against 
E. coli O157:H7 and L. monocytogenes on BHI agar plates. Ovotransferrin without sodium 
bicarbonate did not show any antibacterial activity, but 15 or 20 mg/ml of ovotransferrin 
combined with 40 mM- and 50 mM-sodium bicarbonate showed some antibacterial activity 
against E. coli O157:H7 and L. monocytogenes on BHI agar plates. Therefore, 20 mg/ml 
(final) of ovotransferrin solution was used to determine the effect of sodium bicarbonate on 
antibacterial activity of ovotransferrin in this study. After preparing sterilized ovotransferrin 
(40 mg/ml), the same volume of 2x strength BHI broth and then 2 M-sterilized NaHCO3 
solution were added to make the final concentration of bicarbonate 0, 25, 50, or 100 mM in 
the solution. Also, 103 ~ 104 CFU/ml of E. coli O157:H7 and L. monocytogenes were 
inoculated into the sterilized BHI broth media containing ovotransferrin and sodium 
bicarbonate. After inoculation, the broth culture was incubated at 35oC for 1-8 days and the 
antibacterial capacity of each treatment against E. coli O157:H7 and L. monocytogenes was 
estimated by measuring the turbidity of BHI broth culture at 620 nm.   
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Citric acid and citrate effect   
As some microbial strains possess an iron transport system mediated by citrate (Frost 
and Rosemberg, 1973), the presence of citrate may inhibit the antibacterial activity of 
ovotransferrin. So, the effect of citrate or citric acid on the antibacterial activity of 
ovotransferrin was investigated. Apo-ovotransferrin solution (40 mg/ml) was added to the 
same volume of 2 x-concentrated BHI broth. Stock citric acid solution was added to the BHI 
broth to make the ovotransferrin solution with 0.25% or 0.5% citric acid. BHI broth culture 
with citric acid (but with no ovotransferrin) was inoculated with strains and used as a control. 
Also, 25 mM sodium citrate, equivalent to 0.5% citric acid, was added to the BHI broth 
containing ovotransferrin to determine if the effect of citric acid on antibacterial activity of 
ovotransferrin is due to acidic pH or the function of synergistic anions. Activated E. coli 
O157:H7 and L. monocytogenes at 104 ~ 105 CFU/ml were inoculated aseptically to each 
BHI broth culture. After mixing the broth culture, they were incubated at 35oC. An aliquot (1 
ml) of the culture solution was serially diluted with 0.1% peptone water and 0.1 ml of each 
serially diluted solution was spread homogenously on the BHI agar plate. The viable cells 
were enumerated after incubating the BHI agar plates at 35oC for 24 ~ 48 hrs.  
 
Antimicrobial activity of apo-, Fe-, and Zn-ovotransferrin  
         The content of residual iron in apo-ovotransferrin used in this study was around 0.38 
ppm. To saturate the apo-ovotransferrin with Fe3+ or Zn2+, 0.15 ml of 0.2 M-FeCl3.6H2O  or 
0.16 ml of 0.2 M ZnCl2 was added to 30 ml of ovotransferrin solution (40 mg /ml) including  
50 mM-NaHCO3 solution at pH 7.4 since one ovotransferrin molecule with 80 kDa binds 2 
metal ions. After adding FeCl3 or ZnCl2 to ovotransferrin solution, the prepared solutions 
were incubated at room teperature for 2 ~ 3 hours for complete saturation and then dialysis   
(12kD membrane cut-off size) was conducted to remove sodium bicarbonate. After preparing 
the iron or zinc-saturated ovotransferrin, Zn-ovotransferrin, Fe-ovotransferrin, and apo-
ovotransferrin solutions were added with the same volume of 2 x -concentrated BHI broth 
culture, 50 mM- and 100 mM-NaHCO3 were added, and then 104 ~ 105 CFU/ml E. coli 
O15:H7 or L. monocytogenes strains were inoculated. The treatments were serially diluted in 
sterile 0.1% peptone water and were surface spread (0.1ml, in duplicate) on the BHI agar 
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media. After incubation at 35oC for 24 ~ 48hrs, the viable cells of E. coli O157:H7 and L. 
monocytogenes from each treatment were enumerated.   
 
Antibacterial activity of ovotransferrin with citric acid or NaHCO3 on ham   
Commercial hams were purchased from local retail stores. Hams were sliced to 0.2 
cm-thickness and vacuum packaged (-1 bar of vacuum with 10 seconds dwell time) in low 
oxygen-permeable bags (nylon/polyethylene, 9.3 ml O2/m2/24 hr at 0oC; Koch, Kansas City, 
MO). After randomly separating the sliced hams into two groups and irradiated at 0 or 5 kGy 
using a Linear Accelerator (Circe IIIR; Thomason CSF Linac, Saint-Aubin France). The 
energy and power level were 10 Mev and 10 kW respectively, and the average dose rate was 
88.3 kGy/min. To confirm the target dose, 2 alanine dosimeters per cart were attached to the 
top and bottom surface of a sample. The alanine dosimeter was read using a 104 Electron 
Paramagnetic Resonance Instrument (Bruker Instruments Inc., Billerica, MA). After 
irradiation, the irradiated and non-irradiated hams were transferred to microbiology lab and 
stored at 4oC. E. coli O157:H7 and L. monocytogenes stock suspension (0.1 ml) were 
inoculated aseptically on the surface of a sliced ham to have the number of cells at 106 
CFU/cm2. After inoculated ham samples were manually mixed for 30 second to distribute the 
inocula evenly, the packaged samples were further separated into 3 groups. One ml of 
ovotransferrin solutions (20 mg/ml) containing 100 mM-NaHCO3 or 0.5% of citric acid was 
distributed evenly on the same surface of sliced ham as in the inoculation step, vacuum-
packaged (1 slice per bag, Multivac A300/16, Sepp Haggenmuller KG, Wlfertschwenden, 
Germany) in nylon-polyethylen bags, and stored in a refrigerator. 
The surviving bacteria wwa enumerated after incubating ham samples for 0, 5, 10, 15, 
22, 29 and 34 days at 4oC. Each package was aseptically opened using alcohol-sterilized 
scissors. Sterile 0.1% peptone water (30 ~ 50 ml) was added to each bag and then processed 
at normal speed for 1 minute in a stomacher. Samples were serially diluted with 0.1% 
peptone water and 0.1 ml of the diluted E. coli O157:H7 culture solution was spread on a 
MacConkey sorbitol agar (Difco Laboratories, Detroit, MI), whereas those of L. 
monocytogenes were spread on a MOX media. The number of viable E. coli O157:H7 and L. 
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monocytogenes cells appeared on MacConkey sorbitol agar and MOX media were 
enumerated after incubation for 24 ~ 48 hr at 35oC.  
 
Statistical analysis 
All work was replicated three times and data were analyzed using the JMP software 
(version 5.1.1; SAS Institute., Cary, NC). The differences in the mean values were compared 
by Tukey HSD, and mean values and standard error of the mean (SEM) were reported (Kuehl, 
2000). If a significant F-value was obtained (p < 0.05), the Tukey-Kramer test was performed 
to determine whether the means of treatments were different from control. Statistical 
significance for all comparisons was set at p < 0.05.  
 
Results and Discussion 
 
Antibacterial activity of natural apo-ovotransferrin 
Natural apo-ovotransferrin showed a weak antibacterial property against E. coli 
O157:H7 (Fig. 1A), but its antimicrobial activities against L. monocytogenes were apparent 
after 4 days of refrigerated storage (Fig. 1B). The antibacterial activity of natural apo-
ovotransferrin varied with microorganisms. Valenti et al. (1983a) reported that Pseudomonas 
spp., E. coli, and Streptococcus mutans were susceptible, whereas Staphylococcus aureus, 
Proteus spp., and Klebsiella spp. were relatively resistant to ovotransferrin. Activated 
lactoferrin is reported to have higher antibacterial effectiveness toward L. monocytogenes 
than that of E. coli O157:H7 (http://www.newswise.com/articles/view/525381). Like 
antibacterial activity of lactoferrin, apo-ovotransferrin was more effective in inhibiting the 
growth of L. monocytogenes than E. coli O157:H7. 
 
Sodium bicarbonate  
The influence of NaHCO3 against the growth of E. coli O157:H7 and L. 
monocytogenes was investigated before identifying its synergistic effect with ovotransferrin. 
The turbidity of BHI broth culture with E. coli O157:H7 decreased as the concentration of 
NaHCO3 increased. However, considering the value of turbidity 100 mM-NaHCO3 alone 
 
 122
was around 0.6 from 2 days (Fig. 1A), the solution was demonstrated not to restrain the 
growth of E. coli O157:H7. Corral et al. (1988) reported that 120 mM (1% w/v) sodium 
bicarbonate reduced the number of E. coli in stationary phase by 4 log through the
physicochemical environment of the microorganisms. Our result, however, indicated that E. 
coli O157:H7 was relatively resistant to NaHCO
 changes in 
3 probably because we used five different 
strains of E. coli O157:H7, which have different susceptibility against NaHCO3 and high 
adaptation capability by activation.    
In contrast to E. coli O157:H7, the turbidity of BHI broth culture with L. 
monocytogenes increased as the concentration of sodium bicarbonate increased. The 100 
mM-sodium bicarbonate treatment had higer turbidity value than that of 25 mM or 50 mM 
sodium bicarbonate (Fig. 1B). Czuprynski and Faith (2002) reported that 50 μl of 10% 
sodium bicarbonate (wt/vol) enhanced the virulence of L. monocytogenes EGD or L. 
monocytogenes strain Scott A in mice. These results indicated that L. monocytogenes strains 
are less susceptible to sodium bicarbonate than and E. coli O157:H7. Especially 100 mM-
sodium bicarbonate alone seemed to support the growth of L. monocytogenes after 4 day 
incubation compared with turbidity of control.  
 
Sodium bicarbonate on antibacterial activity of ovotransferrin 
Sodium bicarbonate (25, 50 or 100 mM) was added to BHI broth containing apo-
ovotransferrin to improve its antibacterial activity against E. coli O157:H7 and L. 
monocytogenes. The antibacterial activity of ovotransferrin plus NaHCO3 depended on the 
concentration of sodium bicarbonate added (Fig. 1). As the concentration of sodium 
bicarbonate increased, antimicrobial activity of ovotransferrin plus NaHCO3 increased. 
According to many reports, Fe3+-specific binding capacity of transferrin is promoted at 
constant pH as the concentration of bicarbonate increased (Abdallah and EL Hage Chahine, 
1998; Workman et al., 1975 Aisen, 1989; Pakdaman and El Hage Chahine, 1997). Like 
transferrin, sodium bicarbonate increased the antibacterial effect of apo-ovotransferrin 
against E. coli O157:H7 and L. monocytogenes. Also, with E. coli O157:H7, the turbidity of 
ovotransferrin solutions containing NaHCO3 was lower than that of apo-ovotransferrin or 
NaHCO3 alone (Fig. 1A). This result indicated that sodium bicarbonate promoted the 
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antibacterial activity of apo-ovotransferrin against E. coli O157:H7. The combination of 
ovotransferrin with 100 mM sodium bicarbonate was the best condition for inhibiting the 
growth of E. coli O157:H7. Ovotransferrin added with 25 mM- or 50 mM- sodium 
bicarbonate did not completely inhibit the growth of L. monocytogenes until 4 days of 
incubation, whereas ovotransferrin containing 100 mM-NaHCO3 prevented the growth of L. 
monocytogenes. There was an apparent synergistic effect of 100 mM-NaHCO3 on the 
antimicrobial activity of apo-ovotransferrin against L. monocytogenes (Fig. 1B). Considering 
ovotransferrin plus 100 mM-NaHCO3 has the lowest turbidity value in two strains (Fig 1), 
100 mM-NaHCO3 was the most appropriate concentration to improve the antibacterial 
activity of apo-ovotrasnferrin against E. coli O157:H7 and L. monocytogenes. 
Carbonate anions interact directly with the complex of transferrin- or lactoferrin-bound 
metals such as iron and copper (Eaton et al., 1990). Apo-transferrin is also known to interact 
with two HCO3- or CO32-, and the carbonic ion is considered to result in ionic interactions 
with arginine residues of certain side chain in binding sites of its two lobes (Bellounis et al., 
1996; Pakdaman et al, 1998). NaHCO3 at 50 mM increased the antibacterial activity of 
ovotransferrin against E. coli W1485, whereas ovotransferrin without NaHCO3 did not show 
antibacterial activity (Valenti et al., 1983a). The present study suggests that a certain 
concentration of sodium bicarbonate can increase the antibacterial effectiveness of 
ovotransferrin toward E. coli O157:H7 and L. monocytogenes. 
 
Citric acid alone effect 
The effects of citric acid alone on the growth of E. coli O157:H7 and L. 
monocytogenes were different: L. monocytogenes was more sensitive to citric acid than E. 
coli O157:H7 (Fig. 2.). Also, the antibacterial activity of citric acid depended upon the 
concentration of citric acid. Citric acid at 0.5% showed a much greater antibacterial activity 
than 0.25% citric acid aginst two pathogens. Also, 0.5% citric acid alone did not completely 
inhibit the growth of E. coli O157:H7, even though the number of viable cells of 0.5% citric 
acid alone indicated to be lower than that of control or ovotransferrin itself after 2days of 
incubation at 35oC (Table 1 and Fig. 2A). Also in L. monocytogenes, 0.5% citric acid resulted 
in around 1 log reduction of viable L. monocytogenes cells from inoculated cells (104 
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CFU/ml) after 2 days of incubation (Table 2 and Fig. 2B). At the present study, citric acid 
showed stronger antibacterial activities against L. monocytogenes than E. coli O157:H7.  
Through this study, we found that L. monocytogenes are susceptible to 0.5% citric acid itself.    
 
Citric acid and citrate effect on antibacterial activity of ovotransferrin   
Even though ovotransferrin plus 0.25% citric acid did not show antibacterial activity, 
0.5% citric acid plus ovotransferrin appeared to be bactericidal against E. coli O157:H7 cells  
(Table 1 and Fig. 2A). 0.5% citric acid was found not to inhibit completely the growth of E. 
coli O157:H7, ovotransferrin plus 0.5% citric acid indicated to be 1 log reduction from the 
viable cell number inoculated initially against E. coli O157:H7. Therefore, 0.5% citric acid 
seems to enhanc the antibacterial activity of ovotransferrin against E. coli O157:H7. 
Also ovotransferrin plus 0.25% citric acid did not show significant difference from 
0.25% citric acid alone in bactericidal effect against L. monocytogenes after 2 days of 
incubation at 35oC. Also, 0.5% citric acid alone and ovotransferrin plus 0.5% citric acid 
showed bactericidal effect against L. monocytogenes after 2days of incubation at 35oC (Table 
2 and Fig. 2B). In contrast to E. coli O157:H7, 0.5% citric acid did not enhance antibacterial 
activity of ovotransferrin against L. monocytogenes since there was no significant difference 
in the number of viable cells between 0.5% citric acid alone and 0.5% citric acid plus 
ovotransferrin (Fig. 2B).  
In addition, the antibacterial activities of apo-ovotransferrin plus citric acid against E. 
coli O157:H7 and L. monocytogenes were lost in the presence of 50 mM-NaHCO3. The 
number of viable cells in ovotransferrin plus 0.5% citrate solution in the presence of 50 mM-
NaHCO3 was similar to that of ovotransferrin with 50 mM-NaHCO3 in both pathogens. Also 
the present study indicated that ovotransferrin plus 25 mM-sodium citrate solution did not 
inhibit the growth of the two pathogens in contrast to ovotransferrin plus 0.5% citric acid 
(Tables 1 and 2).  
     Bishop et al. (1976) report that as the molar ratio of citrate to apo-lactoferrin increased, 
the antibacterial capacity of apo-lactoferrin toward coli form bacteria decreased. Reiter et al. 
(1975) reported that the presence of citrate in bovine colostrum counteracted the antibacterial 
effectiveness of lactoferrin against E. coli. Lee et al. (2001, 2002) reported that sodium 
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citrate has strong antimicrobial effects against gram-positive bacteria, but has a weak 
antibacterial activity against gram-negative microorganisms. Also, Frost and Rosemberg 
(1973) reported that an excess of citrate annulled the antibacterial activity of ovotransferrin 
against E. coli O157:H7 because it possesses an iron transport system mediated by citrate. 
Futhermore, an anionic chelating by citrate occurred at high pH values. As one iron molecule 
binds two citrate molecules, the iron binding capacity by ovotransferrin is affected by the 
metal chelater (Phelpa and Antonini, 1975). The effect of sodium citrate on antibacterial 
effectiveness of ovotransferrin is dependent upon its concentration. The growth of E. coli 
was inhibited less in the presence of 50 mM-sodium citrate than 10 mM-sodium citrate 
(Valenti et al., 1983a). The iron release of transferrin is faster in the presence of citrate than 
formate or acetate because citrate interacts with decarbonated monoferric proteins with high 
affinity.  
Generally, iron binding capacity of ovotransferrin is known to decrease under acidic 
pH (Warner and Weber, 1953, Williams et al, 1978; Butterworth et al., 1975). As 0.5% citric 
acid reduces the pH of ovotransferrin solution to around 4 ~ 5, the antibacterial activity of 
ovotransferrin should be decreased due to its low iron binding capacity. However, this study 
indicated that 0.5% citric acid enhanced the antibacterial activity of ovotransferrin against E. 
coli O157:H7. Ovotransferrin plus 25 mM sodium citrate did not show any antibacterial 
activity against the two pathogens, and NaHCO3 annulled the antimicrobial activity of 
ovotransferrin plus 0.5% citric acid. Considering these results, the antimicrobial action of 
ovotransferrin seemed to be enhanced by acidic pH conditions.  
Activated lactoferrin is reported to interact directly with bacterial membrane materials 
including lipopolysaccharides (Elass-Rochard et al., 1995; Appelmelk et al, 1994), 
glycosaminoglycans (Mann et al., 1994), and cell-type-specific receptors on epithelial and 
immune cells (Ward et al., 2002; Brock, 2002, Suzuki et al., 2002; Baveye et al., 1999). Also, 
specific binding of activated lactoferrin against outer membrane proteins of gram-negative 
bacteria can lead to inhibition of various cellular functions and deregulation of adhesion/ 
fimbrial synthesis and increase of the permeability of bacterial outer membrane, which 
increase the susceptibility of cell membrane to hydrophobic antibiotics and lysozyme, and 
facilitate the release of lipopolysaccharides molecules from the cell membrane (Naidu, 2002; 
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Ellison III et al., 1988, 1991). Like the mechanism of antimicrobial action of activated 
lactoferrin, the permeability of the outer membrane of gram negative bacteria might increase 
when ovotransferrin reacts directly on the bacterial membrane. So increased permeability 
may allow the protons formed by citric acid to enter easily inside of cell. In conclusion, the 
synergistic effect of citric acid on antibacterial activity of ovotransferrin against E. coli 
O157:H7 may be due to H+ formation. Also, iron binding capability of ovotransferrin might 
not be the major mechanism of antimicrobial activity of ovotransferrin because the 
antibacterial activity of ovotransferrin against E. coli O157:H7 was improved under acidic 
pH, which generally occurs with a decrease of iron binding capacity of ovotransferrin.  
 
 Antibacterial activity of Apo-, Fe-, and Zn-ovotransferrin 
To see if the antibacterial activity of ovotransferrin is related to its metal binding 
property, the antibacterial activity of ovotransferrin saturated with Fe2+ or Zn2+ against E. coli 
O157:H7 and L. monocytogenes was determined. As expected, natural apo-ovotransferrin 
(OTF) showed no antibacterial activity, but ovotransferrin plus with 50 mM-NaHCO3 
appeared to have a little antibacterial activity against E. coli O157:H7 and a bacteriostatic 
effect against L. monocytogenes (Fig. 3). Ovotransferrin plus 100 mM NaHCO3 showed the 
strongest bacteriostatic activity against both pathogens. Ovotransferrin saturated with iron 
had little or no bactericidal activity against E. coli O157:H7 and L. monocytogenes (Fig 3A 
and 3B). Ovotransferrin bound with Zn2+ also did not show antibacterial activity against E. 
coli O157:H7 (Fig. 3A), but it had a similar degree of antibacterial activity as apo-
ovotransferrin added with 50 mM sodium bicarbonate against L. monocytogenes (Fig. 3B). 
These results did not agree with those of Valenti et al. (1987) who reported that 
ovotransferrin saturated with Zn2+ had higher antibacterial activity against E. coli than apo-
ovotransferrin. Several other reports also suggested that ovotransferrin bound with metals 
such as zinc and iron had antibacterial activity (Ibrahim, 1997; Valenti et al., 1985, 1987). 
However, the present study demonstrates that Fe-bound ovotransferrin had little 
antimicrobial effect and the antibacterial activity of Zn-bound ovotransferrin varied with 
microorganisms. Zn2+ significantly enhanced antibacterial action of ovotransferrin toward L. 
monocytogenes, but not E. coli O157:H7. That Zn-bound ovotransferrin shows bacteristatic 
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activity against L. monocytogenes seems to conflict with a conclusion that the major 
mechanism of antibacterial action of ovotransferrin is ascribed to iron deprivation or metal 
binding capacity. Like these results, Valenti et al. (1982) suggested that the antibacterial 
effectiveness of ovotransferrin is not due simply to the iron deprivation from media. Many 
recent reports indicated that antibacterial activity of ovotransferrin may be associated with 
direct interactions between ovotransferrin and microorganism, regardless of its iron binding 
properties (Arnold et al., 1977, 1980, 1981, Valenti et al., 1982, 1985). According to these 
reports, ovotransferrin saturated with iron still displayed antifungal activity toward Candida 
(Valenti et al., 1985). Ibrahim et al. (2000) suggested that the N-terminal domain of 
ovotransferrin showed more potent bactericidal activity against S. aureus than the C-terminal 
domain regardless of the degree of iron saturation. 
Considering that ovotransferrin has remarkable structural similarity to that of human 
lactoferrin, which can react directly with bacterial surface besides the role of iron deprivation, 
it may not be difficult to reach an assumption that the antimicrobial action of ovotransferrin 
could be intimately related to direct reactions on bacterial membrane rather than iron-
deprivation property of ovotransferrin alone (Valenti et al., 1983b; 1987 Davis and Reeves, 
2002). Ovotransferrin may permeate bacterial outer membrane, reach the inner membrane 
and lead to permeation of other ions, which dissipate electrical potential so that it can exert 
antibacterial action against gram-negative bacteria (Aguilera et al., 2003; Ibrahim, 1997).  
 
Application of ovotransferrin to ham 
Based on the results obtained from in vitro tests, the ovotransferrin solutions plus 
either 100 mM-sodium bicarbonate or 0.5% citric acid were applied on commercial hams to 
determine their antibacterial activity. During storage at 4oC for 4 weeks, the number of viable 
E. coli O157:H7 cells decreased slowly (Table 3), whereas that of L. monocytogenes resulted 
in 1.5 ~ 2 log increase in this study (Table 4) even though Amezquita and Brashears (2002) 
report that cooked ham can inhibit the growth of L. monocytogenes. Through this study, E. 
coli O157:H7 was found to be more sensitive to low temperature than L. monocytogenes. 
Moreover, because commercial hams contain a variety of antibacterial substances such as 
nitrite, salt, low water activity, etc, the growth of E.coliO157:H7 sensitive to low temperature 
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was significantly prevented on the hams, but L. monocytogenes resistant to low temperature 
grew slowly under such a environment. There was little significant difference in the number 
of viable E. coli O157:H7 and L. monocytogenes cells between non-irradiated and irradiated 
hams during 4o C storage in all conditions (Table 3 and Table 4). Changes in the number of L. 
monocytogenes survivors in ovotransferrin plus 0.5% citric acid were low (6.2 log10 CFU/ml 
to 6.9 log 10 CFU/ml) in irradiated sample, whereas that of non-irradiated hams was large 
(6.4 log10 CFU/ml to 8.2 log10 CFU/ml) during storage at 4oC for 4 weeks (Table 4). Zhu et 
al. (2000) reported that during refrigerated storage for 28 days, L. monocytogenes in non-
irradiated turkey breast rolls grew, and non-irradiated samples had greater natural microflora 
population than irradiated samples.   
The antibacterial activity of ovotransferrin combined with 100 mM-NaHCO3 or 0.5% 
citric acid against E. coli O157:H7 inoculated on hams was not significantly different from 
that of control (Table 3). In contrast to the results of model system, little or no antilisterial 
effect of citric acid was found in both of non-irradiated and irradiated hams. The number of 
viable L. monocytogenes cells in ovotransferrin plus 100 mM-NaHCO3 treatment increased 
more than that of any other treatments during storage at 4o C for 4 weeks. The growth of L. 
monocytogenes in both non-irradiated and irradiated hams was promoted by sodium 
bicarbonate rather than suppressed (Table 4) as predicted by our model system results (Fig. 
1). This indicated that the antibacterial activity of ovotransferrin in combination with 100 
mM-NaHCO3 or 0.5% citric acid was annulled completely in commercial hams (Tables 3 
and 4). It might be due to media or matrix compositions, difficulties in treatment distribution,
or binding of ovotransferrin to matrix. Also, as hams have a variety of factors including 
divalent ions that affect antibacterial activity, the antibacterial activity of ovotransferrin o
hams seems to be modulated by these fac
 
n 
tors. 
 Ellison III et al. (1988) reported that the antibacterial effectiveness of lactoferrin was 
not achieved in food or complex media because of divalent cations such as Ca2+ and Mg2+. 
Shimazaki (2000) reported that divalent cations changed the tertiary structure of lactoferrin, 
which prevented antibacterial action of lactoferrin. Besides these ions, the stability of 
ovotransferrin in matrix is a critical factor in antibacterial activity of ovotransferrin. Valenti 
et al. (1982) reported that Sepharose-bound ovotransferrin showed higher antimicrobial 
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activity than free ovotransferrin because matrix-bound proteins have higher stability than 
soluble ovotransferrin. Direct application of lactoferrin to food systems reduces antibacterial 
activity of lactoferrin because active substances in complex media such meat or meat 
products neutralize the antibacterial effectiveness of lactoferrin. Also, the activated 
lactoferrin can be easily diffused into tissues and the antibacterial activity of lactoferrin on 
meat surface is difficult to maintain. Incorporation of lactoferrin into film or finding a film 
matrix appropriate to maintain the antibacterial activity by preventing diffusion of lactoferrin 
into meat has been discussed (http://www.newswise.com/articles/view/525381) and may be 
applied to ovotransferrin. 
 
Conclusion 
The antibacterial activity of natural apo-ovotransferrin against E. coli O157:H7 and L. 
monocytogenes in model systems increased as the concentration of sodium bicarbonate 
increased. NaHCO3 at 100 mM markedly increased antibacterial activity of ovotransferrin 
against E. coli O157:H7 and L. monocytogenes. Citric acid at 0.5% enhanced antibacterial 
activity of apo-ovotransferrin against E. coli O157:H7, but 0.5% citric acid alone also 
showed a strong bactericidal activity against L. monocytogenes. Addition of NaHCO3 
annulled the strong antibacterial activity of ovotransferrin plus citric acid against the two 
pathogens. The antimicrobial activity of ovotransferrin was greatly enhanced by acidic pH 
conditions. Zn-bound ovotransferrin showed bacteriostatic activity against L. monocytogenes, 
but Fe-bound ovotransferrin had little or no antibacterial activity against E. coli O157:H7 and 
L. monocytogenes. According to these results obtained in this study, the iron binding capacity 
of ovotransferrin does not seem to be the major cause of antibacterial action of ovotransferrin.  
Ovotransferrin plus 100 mM-NaHCO3 or 0.5% citric acid did not show antibacterial activity 
in commercial hams, indicating that there are many limitations in using ovotransferrin to 
control pathogens in meat or meat products. To overcome these problems, further studies on 
the mechanisms of antibacterial activity of ovotransferrin and various factors that can 
improve antibacterial activity of ovotransferrin are needed.  
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Table 1. Influences of citric acid and citrate on antibacterial activity of ovtransferrin against 
105 CFU/ml of E. coli O157:H7.  
                          
Treatments                                                    Storage period (days)                      
                                                            1                         2                         4                        8         
          ------------  Number of viable cell ( log10 CFU/ml)  ---------------- 
Citric acid                                  7.90c ± 0.65         6.88c ± 0.43        5.90b ± 1.00         2.23 c ± 0.43      
OTF + Citric acid                     4.71d  ± 0.09         3.92d ± 0.10        2.04c ± 0.00         1.00 d ± 0.00      
OTF + Citric acid +NaHCO3    8.64ab ± 0.10        8.41b ± 0.36        8.97a ± 0.19          8.74a ± 0.15 
OTF + Na-Citrate                     9.24a  ±  0.06        9.35a ± 0.08        8.97a ± 0.05          8.22b ± 0.07    
OTF + NaHCO3                                    8.40bc ± 0.10         8.64ab ± 0.39       8.69a ± 0.18          7.75b ± 0.03  
                               
a-c Values with different letters within a column with the same storage day are significantly 
different (p < 0.05, n=4) 
This study used 0.5% citric acid, 25 mM sodium citrate, and 50 mM-NaHCO3.     
OTF: Apo-ovotransferrin (20 mg/ml).  
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Table 2. Effect of citric acid and citrate on antibacterial activity of ovtransferrin against 104 
CFU/ml of L. monocytogenes.  
                          
Treatments                                                                          Storage period (days)                       
                                                            1                            2                            4                            8   
Citric acid                                   3.52b ± 0.32 ** 2.78b ± 1.14 1.52b ± 0.96    1.00b ± 0.0           
OTF * + Citric acid                     3.52b ± 0.83   2.86b ± 0.99   2.05b ± 1.67    1.91b ± 1.78      
OTF + Citric acid +NaHCO3  8.86a ± 0.14   8.60a ± 0.41    8.14a ± 0.29     7.67a ± 0.60   
OTF + Na-Citrate                        9.23a ± 0.11   8.62a ± 0.17   8.57a ± 0.23    8.43a ± 0.31    
OTF + NaHCO3                                         8.60a ± 0.19    7.74a ± 0.01   8.14a ± 0.07     7.13a ± 0.04 
            
P
a-bValues with different letters within a column with the same storage day are significantly 
different (p < 0.05, n=4) 
This study used 0.5% citric acid, 25 mM sodium citrate, and 50 mM-NaHCO3.     
OTF: Apo-ovotransferrin (15 mg/ml).
    
Table 3. Antibacterial activity of ovotransferrin solutions (20 mg/ml) plus either 100 mM-NaHCO3 or 0.5% citric acid on non-irradiated 
and irradiated vacuum-packaged hams inoculated with E. coli O157:H7 during storage at 4o C  
                                                                                                              
                                                                
  Sample Treatments                                                 Storage period (days)           
                                                                 0                         5                             10                       15                        22           29            
   -----------------------------------  Number of viable cell (log10 CFU/ml)  -----------------------------------------    
                
NR1            Control *        6.1a ± 0.21  5.5a ± 0.22   5.3ab ± 0.12   5.2a ± 0.10   5.0b ± 0.08   5.5a ± 0.01 
      OTF +NaHCO3     6.0a ± 0.11   5.7a ± 0.50   5.2b ± 0.01   5.2a ± 0.17   5.0b ± 0.10   5.0c ± 0.01 
      OTF + Citric acid     5.9a ± 0.10   5.7a ± 0.04   5.2b ± 0.05   5.1a ± 0.42   5.0b ± 0.07   5.1c ± 0.11 138   
IR2                Control         6.0 a ± 0.0    5.5a ± 0.06   5.5a ± 0.05   4.9a ± 0.32   5.3a ± 0.17   5.4ab ± 0.01 
      OTF + NaHCO3      6.1a ± 0.19   5.6a ± 0.08   5.5a ± 0.06   4.9a ± 0.19   5.0b ± 0.07   5.3ab ± 0.04 
     OTF + Citric acid              6.0a ± 0.0    5.7a ± 0.05   5.5a ± 0.08   5.0a ± 0.40   5.0b ± 0.02   5.3ab ± 0.10  
                                               
a-bValues with different letters within a column with the same storage day are significantly different (p < 0.05, n = 4). 
*Only E. coli O157:H7 inoculation 
  OTF: Ovotransferrin (20 mg/ml); NR1: non-irradiated ham;  IR2 : irradiated ham 
  This study used 0.5% citric acid and 100 mM sodium bicarbonate.     
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Table 4. Antibacterial activity of ovotransferrin solution (20 mg/ml) plus either 100mM-sodium carbonate or 0.5% citric acid on non-
irradiated and irradiated vacuum-packaged hams inoculated with L. monocytogenes during storage at 4o C.  
                                                                    
  Sample Treatments                                                 Storage period (days)          
                                                                 0                       5              10                15                       22           29           
                                           ------------------------------------ Number of viable cell (log10 CFU/ml) -----------------------------                
NR1   Control*        6.5a ± 0.15**  6.3ab ± 0.01   6.5 b ± 0.03   6.9b ± 0.10   7.5ab ± 0.10   8.2a ± 0.09 
     OTF *** +NaHCO3  6.4ab ± 0.11   6.4a ± 0.04   7.7a ± 0.09   7.6a ± 0.09   8.3a ± 0.21    8.4a ± 0.05 
     OTF + Citrate       6.4ab ± 0.14   6.5a ± 0.04   6.6b ± 0.14   7.1ab ± 0.03   7.3ab ± 0.12   8.2a ± 0.10  
  
IR2  Control        6.4ab ± 0.04   6.2b ± 0.08  6.4b ± 0.13   6.6b ± 0.25   7.0b ± 0.08    8.0a ± 0.30 
      OTF + NaHC03    6.2b ± 0.14   6.5a ± 0.01   7.5a ± 0.23   7.7a ± 0.45   7.7ab ± 0.63   8.3a ± 0.47 
      OTF + Citrate      6.2ab ± 0.18   6.2b ± 0.03   6.4b ± 0.07   6.5b ± 0.22   6.9b ± 0.53   6.9 b ± 0.57  
                                                            
a-bValues with different letters within a column with the same storage day are significantly different (p< 0.05, n=4). 
*Only L. monocytogenes inoculation.  
OTF: Ovotransferrin (20 mg/ml); NR1: non-irradiated ham;  IR2 : irradiated ham 
This study used 0.5% citric acid and 100 mM sodium bicarbonate.    
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Fig 1. The effect of sodium bicarbonate on antibacterial activity of ovotransferrin (20mg/ml) 
against E. coli O157:H7 (A : 103 CFU/ml inoculation) and L. monocytogenes (B: 104 CFU/ml 
inoculation) during 35o C incubation. Control was inoculated with only E. coli O157:H7. 
OTF: 20 mg/ml apo-ovotransferrin.     
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Fig 2. The influence of citric acid on antibacterial activity of ovotransferrin against 105 
CFU/ml of E. coli O157: H7 (A) and 104 CFU/ml of L. monocytogenes (B) after 2 days of 
incubation at 35o C. The control was inoculated with only E. coli O157:H7 or L. 
monocytogenes. OTF in A: 20 mg/ml apo-ovotransferrin, OTF in B: 15 mg/ml apo-
ovotransferrin. Different letters on bars represent significantly different groups (p < 0.05, n = 
4).  
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Fig 3. Antibacterial activity of OTF, Fe-OTF, and Zn-OTF against E. coli O157:H7 (104 
CFU/ml, A) after 1day of incubation at 35oC and L. monocytogenes (105 CFU/ml, B) after 2 
days of incubation at 35oC. Control: only E. coli O157:H7 or L. monocytogenes. OTF: 20 
mg/ml of apo-ovotransferrin, OTF 50: OTF + 50 mM-NaHCO3, OTF 100: OTF + 100 mM-
NaHCO3, Fe-OTF: Fe-bound ovotransferrin (20 mg/ml), Zn-OTF : Zn-bound ovotransferrin 
(20 mg/ml). Different letters on bars represent significantly different groups (p < 0.05, n = 4).  
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CHAPTER 6. EDTA AND LYSOZYME IMPROVES ANTIMICROBIAL 
ACTIVITIES OF OVOTRANSFERRIN AGAINST ESCHERICHIA COLI O157:H7 
 
A paper which will be submitted to Journal of Food Protection 
K. Y. Ko1, D. U. Ahn2 and A. Mendonca 
 
Abstract 
The aim of present study was to evaluate the effect of EDTA or/and lysozyme on 
antibacterial activity of ovotransferrin solution (20 mg/ml) including 100 mM-NaHCO3 (OS) 
against a cocktail of 5 strains of E. coli O157:H7. First, disc tests were performed to find the 
appropriate concentrations of EDTA and lysozyme that affect the antibacterial activity of OS. 
Also, the turbidity of OS solutions inoculated with E. coli O157:H7 and contained either 
EDTA (OSE) or lysozyme (OSL) and the viability of E. coli O157:H7 in the solutions were 
investigated. Furthermore, OS combined with EDTA or/and lysozyme (OSE, OSL, OSEL) 
were applied on irradiated pork chops and commercial hams to determine if the solutions 
have antibacterial activity on meat products. In addition, the effect of initial cell population 
on the antibacterial activity of ovotransferrin and EDTA or lysozyme combinations was 
determined. EDTA at 1 mg/ml plus OS (OSE) induced 3 ~ 4 log reduction in viable E. coli 
O157:H7 cells in BHI broth media, and 1 mg/ml lysozyme plus OS (OSL) resulted in around 
0.5 ~ 1.0 log reduction during 35o C incubation for 36 hr. However, ovotransferrin plus 
EDTA or/and lysozyme did not show significant antibacterial effect on pork chops and hams 
during storage at 10o C. Also, initial cell number in media did not affect the antibacterial 
activity of OSE or OSEL against E. coli O157:H7. This study demonstrates that even though 
combinations of ovotransferrin, NaHCO3, and EDTA (OSE) have potential to control E. coli 
O157:H7. Also further studies related to the mechanisms of antibacterial action of 
ovotransferrin in meat products are needed for food application of ovotransferrin.    
 
1 Primary researcher and author 
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Introduction 
Natural antimicrobials that are environmentally friendly, medically acceptable, and 
highly effective and economical to manufacture have gained attention due to consumers’ 
desire for natural food products (Payne et al., 1994). Ovotransferrin, one of the main iron-
binding glycoproteins present in egg white, transports and scavenges Fe (III) in eggs of 
poultry (Kurokawa et al., 1995). It is a major contributor to the egg’s defense against 
microbial infection and rotting. Many studies have described the antibacterial properties of 
ovotransferrin against various microorganisms including Escherichia coli (Shade and Carolin, 
1944; Valenti et al., 1983), Pseudomonas spp., Streptococcus mutans (Valenti et al., 1983), 
Staphylococcus aureus, Bacillus cereus (Ibrahim, 1997), Salmonella enteritidis (Baron et al., 
1997; 2000), and Candida (Valenti et al., 1985). However, the antimicrobial mechanisms of 
ovotransferrin have not been fully elucidated yet. Initially, the iron binding capability of 
ovotransferrin, which limits the availability of iron required for microbial growth, was the 
major antibacterial mechanism of ovotransferrin. However, subsequent studies have 
suggested that the antimicrobial action of ovotransferrin could be intimately related to direct 
interactions of ovotransferrin with bacterial surface, which result in damage of outer 
membranes of microorganisms or destroy microbial function (Valenti et al., 1983, 1985; 
Arnold et al., 1981, Ibrahim, 1997; Ihbrahim et al., 2000).   
E. coli O157:H7 possesses specific cell-surface appendages such as fimbria or 
colonization factor antigens that facilitate their adhesion to host-tissue-matrix components 
such as fibronectin, collagens, elastin and mucin so that it can tightly attach to beef tissues 
(Naidu, 2002). Due to these attributes, illness caused by E. coli O157:H7 are frequently 
linked to cattle and their products, undercooked ground beef, and raw milk (Firstenberg-Eden, 
1997; Weeranta and Doyle, 1991 Bell et al., 1994). E. coli O157:H7 is a shiga toxin-
producing strain that some products contaminated with the microorganism sometimes cause 
bloody diarrhea in humans and cause more serious complications such as hemorrhagic colitis 
and hemolytic uremic syndromes (Griffin and Tauxe, 1991). 
The combinations of antimicrobials with different mechanisms can increase the 
antibacterial effectiveness. Ethylenediaminetetraacetic acid (EDTA) has been used in a 
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number of food products as a chelating agent to prevent oxidation and deteriorative reactions, 
which are catalyzed by metal ions. Also, it is known to enhance the effectiveness of 
antimicrobials and antibiotics, especially against gram-negative bacteria. For instance, EDTA 
promotes the antimicrobial activity of nisin, lysozyme, and monolaurin against gram-
negative microorganisms (Hughey and Jonhson, 1987; Stevens et al., 1991; Razavi-Rohani 
and Griffiths, 1994). Even though the mechanism of antibacterial effectiveness by EDTA is 
not fully understood, generally chelating property to divalent cations like Ca2+ or Mg2+ has 
been considered as a major cause of its antibacterial activity (Shelef and Seiter, 1993). EDTA 
inhibits the growth of microorganisms by depriving Ca2+, Mg2+, or Fe2+, which are essential 
factors for microbial growth (Banin et al., 2006). Also, it destabilizes outer membrane of 
gram-negative bacteria by chelating Ca2+ and Mg2+ salts that function as bridges between 
lipopolysaccharides (LPS) of microbial outer membrane, and thus results in the release of 
LPS from gram-negative bacteria (Shelef and Seiter, 1993; Vaara, 1992, Banin et al., 2006). 
Also, chelating divalent cations facilitate the detachment of cells from biofilm and enhance 
the killing of biofilm-producing microorganisms by depriving Mg2+ associated with 
lipopolysaccharides (Banin et al., 2006).  
Lysozyme, a single peptide protein with 14.6 kDa, catalyzes the hydrolysis of (1-4) 
glycosidic linkages between N-acetylmuramic acid and N-acetylglucosamine in cell wall 
peptidoglycan (Proctor and Cunningham, 1988). When peptidoglycan, the major component 
of cell wall in both gram-positive and gram-negative bacteria, is hydrolyzed by lysozyme, the 
structural integrity of cell wall can be damaged (Proctor and Cunningham, 1988). Therefore, 
the antimicrobial activity of lysozyme is ascribed primarily to enzymatic lysis of 
peptidoglycan in microbial cell wall (Branen and Davidson, 2004). As the cell walls of gram-
negative bacteria are protected by an outer membrane, gram-negative microorganisms are 
relatively resistant to antimicrobial activity of lysozyme, and thus the application of 
lysozyme in foods has been limited (Gill and Holley, 2003; Proctor and Cunningham, 1988). 
However, lysozyme gained a considerable interest for use in food systems because it is a 
natural enzyme produced by many animals and its activity targets a specific cellular structure 
of microorganism (Proctor and Cunningham, 1988). 
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Ovotransferrin alone has little antibacterial activity against E. coli O157:H7 in 
previous study (unpublished data). Even though 100 mM-NaHCO3 enhanced the 
antibacterial activity of ovotransferrin, the ovotransferrin combining 100 mM-NaHCO
was bacteriostatic, not bactericidal against the pathogens. Therefore, it is necessary to 
enhance antimicrobial activity of ovotransferrin for food application. Ovotransferrin and 
lysozyme are natural antimicrobials and EDTA is a chelating agent used in a wide variety of 
food products (Hansen et al., 2001). Therefore the use of ovotransferrin combined with 
EDTA or/and lysozyme on the surface of meat or meat products is an interesting approach 
because all those components are generally regarded as safe (GRAS). The aim of the pres
study was to enhance the antimicrobial activity of OS against 5 strains of E. coli O157:H7 by
combining EDTA and lysozyme. Also, the effects of NaHCO
3 (OS) 
ent 
 
ops were also tested. 
3, EDTA and lysozyme 
combinations on the antimicrobial activity of ovotransferrin against E. coli O157:H7 in 
commercial hams and irradiated pork ch
 
Material and Methods 
 
Ovotransferrin 
Apo-ovotransferrin (iron-free) used in this study was prepared by the method of Ko 
and Ahn (2007, unpublished). After iron saturation of 2x-diluted egg white solution, holo-
ovotransferrin (iron-saturated) were separated using ethanol. Iron was removed from the 
holo-ovotransferrin using AG ®1-X2 resin (chloride form, Bio-Rad, California, U.S.A), and 
then freeze-dried. The dried apo-ovotransferrin was dissolved in distilled water, its pH 
adjusted to 7.4, and 0.15 M NaCl was added. The purity of ovotransferrin used in this study 
was around 80% and the residual iron in prepared apo-ovotransferrin solution was less than 
0.5 ppm. Prior to microbial study, the ovotransferrin solution was sterilized by filtering 
through a 0.22 μm syringe filter (Whatman Inc. Florbam Park, NJ. USA). 
 
Bacterial strains  
Five different strains of E. coli O157:H7 (ATCC 43890, C467, FRIK 125, ATCC 
43895, and 93-062) were used. Prior to inoculation, each strain was individually cultured in 
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brain heart infusion broth (BHI, Remel Inc., Lenexa, KS, USA) for 24 hours at 35oC and 
harvested twice in order to activate the strain appropriately. An aliquot (5 ml) of each culture 
solution was transferred to a sterilized centrifuge bottle and centrifuged at 100,000 x g for 10 
min at 4oC. Pellet was collected, washed with saline, and then resuspended in 25 ml saline. 
An inoculation cocktail was prepared by mixing equal volumes of each cell suspension to 
have approximately the same population of five strains of E. coli O157:H7.  
 
Formation of clear zone  
Prior to performing viability and turbidity tests to identify the antibacterial activity, 
disc diffusion method (Bauer et al, 1966) was used to determine the concentrations of EDTA 
(disodium salt, Fisher Scientific, Fairlawn, NJ, USA) and lysozyme (from egg white, Sigma-
Aldrich Inc., St. Louis, USA) capable of promoting antibacterial capability of ovotransferrin. 
An E. coli O157:H7 cocktail containing equal number of each strain was serially diluted and 
then 0.1 ml of cell suspension corresponding to 105 or 106 number was spread homogenously 
on the BHI media agar plate. The BHI agar plates inoculated with E. coli O157:H7 were 
dried for 30 ~ 60 minutes in an incubator at 35oC. EDTA (1, 0, 1.5, 2.0, or 2.5 mg/ml) or 
lysozyme (1.0, 1.5, 2.0, or 2.5 mg/ml) was added to ovotransferrin solution or ovotransferrin 
plus 100 mM-NaHCO3 (OS) solution. All solutions prepared were sterilized using 0.22 μm 
syringe filters (Whatman Inc. Florbam Park, NJ. USA) prior to distribution on plates. 
Ovotransferrin solutions (120 μl) containing different concentrations of EDTA or lysozyme 
were dispensed on a sterilized glass microfiber filter (2.1 cm diameter, Whatman Inc. 
Florbam Park, NJ. USA) placed on the dried BHI agar media. Three replications were 
prepared. The BHI agar plates were incubated at 35o C for 24 ~ 48 hrs and then the 
antibacterial activity of each ovotransferrin solution against E. coli O157:H7 was estimated 
by the size and clarity of clear zones.      
 
Turbidity test 
The antimicrobial capacity of ovotransferrin solutions combined with EDTA or 
lysozyme against E. coli O157:H7 was analyzed by measuring the turbidity of solution after 
incubation in a BHI broth culture at 35oC. Disc test indicated that the concentrations of 
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EDTA and lysozyme showing antibacterial activity against E. coli O157:H7 when combined 
with ovotransferrin solutions were > 2.0 mg/ml and > 1.0 mg/ml, respectively (Table 1). 
After 2 ml of 40 mg/ml ovotransferrin solution was added to 2 ml of 2x-strength BHI broth, 
stock solutions of EDTA or lysozyme was added to the broth culture media including 
ovotransferrin or OS and then the final concentration of EDTA was adjusted to 2.0 or 2.5 
mg/ml, and lysozyme to 1.0, 1.5, or 2.0 mg/ml. Also, 40 μl of cell suspension containing 106 
~ 107 cells of activated E. coli O157:H7 cocktail was inoculated to the prepared solution to 
make the initial population of E. coli O157:H7 104 ~ 105 CFU per ml. The antibacterial 
activity of EDTA or lysozyme solution was determined. After inoculation, the samples were 
incubated at 35o C for 36 hrs. Multiplication of E. coli O157:H7 in each solution was 
evaluated by measuring the turbidity of solution with a spectrophotometer at 620 nm every 3 
- 6 hrs.  
   
Viability test  
The antibacterial activity of ovotransferrin plus either EDTA or lysozyme was 
investigated using a viability test. First, 2 ml of ovotransferrin solution (40 mg/ml) was added 
to 2 ml of 2x-concentrated BHI broth media containing 100 mM-NaHCO3. Stock solution of 
either EDTA or lysozyme was added to the ovotransferrin plus 100 mM NaHCO3 solution so 
that each solution contained 2 mg/ml of EDTA or 1 mg/ml lysozyme. Also, 40 μl of cell 
suspension containing 106 ~ 107 cells of activated E. coli O157:H7 was inoculated to the 
prepared solution to make 104 ~ 105 CFU per ml in the initial solution. EDTA or lysozyme 
alone was prepared as a control group. After inoculation, the prepared culture solutions were 
incubated at 35oC for 36 hrs. The number of viable cells was analyzed by spread plate of  
each culture solution (0.1 ml) after diluting (1:10) with 0.1% sterile peptone water (Difco 
Laboratories, Detroit, MI). The samples were incubated at 35oC for 24 ~ 36 hrs. The number 
of survivors on BHI agar plates was counted as colony-forming units per ml (CFU/ml) of 
sample.  
 
Cell number effect 
 
 149
This study was performed to know if the population of cell affects the antibacterial 
activity of ovotransferrin solutions combined with various solutions. The BHI broth media 
containing ovotransferrin was prepared with the same method described above. OS plus 
either 2 mg/ml EDTA or 2 mg/ml EDTA and 1 mg/ml lysozyme were added to prepared BHI 
broth media. The BHI broth culture containing EDTA (2 mg/ml) and lysozyme (1 mg/ml) 
without added ovotransferrin was prepared to identify whether the solution itself has 
antibacterial activity against E. coli O157:H7. Also, 40 μl of cell suspension containing 106, 
107, or 108 cells of activated E. coli O157:H7 was inoculated to 4 ml BHI broth media to 
make the number of E. coli O157:H7 104, 105 or 106 CFU per ml. After the prepared culture 
solutions were incubated at 35oC for 24 ~ 36 hrs, the viability of each treatment was 
measured using the same method described above. 
 
Application to pork chop  
Fresh pork chops from different animals were purchased from the Meat Laboratory at 
Iowa State University and sliced to 1 cm-thick pieces (7 cm x 5 cm). Sliced pork chops were 
vacuum packaged (-1 bar of vacuum with 10 second dwell time) in low oxygen-permeable 
bags (nylon/polyethylene, 9.3 ml O2/m2/24hr at 0oC; Koch, Kansas City, MO). After vacuum 
packaging, the sliced pork chops were irradiated at 0 or 5 kGy using a Linear Accelerator 
(Circe IIIR; Thomason CSF Linac, Saint-Aubin France) to kill bacteria, which may exist in 
the pork chop. After irradiation, the pork chops were frozen and defrosted completely prior to 
use for the microbial study. Each package was aseptically opened using an alcohol-sterilized 
scissors. E. coli O157:H7 cocktail stock suspension (0.2 ml) was inoculated on the surface of 
each pork chop to make the initial inoculated number 104 CFU per gram meat and then the 
pork chop samples were randomly divided into 5 groups. Inoculated strains were spread 
manually for 30 second to distribute the inoculum evenly.            
Lysozyme or/and EDTA were added to OS solution containing 0.15 M NaCl. The 
treatments are as follow: 20 mg/ml ovotransferrin containing 100 mM NaHCO3 (1OS) plus 2 
mg/ml EDTA (1OSE), 1OS plus 2 mg/ml EDTA and 1 mg/ml lysozyme (1OSEL), 30 mg/ml 
ovotransferrin (2OS) plus 2 mg/ml EDTA (2OSE), and 2OS plus 2 mg/ml EDTA and 1 
mg/ml lysozyme (2OSEL). One ml of each ovotransferrin solution was distributed on the 
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same surface of pork chops and spread manually for 30 ~ 60 sec to distribute the solution 
homogenously. Control group was prepared by inoculating E. coli O157:H7 to pork chops. 
After adding ovotransferrin to pork chops, the samples were stored in a 10oC incubator. 
Viable cells on the pork chops were analyzed by sprea plate method after 0, 2, 4, 8, and 12 
days of storage: 30 ~ 50 ml of sterile 0.1% peptone water solution was added to each bag 
followed by pummeling for 1min in a stomacher at normal speed. After serial dilution of the 
sample with 0.1% peptone water, 0.1 ml of diluted sample was spread homogenously on the 
MacConkey agar (Difco Laboratories, Detroit, MI) plate in duplicate. Survivors were 
enumerated as CFU per ml by the same method presented above.  
 
Application of ovotransferrin on ham   
Commercial hams were purchased from 3 local retail stores, and hams from each store 
were used as a replicate. Hams were sliced to 0.2 cm-thick pieces and vacuum-packaged (-1 
bar of vacuum with 10 second dwell time) in low oxygen-permeable bags 
(nylon/polyethylene, 9.3 ml O2/m2/24hr at 0o C; Koch, Kansas City, MO). Prior to 
inoculation, each package was aseptically opened using an alcohol-sterilized scissors. 
Activated E. coli O157:H7 cocktail stock suspension (0.1 ml) was inoculated aseptically on 
the surface of sliced ham to make 103 CFU/ml level. After inoculated ham samples were 
manually mixed for 30 second to distribute the inoculum evenly, the packaged samples were 
randomly divided into 5 groups. Also, 1 ml of 4 different ovotransferrin solutions prepared as  
pork chops studies was distributed evenly on the surface of hams. Samples inoculated with 
only E. coli O157:H7 without any solution added was used as a control. All hams were 
stored in a 10oC incubator. The number of surviving bacteria was enumerated using the same 
method as in the pork chop study after incubating for 0, 3, 8, and 13 days.  
 
Statistical analysis 
All experiments were replicated three times and data were analyzed using the JMP 
software (version 5.1.1; SAS Institute., Cary, NC). The differences in the mean values were 
compared by Tukey HSD, and mean values and standard error of the means (SEM) were 
reported (Kuehl, 2000). Statistical significance for all comparisons was obtained at P < 0.05. 
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Results and Discussion 
Formation of clear zone  
EDTA alone at 2.5 mg/ml formed a weak clear zone, but less than 2.0 mg/ml did not 
make any clear zones. Also, all ovotransferrin solutions plus various concentrations of EDTA 
(OE) did not form clear zones. Ovotransferrin solution combined with 100 mM NaHCO3 and 
2.5 mg/ml EDTA (OSE) formed more apparent clear zones than 2.5 mg/ml EDTA alone. 
Lysozyme alone at 1.0, 1.5, 2.0 or 2.5 mg/ml did not form clear zones, but ovotransferrin 
plus lysozyme (OL) and OS plus lysozyme (OSL) formed clear zones (Table 1).  
The membrane of most bacteria is surrounded by a rigid peptidoglycan to prevent cell 
rupturing by high internal osmotic pressure. In gram-negative bacteria, their outer membrane 
lies outside the peptidoglycan but it is protected by lipopolysaccharides (LPS) molecules and 
is stabilized by divalent cations, which act as salt bridges on neighboring LPS molecules and 
proteins (Marvin et al., 1989). EDTA can destabilize outer membrane of microorganisms by 
chelating divalent cations such as Ca2+ and Mg2+ (Vaara, 1992; Shelef and Seiter, 1993; 
Pelletier et al. 1994). Payne et al. (1994) reported that more than 1 mg/ml EDTA inhibited E. 
coli O157:H7 in UHT milk. Jarvis et al., (2001) demonstrated that 30 mM EDTA reduced the 
optical density of E. coli by 50% and induced a complete loss of viability. Park (1997) 
reported that 0.1~ 0.4 g/l lysozyme has antibacterial activity against E. coli in nutrient broth 
and vegetable juice.  
In this study, the growth of E. coli O157:H7 appeared to be inhibited by 2.5 mg/ml 
EDTA. Also 1.0 ~ 2.0 mg/ml EDTA did not enhance antibacterial activity of ovotransferrin 
against E. coli O157:H7 significantly, whereas EDTA at 2.5 mg/ml or lysozyme at 1.0 ~ 2.5 
mg/ml enhanced the antimicrobial activity of OS against 5 strains of E. coli O157:H7 
synergistically. Gill and Holley (2003) reported that using cells harvested from log or 
stationary phase culture was a poor model for assessing antimicrobial activities in food 
products because the repairing ability of bacteria on log phase or stationary phase was not 
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equivalent to that of cells on lag adaptation phase. In this study, E. coli O157:H7 strains 
showed resistance to lysozyme and EDTA probably because the strains used were from the 
stationary phase. 
 
Antibacterial activity of EDTA alone or in combination with ovotransferrin  
E. coli O157:H7 in BHI broth entered log phase after 6 hr incubation and the stationary 
phase after around 10 hr incubation at 35oC. E. coli O157:H7 in the media containing 2 
mg/ml or 2.5 mg/ml EDTA alone showed a lag time for 10 hr and entered stationary phase 
after 18 hr of incubation (Fig. 1). OS, OS plus 2 mg/ml EDTA (OSE2), and OS plus 2.5 
mg/ml EDTA (OSE2.5) inhibited E. coli O157:H7 during 35o C incubation for 36 hr (Fig. 1). 
However, it was difficult to assure that if there was any synergistic effect of EDTA through 
turbidity test alone because all turbidity values of OS, OSE2 and OSE2.5 were less than 0.1 
at 620 nm. Therefore, viability test was performed to determine the synergistic effect of 
EDTA on antibacterial activity of OS. The number of survivors in media containing 2 mg/ml 
EDTA alone was not significantly different from that of control as in the turbidity test. 
However, a significant difference in antibacterial activity (p < 0.05) between OS and OSE2 
was found in viability test (Fig. 3).  
Many other researchers also suggested that EDTA at 2 mg/ml synergistically enhanced 
the antibacterial activity of OS against E. coli O157:H7. Al-Nabulsi and Holley (2007) 
reported that lactoferrin plus EDTA inactivated E. coli O157:H7 and affected meat starter 
cultures. They concluded that EDTA enhanced the antibacterial activity of lactoferrin against 
E. coli O157:H7. Enhancement of lactoferrin activity by EDTA could be explained by the 
divalent cation-chelating attributes of EDTA, which destabilizes the outer membrane of 
microorganism and increases its permeability (Coughlin et al., 1983; Vaara, 1992, Boland et 
al., 2004). Erdei et al. (1994) identified porins, which are proteins of outer membrane and 
form cross-membrane channel (Stanier, et al.,1986), at the sites in which lactoferrin is bound 
on the surface of E. coli and demonstrated that the affinity of lactoferrin to the site is 
dependent upon the lipopolysaccharides (LPS) of microorganism associated with interactions 
of lactoferrin. Apo-lactoferrin and holo-lactoferrin induced LPS release from outer 
membrane of gram-negative bacteria by chelating Ca2+, and thus they are considered to 
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interact directly with LPS (Rossi et al., 2002; van Berkel et al., 1997). The bactericidal effect 
of lactoferrin is affected by the concentration and the degree of iron saturation in lactoferrin 
and is prevented by high calcium levels even though the protein does not chelate Ca2+ 
(Ellison and Giehl, 1991). 
Even though OS was bacteriostatic against E. coli O157:H7, the combination consisted 
of ovotransferrin, NaHCO3, and EDTA (OSE2) showed potent bactericidal effects against E. 
coli O157:H7 by resulting in 3 ~ 4 log reduction. Yakandawala et al. (2006) reported that a 
combination of ovotransferrin, protamine sulfate and EDTA reduced biofilm formation by 
catheter-associated bacteria including K. pneumoniae, Pseudomonoas aeruginosa, and 
Staphylocococus epidermidis. Al-Nabulsi and Holley (2006) claimed that when NaHCO3 
was combined with lactoferrin and EDTA, 4 log reduction in viable cells occurred due to 
increased lactoferrin stability by bicarbonate. 
 
Antibacterial activity of lysozyme alone or in combination with ovotransferrin  
In turbidity test, lysozyme itself at 1.0, 1.5, and 2.0 mg/ml could not inhibit the growth 
of E. coli O157:H7. However, OS, OS plus either 1 mg/ml lysozyme (OSL1) or 2 mg/ml 
lysozyme (OSL2) elucidated lower than 0.1 turbidity value at 620 nm (Fig. 2). When both 1 
mg/ml and 2 mg/ml lysozyme were combined OS, they showed antibacterial activity against 
E. coli O157:H7 in turbidity test. Therefore, l mg/ml lysozyme was chosen for viability test 
to determine if OSL was bactericidal or bacteriostatic after 24 hr incubation at 35oC. As 
shown at Fig. 3, there was no significant difference in antibacterial activity between 1 mg/ml 
lysozyme (L1) and control, whereas the number of survivors in OSL1 was significantly lower 
than that of L1 (p < 0.05). This study confirmed the result obtained from turbidity test that L1 
itself did not have antibacterial activity against E. coli O157:H7. When 4.0 log CFU/ml of E. 
coli O157:H7 was initially inoculated to each treatment, the population of viable cells by OS 
was 4.5 log CFU/ml, while that of OSL1 was 3.2 log CFU/ml after 24 hr incubation at 35oC 
(Fig. 3). According to these results, OS is bacteriostatic, whereas OSL1 is slightly 
bactericidal against E. coli O157:H7. However, there was no significantly different in 
antibacterial activity against E. coli O157:H7 between OS and OSL.  
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 Naidu et al (1993) reported that some strains of E. coli with low binding capacity to 
lactoferrin was recovered relatively easily from its antimicrobial actions, whereas other 
strains of E. coli with high binding capacity failed to be repaired. Therefore, use of 5 
different E. coli O157:H7 strains may indicate increased resistance against OS or OSL 
treatment than that of a specific strain. Ellison and Giehl (1991) reported that combination of 
2 mg/ml lactoferrin and 0.5 mg/ml lysozyme showed bactericidal capacity against E. coli. In 
addition, they demonstrated that lactoferrin destabilized outer membrane of gram-negative 
bacteria by releasing LPS. Other researchers (Yamauchi, et al., 1993 Boesman-Finkelstein 
and Finkelstein, 1985; Ellison and Giehl, 1991) reported that lysozyme enhanced bactericidal 
activity of lactoferrin and lactoferricin against E. coli even though bovine lactoferrin was 
bacteriostatic at most. In conclusion, this study demonstrates that L1 enhanced the 
antimicrobial activity of OS against E. coli O157:H7 and the combination of ovotransferrin 
with NaHCO3, and L1 (OSL) had a weak bactericidal property against E. coli O157:H7.  
 
Cell number effect  
This study was performed to know if the population of existing cell affects the 
antibacterial activity of OS plus 2 mg/ml EDTA (OSE) or OS combined with 2 mg/ml EDTA 
and l mg/ml lysozyme (OSEL). After 24hr incubation at 35oC, OS did not restrain completely 
the growth of E.coli O157:H7. According to the results, in antibacteri activity of OS, there 
was significantly different in antibacterial activity of OS in between 104 CFU/ml and 106 
CFU/ml of initial cells. As the number of initial bacteria was relatively small, the 
antibacterial action of OS against E. coli O157:H7 indicated to be more effective. However, 
antibacterial activities of OSE and OSEL, which were bactericidal against E. coli O157:H7, 
were not affected by the number of initial bacteria (Fig. 4). Combinations (EL) consisting of 
EDTA (2 mg/ml) and lysozyme (1 mg/ml) could not inhibit the growth of E. coli O157:H7 in 
BHI broth media when inoculated with 105 CFU/ml and 106 CFU/ml cells initially. However, 
when EL was combined with OS (OSEL), the solution showed a powerful bactericidal 
activity against E. coli O157:H7 after 35oC incubation in BHI broth for 24 hrs. Many 
researchers reported that the antibacterial activities of lysozyme against gram-negative and 
gram-positive microorganisms are related to membrane disruption (Shively and Hartsell, 
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1964a, b; Hughery and Johnson, 1987; Ellison and Giehl, 1991; Payne et al., 1994; Park, 
1997; Carneiro De Melo et al., 1998; Kalashyanand et al., 1992). EDTA treatment increased 
the permeability of outer membrane by releasing LPS and enhanced the antibacterial action 
of lysozyme. When EDTA and lysozyme were combined, bactericidal activity against E. coli 
increased (Branen and Davidson, 2004). 
Contrary to these reports, this study found that 2 mg/ml EDTA plus l mg/ml lysozyme 
did not inhibit the growth of E. coli O157:H7. Gill and Holly (2003) reported that even 
though lysozyme and EDTA enhanced antibacterial activity against gram-positive organisms, 
the combination did not show antimicrobial activity against some gram-negative organisms. 
Susceptibility of E. coli O157:H7 to EDTA plus lysozyme may be dependent upon the state 
of strains in inoculation. Arnold et al. (1981) demonstrated that cultures on early exponential 
phase are more susceptible to antimicrobial action of lactoferrin than that of early stationary 
phase, which are more resistant. Based on such a suggestion this study used E. coli O157:H7 
on stationary phase, and the susceptibility of E.coli O157:H7 to EDTA plus lysozyme was 
much lower than those obtained from other studies.  
      
Ovotransferrin applications on pork chops and hams  
E. coli O147:H7 inoculated at 104 CFU/ml grew on the pork chop and increased to 107 
CFU/ml after 10oC storage for 12 days. In contrast to the results obtained from in vitro test, 
20 mg/ml OS plus 2 mg/ml EDTA (1OSE), 20 mg/ml OS combined with 2 mg/ml EDTA and 
1 mg/ml lysozyme (1OSEL), 30 mg/ml OS plus 2 mg/ml EDTA (2OSE) or 30 mg/ml OS 
combined with 2 mg/ml EDTA and 1 mg/ml lysozyme (2OSEL) did not show any 
antimicrobial activities (Table 2). Unlike pork chop samples, the viable E. coli O157:H7 cells 
decreased slowly in commercial hams during 10oC storage for 13 days (Table 3). E. coli 
O157:H7 grew better in pork chops, which contain more drips by defrosting than commercial 
hams. Cured meat products provided several restrictive factors in the growth of some 
microorganisms including low storage temperature, nitrite (less than 200 ppm), NaCl, and 
lower water activity (Gill and Holley, 2003). Viable E. coli O157:H7 cells inoculated on 
hams decreased slowly due to these restrictive factors unlike in pork chops.  
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 Like the pork chop study, 1OSE, 1OSEL, 2OSE or 2OSEL did not show any 
antibacterial activity against E. coli O157:H7 inoculated on ham (Table 3). Even though OSE 
and OSEL showed potent bactericidal effects against E. coli O157:H7 in vitro test, there was 
no significant difference in the number of survivors between control and all treatments in 
both pork chops and commercial hams (p < 0.05). Therefore this study demonstrates that 
there are some limits to overcome to apply ovotransferrin on meat or meat products.  
The bactericidal effect was affected by concentration and the degree of iron saturation 
in lactoferrin, and was prevented by high calcium levels even though the protein did not 
chelate Ca2+ (Ellison and Giehl, 1991). Antibacterial activities of some antimicrobials 
sometimes can be modulated by nutrient or laboratory media. Cutter and Siragusa (1995a, b) 
demonstrated that combination of nisin with chelators showed antibacterial activity against E. 
coli and Salmonella spp. in buffer, but it did not show any antibacterial effectiveness against 
the same organisms on beef. Branen and Davidson (2004) reported that in spite of 
antibacterial activity of EDTA and nisin combination against E. coli, the activity did not 
appear in 2%-fat UHT (ultra high temperature) milk stored at abuse temperatures. Also, Gill 
and Holly (2003) reported that a combination consisted of lysozyme and nisin had an 
enhanced bactericidal activity in MRS (de Man, Rogosa, Sharpe) media, but did not show 
such an effect in pork juice at the same conditions. Al-Nabulsi and Holley (2007) 
demonstrated that lactoferrin induced cell injury rather than killing E. coli O157:H7 
completely, which was responsible for weaker antibacterial activities in fermented meat 
products.  
Like these reports, the results from application of antimicrobials to meat products were 
significantly different from those of model system. Generally, food products provide a 
nutrient-rich environment, so that microorganisms injured by some antimicrobials can be 
recovered more easily in the systems than under cell starvation conditions or limited 
laboratory media. In addition, many divalent cations blocked the biological activity of 
lactoferrin by forming tetramers in the presence of high concentration of Ca2+ and Mg2+ 
(Bennett et al, 1981) and modulated the membrane damage by chelators (Gill and Holley, 
2003) or inhibited the direct interaction of lactoferrin to LPS (Rossi et al., 2002). Some 
studies suggested that Ca2+ caused the aggregation of lactoferrin (Bennett et al., 1981) and 
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hindered the LPS release by lactoferrin (Ellison et al., 1988, 1990; Ellison and Giehl, 1991; 
Yamauchi et al., 1993). A certain concentration of Ca2+ and Mg 2+ decreased the antibacterial 
activity produced by lactoferrin plus EDTA (Ellison, et al 1988) because lactoferrin was 
incapable of binding cell surfaces (Ellison et al., 1990). 
 Hams and pork chops used at this study also contained a number of free ions such as 
Ca2+ and Mg2+. In contrast to the in vitro tests, lack of antibacterial activity of ovotransferrin 
in pork chops and commercial hams may be due mainly to such divalent ions. For food 
applications of ovotransferrin, significant amounts of chelators may be necessary to remove 
the divalent cations and destabilize outer membrane of E. coli present in food systems. Also, 
distribution or dilution effect of ovotransferrin on the products could be another explanation 
for the low antibacterial activity of ovotransferrin in pork chops and hams. Al-Nabulsi and 
Holley (2007) suggested that the low antimicrobial activity occurred by microencapsulated 
lactoferrin (LF) was partially ascribed to the dilution of LF when microcapsules were 
incorporated in the sausage batters. Even though at the present study 20 ~ 30 mg/ml of 
ovotransferrin was distributed on the surface of pork chops and hams, the concentration was 
likely to be diluted on the surface of the products. In addition, as ovotransferrin was spread 
manually, homogenous distribution of ovotransferrin on whole products might be impossible. 
Furthermore, ovotransferrin incorporated might also be penetrated or absorbed inside 
products so that antimicrobial action against E. coli O157:H7 might not occurr on the surface 
of the products. Due to significant amount of drip, which were formed during the defrosting 
process in pork chops, all ovotransferrin incorporated might not have remained on the surface 
of the pork chops. So, antimicrobial action by ovotransferrin in pork chop and hams seemed 
to be limited.  
 
Conclusion 
EDTA at 2 mg/ml and lysozyme at 1 mg/ml enhanced antibacterial activity of 
activated ovotransferrin plus NaHCO3 (OS) against E. coli O157:H7 in vitro test. EDTA at 2 
mg/ml plus OS resulted in 3 ~ 4 log reduction, while 1 mg/ml lysozyme plus OS resulted in 
around 0.5 ~ 1 log reduction during incubation at 35oC for 36 hr. Also, initial cell number in 
media did not affect the antibacterial activity of OSE or OSEL against E. coli O157:H7. 
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EDTA at 2 mg/ml enhanced the antimicrobial activity of OS against E. coliO157:H7 in vitro 
significantly. However, OSE or OSEL did not show any antimicrobial activity on pork chops 
and commercial hams. Such differences were ascribed to media compositions or distribution 
problem. Therefore, further studies on mechanisms of antibacterial action and application 
methods of ovotransferrin in food are necessary.   
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Table 1. Effect of ovotransferrin solutions combined with NaHCO3 and EDTA or lysozyme 
on the formation of clear zone in BHI agar media inoculated with E. coli O157:H7 during 
35oC incubation for 24 ~ 48 hrs  
                                                        
Treatment    Conc. (mg/ml)       Control           OTF         OTF + NaHCO3a        
                                                                   
                                  0                           -*                        -                        - 
                                1.0                    -                   -                        - 
EDTA               1.5                        -                   -                        - 
                                2.0                        -                   -                      +/- 
                                2.5                            +**                -                     ++     
                                                                         
                               1.0                          -                  +                      ++ 
Lysozyme        1.5                         -             +         ++ 
                         2.0                          -                   +                      +                   
                            2.5                          -                   +                     ++                     
                                                                   
 OTF: 20 mg/ml apo-ovotransferrin. 
a100 mM-NaHCO3 was used at this study. 
* no clear zone formation on BHI agar media plate. 
** formation of clear zone : the strength of clear zone was described as + (weak), ++ (middle),  
and +++ (strong) by its size and clarity on the BHI agar plates (n = 3). 
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Table 2. Changes of the number of E. coli O157:H7 survivors on e-beam irradiated pork 
chops treated with or without ovotransferrin solutions contained 100 mM NaHCO3 plus 
either EDTA (2 mg/ml) or/and lysozyme (1 mg/ml) during 10o C storage 
  
    Treatments                                              Storage period (days)                
                                                  0                      2                    4                     8                    12                         
                                            ---------------------- Number of viable cell (log10 CFU/ml) --------------  
Control*                          4.1a ± 0.1**       4.2a ± 0.1      5.0a ± 0.1      5.2a ± 0.1       7.3a ± 0.1                                 
1OS + EDTA                 4.1a ± 0.1      4.5a ± 0.2       4.7a ± 0.6      6.0a ± 1.5       7.2a ± 0.7                                
1OS + EDTA + Lyso     4.2a ± 0.1      4.0a ± 0.2      5.0a ± 0.8       5.9a ± 0.7       7.2a ± 1.3                                
2OS + EDTA                  4.2a ± 0.0      4.3a ± 0.6      5.4a ± 0.6       6.2a ± 0.3      6.9a ± 1.0                                 
2OS + EDTA + Lyso     4.0a ± 0.2      4.2a ± 0.1      5.9a ± 0.4        5.9a ± 1.2      7.0a ± 1.3 
                                 
aValues with different letters within a column are significantly different (p< 0.05). n = 3 
Control: Only E. coli O157:H7 inoculation.  
1OS: Ovotransferrin (20 mg/ml) + 100 mM-NaHCO3 
2OS: Ovotransferrin (30 mg/ml) + 100 mM-NaHCO3 
Lyso: lysozyme (1mg/ml),   
2 mg/ml EDTA was used at this study 
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Table 3. Survivors of E. coli O157:H7 in commercial hams treated with or without 
ovotransferrin solutions contained 100 mM-NaHCO3 plus EDTA or/and lysozyme during 
storage at 10o C 
                                 
     Treatment                                                         Storage period (days)   
                                                       0                       3                       8                      13                
  ---------------  Number of viable cell (log10 CFU/ml)   ----------  
Control                 3.7a ± 0.0 **     3.8 a ± 0.2    3.3 a ± 0.4   2.8 a ± 0.1     
1OS + EDTA            3.5 a ± 0.0        3.5 a ± 0.1    3.6 a ± 0.1    2.9 a ± 0.2    
1OS + EDTA + Lyso             3.5 a ± 0.1     3.5 a ± 0.3  3.2 a ± 0.3      3.2 a ± 0.3     
2OS + EDTA                          3.4 a ± 0.1     3.5 a ± 0.1    3.7 a ± 0.3      2.7 a ± 0.2  
2OS + EDTA + Lyso             3.3 a ± 0.2        3.5 a ± 0.3    3.1 a ± 0.5      2.7 a ± 0.2  
                                         
aValues with different letters within a column are significantly different (p< 0.05). n = 3 
Control: Only E. coli O157:H7 inoculation.  
1OS: Ovotransferrin (20 mg/ml) + 100 mM NaHCO3 
2OS: Ovotransferrin (30 mg/ml) + 100 mM NaHCO3 
Lyso: lysozyme (1 mg/ml) 
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Fig. 1. Turbidity of BHI broth cultures inoculated E. coli O157:H7 and ovotransferrin (20 
mg/ml) solution combined NaHCO3 or/and EDTA during 35o C incubation  
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C: control, only 104 CFU/ml of E. coliO157:H7  
E2: 2 mg/ml EDTA 
E2.5: 2.5 mg/ml EDTA 
OS: 20 mg/ml ovotransferrin + 100 mM-NaHCO3 
OSE2: OS + 2 mg/ml EDTA 
OSE2.5: OS + 2.5 mg/ml EDTA. 
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Fig. 2. Turbidity of BHI broth cultures inoculated E. coli O157:H7 and ovotransferrin (20 
mg/ml) combining NaHCO3 or/and lysozyme during 35o C incubation  
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C: control, only 104 CFU/ml of E. coliO157:H7 
L1: 1 mg/ml Lysozyme  
L1.5: 1.5 mg/ml Lysozyme  
L2: 2 mg/ml lysozyme  
OS: 20 mg/ml ovotransferrin + 100 mM NaHCO3  
OSL1: OS + 1 mg/ml lysozyme  
OSL1.5: OS + 1.5 mg/ml lysozyme 
OSL2: OS + 2 mg/ml lysozyme  
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Fig. 3. Antibacterial activity of ovotransferrin (20 mg/ml) containing 100 mM NaHCO3 and 
lysozyme (1 mg/ml) or EDTA (2 mg/ml) against the growth of E. coli O157:H7 in BHI broth 
culture during 35oC incubation for 24 ~ 36 hr.   
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C: control, only 104 CFU/ml of E.coli O157:H7  
L1: 1 mg/ml Lysozyme 
E2: 2 mg/ml EDTA  
OS: 20 mg/ml ovotransferrin + 100 mM-NaHCO3 
OSL1: OS + 1 mg/ml lysozyme 
OSE2: OS + 2 mg/ml EDTA  
            a~cletters labeled on bars means there were significantly different (p < 0.05, n=3)    
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Fig. 4. Effect of initial cell population on antibacterial activity of ovotransferrin (20 mg/ml) 
combining 100 mM NaHCO3 and EDTA (2 mg/ml) or Lysozyme (1 mg/ml) against E. coli 
O157:H7 in BHI broth culture during 35o C incubation for 24 ~ 36 hr.   
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A: 104 CFU/ ml BHI broth 
B: 105 CFU/ ml BHI broth 
C: 106 CFU/ ml BHI broth   
OS: 20 mg/ml ovotransferrin + 100 mM-NaHCO3  
OSE: OS + 2 mg/ml EDTA  
OSEL: OS + 2 mg/ml of EDTA + 1 mg/ml lysozyme 
EL: 2 mg/ml EDTA + 1 mg/ml lysozyme 
                      a~cletters labeled on bars means there were significantly different (p <0.05, n=3) 
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CHAPTER 7. EFFECT OF EDTA AND LYSOZYME ON THE ANTIMICROBIAL 
ACTIVITY OF OVOTRANSFERRIN AGAINST LISTERIA MONOCYTOGENES  
 
A paper which will be submitted to Journal of Food Protection 
K. Y. Ko1, D. U. Ahn2  and  A. Mendonca 
 
Abstract 
This study evaluated the effect of EDTA and lysozyme on the antibacterial activities of 
activated ovotransferrin against 5 strains of L. monocytogenes. First, a disc test was 
performed to screen the concentrations of EDTA or lysozyme that showed antibacterial 
activities in ovotransferrin (O) or ovotransferrin in 100 mM NaHCO3 (OS) solution. 
Turbidity and viability test were conducted using O or OS solution combined with either 
lysozyme (OL and OSL) or EDTA (OE and OSE). Also, OS combined with 2 mg/ml 
lysozyme (OSL) or/and 1 mg/ml EDTA (OSLE) were applied on commercial hams to 
determine if the solutions show antibacterial activities on meat products. The effect of initial 
cell population on the antibacterial activities of ovotransferrin combined with either EDTA or 
lysozyme was also determined. L. monocytogenes started to grow after 1 day of incubation in 
the presence of > 2.0 mg/ml lysozyme. OL groups showed weak antibacterial activities 
against L. monocytogenes in BHI broth culture and their activities were bacteriostatic. OSL 
groups were bactericidal against L. monocytogenes, resulting in 1 log reduction from initial 
cell population. Even though OSL showed stronger antibacterial activity than OS, lysozyme 
did not significant effect on antibacterial activity of OS against L. monocytogenes. Also, 
EDTA itself at 1.0 and 2.0 mg/ml were bacteriostatic against 5 strains of L. monocytogenes. 
They were more susceptible to EDTA than lysozyme, and OSE1 and OSE2 had bactericidal 
activity against L. monocytogenes. There was a significant difference in the survivor cell 
populations between OS and OSE groups (p < 0.05). Therefore, EDTA enhanced the  
 
1 Primary researcher and author 
2 Author of correspondence. 
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antibacterial activity of OS against L. monocytogenes. However, ovotransferrin plus either 
lysozyme or/and EDTA did not show any antibacterial effect in commercial hams during 
storage at 10oC. In addition, the initial population of L. monocytogenes cells influenced the 
antibacterial activity of OSL or OSE.  
 
Introduction 
Natural antimicrobial agents originat from plant, animal, and bacterial sources are 
expected to provide great satisfaction to consumers who are sensitive to health and safety 
issues. Ovotransferrin, the second major egg white protein, is an iron-binding glycoprotein 
and transports and scavenges Fe (III) in eggs of poultry (Kurokawa et al., 1995). 
Antibacterial properties of ovotransferrin against a variety of microorganisms including 
Escherichia coli (Shade and Carolin, 1944; Valenti et al., 1983), Pseudomonas spp., 
Streptococcus mutans (Valenti et al., 1983), Staphylococcus aureus, Bacillus cereus (Ibrahim, 
1997), Salmonella enteritidis (Baron et al., 1997; 2000), and Candida (Valenti et al., 1985) 
have been reported. However, the antimicrobial mechanisms of ovotransferrin are not fully 
defined yet. The iron binding capability of ovotransferrin was initially believed to be the 
major antimicrobial action of ovotransferrin. However, recent studies demonstrated that 
direct interactions of ovotransferrin with bacterial surface were the major cause of 
antimicrobial action of ovotransferrin (Valenti et al., 1983, 1985; Arnold et al., 1981; Ibrahim, 
1997; Ibrahim et al., 2000).  
L. monocytogenes can proliferate in the presence of curing salt at refrigerated 
temperature (Lou and Yousef, 1999), and colonize, multiply and persist on processing 
equipment or plant substances (Rocourt and Seeliger, 1985). The strains are sensitive to heat 
treatment and can be easily inactivated by cooking. However, ready-to-eat (RTE) meat 
products such as frankfurters, and deli meats have high incidence rates of listeriosis due to 
contamination during multiple handling and processing steps performed after cooking 
(Uyttendaele et al., 1999; Giovannacci et al., 1999; Lunden et al., 2003). Centers for Disease 
Control and Prevention (CDC, 2002) reported that 2,500 people suffer by listeriosis annually 
in the United States and one in five die from the disease (FSIS). Due to this risk, the U.S. 
Department of Agriculture currently established a “zero tolerance” policy for L. 
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monocytogenes in RTE meat products. Therefore, developing potent antimicrobials against L. 
monocytogenes for RTE meat is necessary.           
According to previous study, apo-ovotransferrin alone was not effective in controlling 
L. monocytogenes in BHI broth. To improve the antimicrobial activities of ovotransferrin, 
therefore, combinations of several antimicrobial agents are necessary (Sofos et al., 1998)     
The combinations of materials with different antimicrobial mechanisms are expected to 
increase antibacterial effectiveness since a simultaneous attack on different targets are likely 
to make the microorganism more difficult to overcome the environment. The use of 
ovotransferrin combined with EDTA or/and lysozyme as antimicrobials on the surface of 
meat or meat products is appealing to meat industry because all the components are generally 
regarded as safe (GRAS).  
Lysozyme, a single peptide protein with 14.6 kDa of molecular weight catalyzes the 
hydrolysis of (1-4) glycosidic linkages between N-acetylmuramic acid and N-
acetylglucosamine of cell wall peptidoglycan (Proctor and Cunningham, 1988). Therefore, 
the antimicrobial activity of lysozyme is ascribed primarily to the enzymatic lyses of 
peptidoglycan in the cell wall of microorganisms (Branen and Davidson, 2004). The 
application of lysozyme in foods has been limited because gram-negative bacteria that are 
protected by an outer membrane, which is relatively resistant to antimicrobial activities of 
lysozyme (Gill and Holley, 2003; Proctor and Cunningham, 1988). However, lysozyme 
gained considerable interest for use in food systems because it is a natural enzyme produced 
by animals and its activity targets a specific cellular structure of microorganisms (Proctor and 
Cunningham, 1988). 
Ethylenediaminetetraacetic acid (EDTA) has been used in a number of food products 
as a chelating agent to prevent oxidation (Hansen et al., 2001). Although the mechanism of 
antibacterial effectiveness by EDTA is not fully understood, its chelating property to divalent 
cations like Ca2+ or Mg2+ should be involved (Shelef and Seiter, 1993). EDTA inhibits the 
growth of microorganisms by depriving Mg2+, Ca2+, and Fe2+, which are essential factors for 
microbial growth, from microorganisms (Banin et al., 2006). EDTA is reported to enhance 
the antimicrobial activity of lactoferrin by destabilizing the outer membrane of bacteria and 
increasing the permeability of divalent cations (Coughlin et al., 1983; Vaara, 1992; Boland et 
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al., 2004). Also, chelating agents facilitate the detachment of cells from biofilm and enhance 
the killing of biofilm-producing microorganisms by depriving Mg2+ associated with 
lipopolysaccharides (Banin et al., 2006).  
The objective of this study was to enhance the antimicrobial activity of ovotransferrin 
solution supplemented with 100 mM-sodium bicarbonate against a cocktail of 5 strains of L. 
monocytogenes by combining with lysozyme or EDTA. Many studies related to antibacterial 
activity of ovotransferrin in vitro have been reported, but little work has been done to apply 
ovotransferrin as an antimicrobial agent in meat or meat products. Therefore, the present 
study applied OS plus lysozyme or/and EDTA on commercial hams to determine their effect 
on the growth of L. monocytogenes in meat products.  
 
Material and Methods 
 
Ovotransferrin 
Apo-ovotransferrin (iron-free) used in this study was prepared by the method of Ko 
and Ahn (2007, unpublished). After iron saturation of 2x-diluted egg white solution, holo-
ovotransferrin (iron-saturated) were separated using ethanol. Iron was removed from the 
holo-ovotransferrin using AG ®1-X2 resin (chloride form, Bio-Rad, California, U.S.A), and 
then freeze-dried. The dried apo-ovotransferrin was dissolved in 0.15 M NaCl solution and 
pH adjusted to 7.4. The purity of ovotransferrin used in this study was around 80% and the 
residual iron in prepared apo-ovotransferrin solution was less than 0.5 ppm. Prior to 
microbial study, the ovotransferrin solution was sterilized by passing through a 0.22 μm 
syringe filter (Whatman Inc. Florbam Park, NJ. USA). 
 
Bacterial strains  
Five different strains of Listera monocytogenes (NADC 2045, H7962, H7969, H7762, 
and H7596) were used. Prior to inoculation, each strain was individually cultured on brain 
heart infusion broth (BHI, Remel Inc., Lenexa, KS, USA) for 24 hours at 35oC and harvested 
twice in order to activate the strain appropriately. Each strain culture solution (5 ml) was 
transferred to a sterilized centrifuge bottle and centrifuged at 100,000 x g for 10 min at 4oC. 
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The pellet was collected, washed with saline, and then resuspended in 25 ml saline. 
Inoculation cocktail was prepared by mixing equal volumes of each cell suspension to have 
approximately the same population of five strains of L. monocytogenes. The number of 
inoculated L. monocytogenes strain was analyzed on BHI agar plates after serial dilution with 
0.1% peptone (Difco Laboratories, Detroit, MI) water and incubation at 35oC.  
 
Formation of Clear Zone  
Prior to analyzing the antibacterial activity through viability and turbidity tests, disc 
diffusion method (Bauer et al, 1966) was used to determine the concentration of EDTA 
(disodium salt, Fisher Scientific, Fairlawn, NJ, USA) or lysozyme (from egg white, Sigma-
Aldrich Inc., St. Louis, USA) capable of promoting antibacterial capability of ovotransferrin. 
L. monocytogenes cocktail containing equal amount of each strain was diluted in series and 
then 0.1 ml of cell suspension corresponding to 105 or 106 CFU/ml was spread 
homogenously on the BHI agar media plates. The BHI agar plates inoculated with L. 
monocytogenes were dried for 30 ~ 60 minutes in an incubator at 35o C. EDTA (1, 0, 1.5, 2.0, 
or 2.5 mg/ml) or lysozyme (1.0, 1.5, 2.0, or 2.5 mg/ml) was added to ovotransferrin solution 
or ovotransferrin solutions in 100 mM-NaHCO3 (OS). All solutions prepared were sterilized 
using 0.22 μm syringe filters (Whatman Inc. Florbam Park, NJ. USA) prior to performing 
this experiment. Ovotransferrin solutions (120 μl) containing different concentrations of 
EDTA or lysozyme were dispensed to sterilized glass microfiber filter (2.1cm diameter, 
Whatman Inc. Florbam Park, NJ. USA) on the dried BHI agar media. Three replications were 
prepared. The BHI agar plates were incubated at 35oC for 24 ~ 48 hrs and then antibacterial 
activity of each ovotransferrin solution against L. monocytogenes was estimated through the 
existence of clear zones. 
    
Turbidity test 
The antimicrobial capacity of ovotransferrin solutions combined with EDTA or 
lysozyme against the growth of L. monocytogenes was analyzed by measuring the turbidity 
of solution after incubation in a BHI broth culture at 35o C. Disc diffusion test indicated that 
when ≥ 2.0 mg/ml EDTA and ≥ 1.5 mg/ml lysozyme was combined with ovotransferrin, the 
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solutions had antibacterial activity against L. monocytogenes (Table 1). After 2 ml of 40 
mg/ml ovotransferrin solution was added to 2 ml of 2x-strength BHI broth, stock solutions of 
EDTA or lysozyme was added to the media including ovotransferrin (O) or OS. The final 
concentration of lysozyme was adjusted to be 2.0 mg/ml  (OL2 and OSL2), 2.5 mg/ml 
(OL2.5 and OSL 2.5), or 3.0 (OL3 and OSL3) mg/ml, and that of EDTA was adjusted to 1.0 
mg/ml (OE1 and OSE1), 1.5 mg/ml (OE1.5 and OSE1.5) or 2.0 mg/ml (OE2 and OSE2.5). 
Also, 40 μl of cell suspension containing 106 ~107 level of activated L. monocytogenes was 
inoculated to the prepared solution to make the initial population of L. monocytogenes 104 ~ 
105 CFU per ml. EDTA and lysozyme solution without ovotransferrin was prepared to 
determine the antibacterial activity of EDTA or lysozyme alone. After inoculation, the 
samples were incubated at 35o C for 36 hrs. Proliferation degree of L. monocytogenes in each 
treatment was evaluated by measuring its turbidity with a spectrophotometer at 620 nm every 
3 ~ 6 hrs. 
 
Viability analysis  
The antibacterial activities of ovotransferrin plus lysozyme (OSL) and ovotransferrin 
plus EDTA (OSE) were investigated using a viability test. First, 2 ml of ovotransferrin 
solution (40 mg/ml) was added to 2 ml of 2x-concentrated BHI broth media, and then 100 
mM sodium bicarbonate was added. Stock solution of either EDTA or lysozyme was added 
to the BHI broth culture contained with ovotransferrin alone or OS. The final concentration 
of lysozyme and EDTA in solution was identical to that of turbidity test. Also, 40 μl of cell 
suspension containing 106 ~ 107 cells of activated L. monocytogenes was inoculated to make 
initially 104 ~ 105 CFU per ml in BHI broth culture. EDTA or lysozyme alone was prepared 
as a control group. After inoculation, the prepared culture solutions were incubated at 35oC 
for 36 hrs. The number of viable cells was analyzed by spreading each culture solution after 
diluting (1:10) with 0.1% sterile peptone water (Difco Laboratories, Detroit, MI), spreading 
0.1 ml of diluted samples homogenously on a BHI agar plate, and incubating at 35oC for 24 ~ 
36 hrs. The number of survivors on BHI agar plates was counted as colony-forming units per 
ml (CFU/ml) of sample.  
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Effect of initial cell number 
This study was performed to know if the populations of initial cells affect the 
antibacterial activity of ovotransferrin combined with various additives. The BHI broth 
media containing ovotransferrin were prepared with the same method described above. Stock 
solution of either EDTA or lysozyme was added to OS so that the final concentration of 
lysozyme and EDTA in the ovotransferrin solution became 2 mg/ml lysozyme (OSL2) or 1 
mg/ml EDTA (OSE1), respectively. EDTA (2 mg/ml) or lysozyme (1 mg/ml) alone was 
prepared to identify antibacterial activity of the solution itself against L. monocytogenes. 
Also, 40 μl of cell suspension containing 106, 107, or 108 cells of activated E. coli O157:H7 
was inoculated to 4 ml BHI broth media to make the number of L. monocytogenes 104, 105 or 
106 CFU per ml. After the prepared culture solutions were incubated at 35oC for 24 ~ 36 hrs, 
and the viability of each treatment was measured using the same method as above. 
 
Application of ovotransferrin to hams and pork chops   
Commercial hams were purchased from local retail stores. Hams were sliced to 0.2 
cm-thick pieces and vacuum packaged (-1 bar of vacuum with 10second dwell time) in low 
oxygen-permeable bags (nylon/polyethylene, 9.3ml O2/m2/24hr at 0oC; Koch, Kansas City, 
MO). Prior to inoculation, each package was aseptically opened using an alcohol-sterilized 
scissors. Activated L. monocytogenes cocktail stock suspension (0.1 ml) was inoculated 
aseptically on the surface of sliced ham to make the initial cell number around 103 CFU /ml. 
After manually mixing for 30 second to distribute the inocula evenly, the packaged samples 
were randomly divided into 7 groups. Lysozyme or/and EDTA were added to ovotransferrin 
solution included 100 mM NaHCO3 and 0.15 M NaCl. Therefore, the finally treatments 
comprised of 2 mg/ml lysozyme (L), 2 mg/ml lysozyme plus 1 mg/ml EDTA (LE), 20 mg/ml 
of ovotransferrin plus 2 mg/ml lysozyme (1OSL), 20 mg/ml of ovotransferrin plus 2 mg/ml 
lysozyme and 1 mg/ml EDTA (1OSLE), 30 mg/ml of ovotransferrin plus 2 mg/ml lysozyme 
(2OSL), and 30 mg/ml of ovotransferrin plus 2 mg/ml lysozyme and 1 mg/ml EDTA 
(2OSLE). Each prepared ovotransferrin solution (1 ml) was distributed evenly on the surface 
of a ham. Control group was prepared by inoculating L. monocytogenes to hams without 
adding any solution, and all hams were stored in a 10oC incubator. 
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Viable L. monocytogenes cells on the pork chops were analyzed after 0, 2, 5, 10, 15, 22, 
and 29 days of storage: 30 ~ 50 ml of sterile 0.1% peptone water solution was added to each 
vacuum package bag followed by pummeling for 1 minute in a stomacher at normal speed. 
After serial dilution of the sample with 0.1% peptone water, 0.1 ml of diluted sample was 
spread homogenously on MOX media (Difco Laboratories, Detroit, MI) plates in duplicate. 
Survivors were enumerated as CFU per ml by the same method as above.   
 
Statistical analysis 
All experiments were replicated three times and the data were analyzed using the JMP 
software (version 5.1.1; SAS Institute., Cary, NC). The differences in the mean values were 
compared by Tukey HSD, and means values and standard error (SEM) were reported (Kuehl, 
2000). Statistical significance for all comparisons was obtained at p < 0.05. 
 
Results and Discussion 
 
Formation of clear zone  
Lysozyme at 1.0 and 1.5 mg/ml did not form clear zones, but 2.0, 2.5 and 3.0 mg/ml 
lysozyme did. The strength of clear zone formed by lysozyme combined with ovotransferrin 
or OS did not show significant difference compared with that of lysozyme (Table 1). L. 
monocytogenes was susceptible to ≥ 2.0 mg/ml lysozyme. The antimicrobial activity of 
lysozyme has long been believed to be due to its bacteriolytic actions, which hydrolyze ß-
1.4-glycosidic bond in peptidoglycan of gram-positive bacteria that do not possess any outer 
membrane, but gram-negative bacteria with outer membrane is reported to be relatively 
resistant to lysozyme (Davis and Reeves, 2002; Davies et al., 1980; Spitznagel, 1984). The 
antibacterial action of lysozyme against L. monocytogenes in vegetables were strong, but that 
in animal-derived foods such as pork sausage and cheese were weak (Hughey et al., 1989). 
Carminati and Carni (1989) reported that no antimicrobial activities by lysozyme against L. 
monocytogenes were shown in whole milk.  
EDTA at 1.5 and 2.0 mg/ml made clear zone, but no clear zone was formed at 1.0 
mg/ml EDTA. When EDTA was combined with ovotransferrin or OS, the strength of clear 
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zone decreased (Table 1). Zhang and Mustapha (1999) demonstrated that EDTA itself was 
not lethal to L. monocytogenes under the concentrations permitted in foods. EDTA is usually 
used in combination with other preservatives and promotes the suppression of L. 
monocytogenes in meat (Monk et al., 1996; Parente et al., 1998), but sometimes EDTA 
seems to modulate the antibacterial activity of antimicrobials such as nisin (Zhang and 
Mustapha, 1999). This study indicated that more than 1.5 mg/ml of EDTA inhibited the 
growth of L. monocytogenes. However, when EDTA was combined with ovotransferrin or 
OS, the strength of clear zone decreased. Based on the disc test, more than 2 mg/ml lysozyme 
or 1 mg/ml of EDTA were chosen in turbidity and viability tests, and tests were performed to 
identify EDTA and lysozyme effects on antibacterial activities of ovotransferrin.   
 
Lysozyme on antibacterial activity of ovotransferrin 
As shown in Fig. 1, L. monocytogenes entered log phase after 7 ~ 8 hr incubation at 
35oC in BHI broth culture. They seemed to face stationary phase after 24 hr incubation and 
then death. Lysozyme at 2 mg/ml delayed the growth of L. monocytogenes for 24 hrs, 
whereas lysozyme 2.5 mg/ml and 3 mg/ml delayed it for 30 hrs and 36 hr, relatively. 
Therefore, L. monocytogenes seemed to have a lag time to adapt new environment when 
lysozyme was added (Fig. 1). Even though lysozyme alone delayed the growth of L. 
monocytogenes during initial period, L. monocytogenes started to grow after 24 ~ 36 hr 
incubation at 35oC. The turbidity values obtained from all OL or OSL groups were lower 
than 0.1 as in OS treatment (Fig 1). According to turbidity test, L. monocytogenes were found 
to be controlled by OL or OSL groups even though they were resistant to lysozyme alone 
under the concentrations used in this study.  
In viability test, which measures the number of viable L. monocytogenes cells after 48 
hr incubation at 35o C, with 2.0, 2.5 or 3.0 mg/ml lysozyme was not different from that of the 
control (p < 0.05) (Fig. 2). The activities of lysozyme against L. monocytogenes is reported to 
vary depending upon food products or media: L. monocytogenes are susceptible to lysozyme 
in media and phosphate buffer, whereas they are highly resistant to lysozyme in whole milk 
containing diavalent cations such as Ca2+ and Mg2+ (Kihm et al., 1994). As BHI media used 
in this study is relatively nutrient-rich media, injured cells of L. monocytogenes by lysozyme 
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treatment should have been repaired easily in the media. Thus they showed resistance to 2.0 
~ 3.0 mg/ml lysozyme. Another possible explanation for resistance of L. monocytogenes to 
lysozyme may be attributed to using a cocktail of 5 different strains of L. monocytogenes 
instead of using a specific strain.  
The number of viable cells obtained when using OS slightly increased from 4.6 log 
CFU/ml, the number of the initial inoculation, to 4.9 log CFU/ml during 48 hrs incubation at 
35oC. Therefore, OS seemed to be bacteriostatic against L. monocytogenes. Also the number 
of viable L. monocytogenes cells in OL2, OL2.5, and OL3 increased from 4.6 log CFU/ml, 
the number of initial inoculated cell, to 5.1, 7.2, and 6.0 log CFU/ ml, respectively (Fig. 2). 
OL groups showed a weak antibacterial activity against L. monocytogenes compared with 
control. However, OSL groups showed a stronger antilisterial activity against L. 
monocytogenes than that of OL groups. In addition, OSL2, OSL2.5, and OSL3.0 were 
listericidal considering their changes from 4.6 log CFU/ml to 3.3, 3.0 or 2.9 log CFU/ml, 
respectively. Also there was significant difference in antibacterial activity against L. 
monocytogenes between OL and OSL under lysozyme at 2.5 mg/ml and 3.0 mg/ml (Fig. 2). 
Therefore, this study demonstrates that 100 mM sodium bicarbonate enhanced the 
antimicrobial activity of OL against L. monocytogenes, while lysozyme at 2.0, 2.5, or 3.0 
mg/ml did not show clearly effect on antibacterial activity of OS toward L. monocytogenes.  
Payne et al. (1994) demonstrate that a combination of 15 mg/ml lactoferrin and 0.15 
mg/ml lysozyme delayed the growth of L. monocytogenes in UHT (ultra high temperature) 
milk, whereas Boesman-Finkelstein and Finkelstein (1985) report that synergistic activity by 
lactoferrin plus lysozyme was not clearly found. Cultures inoculated with the strains at early 
exponential phase are relatively susceptible to lactoferrin, while those at the early stationary 
phase are comparatively resistant to the antimicrobial (Arnold et al., 1981).  However, using 
multiple L. monocytogenes strains at stationary phase, and nutrient rich media resulted in a 
weak synergistic effect of lysozyme on antibacterial activity of ovotransferrin.  
 
EDTA on antibacterial activity of ovotransferrin 
EDTA alone at 1.0, 1.5 or 2.0 mg/ml, OS, OE group, and OSE group showed < 0.1 
optical density at 620 nm (Fig. 3). This confirmed that L. monocytogenes were susceptible to 
 
 180
EDTA as shown in disc test. As EDTA alone showed a lower turbidity than OE or OSE at 
initial point, it was impossible to compare the antibacterial activity of OE or OSE with 
EDTA itself by turbidity analysis (Fig. 3). As almost all treatments showed similar turbidity 
values of less than 0.1, it was difficult to determine if EDTA had a synergistic effect with 
ovotransferrin using turbidity test. However, according to turbidity test, EDTA increased the 
antibacterial activity of OS (Fig.3).  
In viability test, E1 and E2 resulted in a decrease in viable cell numbers (from 4.6 log 
CFU/ml to 4.1 and 4.0 log CFU/ml, respectively), whereas OSE1 and OSE2 occurred 1 log 
reduction in cell numbers (from 4.6 log CFU/ml to 3.1 and 3.1 log CFU/ml, respectively) 
(Fig. 4). Based on these results, L. monocytogenes was found to be more susceptible to 
EDTA than lysozyme under the concentrations used in this study. This result is consistent 
with that of Parente et al. (1998) who reported that the survivors of L. monocytogenes 
decreased when the concentration of EDTA increased. 
Considering that the survivors of OS treatment were 4.9 log CFU/ml and those of OSE 
were 3.1 log CFU/ml, EDTA addition to OS was found to result in 1.8 log reduction (Fig. 4). 
As the bactericidal action of OSE against L .monocytogenes was not large and EDTA itself 
had bacteriostatic activity against L. monocytogenes, EDTA seemed to have an additive 
effect on antibacterial activity of OS rather than a synergistic effect. Like the result shown at 
this study, Al-Nabulsi and Holley (2006) reported that the combination consisted of NaHCO3, 
lactoferrin, and EDTA accomplished 4 log reduction.  
EDTA chelates divalent cations of outer membrane (Coughlin et al., 1983; Vaara, 
1992; Boland et al., 2004), which enhanced the activity of lactoferrin through the 
destabilization of outer membrane of gram negative bacteria and increased membrane 
permeability. Negatively charged head groups of phosphatidylglycerol and caridiolipin, 
which are predominant phospholipids existing in cytoplasmic membrane of L. 
monocytogenes (O’Leary and Wilkinson), can be neutralized by divalent cations such as 
Mg2+ and Ca2+. As a result, more rigid membrane is formed by condensation of membrane 
lipids (Harwood and Russel, 1984) and became less efficient for nisin insertion and pore 
formation (Abee et al., 1994). As EDTA is combined with nisin and leucosin, their 
bactericidal effect against L. monocytogenes in TSBYE is enhanced (Parente et al., 1998) 
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probably due to the chelating property of EDTA to divalent cations that play a role to protect 
L. monocytogenes (Abee et al., 1994). Aguilera et al (2003) reported that transferrin family 
proteins including ovotransferrin interacted directly with cell membrane and resulted in 
dissipation of electrical potential inside cells.  
In conclusion, EDTA increased the antibacterial activity of OS against L. 
monocytogenes. However, antimicrobial effects by EDTA itself seemed to be the major 
contributor to the listericidal activity of OSE. Antibacterial activity of the combinations 
consisted of EDTA and OS, which were shown to be bacteriostatic, was likely to be ascribed 
to the additive interactions rather than synergistic effect. 
 
Cell number effect 
OS treatment to BHI broth media inoculated with 104 and 105 CFU/ml occurred 1 log 
increase from the initial cell number during 35oC incubation for 48 hrs. However, the viable 
cells in BHI broth culture inoculated with 106 cells and treated with OS did not indicate any 
increase (Fig. 5). BHI broth culture added with OSL2 and inoculated with 104, 105 or 106 
CFU/ml of L. monocytogenes resulted in 3.3, 3.7, or 4.5 log CFU/ml of viable cells, 
respectively, after 48 hrs incubation at 35oC. BHI broth inoculated with 104, 105 or 106 
CFU/ml of L. monocytogenes cells and OSE1 showed 3.1, 4.0, or 4.4 log CFU/ml of viable 
cells, respectively (Fig 5). These results demonstrate that OSL2 or OSE1 had listericidal 
activity against L. monocytogenes and the number of initial cells existing in the media 
affected the antibacterial activity of OSL2 and OSE1 (p < 0.05). However, the influence by 
initial cell population on antimicrobial actions of ovotransferrin against L. monocytogenes 
was not overwhelming. 
 
Ovotransferrin application on commercial hams  
L. monocytogenes with 104 initial cells grew slowly in commercial hams to 105 
CFU/ml during storage at 10oC for 29 days. In contrast to in vitro test, 1OSL, 1OSLE, 2OSL, 
and 2OSLE did not show any antimicrobial activity against L. monocytogenes. No significant 
difference between control and all treatments were detected (Table 2). Therefore, it was 
suggested that even though OSL2 and OSE1 showed clear bactericidal effect against L. 
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monocytogenes in model systems, they did not have antibacterial activities against L. 
monocytogenes in commercial hams during storage.  
Antibacterial activities of some antimicrobials shown in buffer or laboratory media 
sometimes can be modulated in nutrient media or in presence of cations and salts, which are 
capable of supporting the growth of microorganisms (Branen and Davidson, 2000; Bellamy 
et al., 1992; Jones et al., 1994). Murdock et al. (2007) reported that the inhibitory activities of 
lactoferrin against L. monocytogenes could be eliminated or reduced in some media like 
trypticase soy broth since they provided many divalent cations that might affect the 
antibacterial activity of lactoferrin. Exogenous Ca2+ and Mg2+ may block the biological 
activity of lactoferrin by forming lactoferrin tetramers, increasing iron strength in the 
presence of high concentration of Ca2+ and Mg2+ or inhibiting binding to cell surface (Bennett 
et al, 1981; Viejo-Díaz et al, 2004; Ellison et al., 1988, 1990)  
Low level of EDTA synergistically enhanced the antibacterial activity of lysozyme 
against L. monocytogenes (Branen and Davidson, 2004). Payne et al. (1994) reported that 
more than 1 mg/ml EDTA synergistically enhanced the effect of 0.1 ~ 0.2 mg/ml lysozyme 
against L. monocytogenes in UHT milk. EDTA enhanced the antibacterial activity by 
lysozyme against L. monocytogenes in microbiological media as well as food products 
(Hughey and Johnson, 1987, Hughey et al., 1989). Johnson (1994) reported that antibacterial 
action of lysozyme is limited to a part of bacteria and fungi and could be improved by certain 
substances such as EDTA, butyl paraben, tripolyphosphate, and some other naturally 
occurring antimicrobial agents. However, EDTA plus lysozyme did not show any 
antimicrobial activity against L. monocytogenes in hams in this study. Such a difference may 
be due partially to media compositions. Antimicrobial combinations consisting of lysozyme 
and nisin had an enhanced bactericidal activity in MRS media, but they did not show such an 
effect in pork juice at the same conditions (Gill and Holly, 2003). As food products provide a 
nutrient-rich environment, injured microorganisms by antimicrobials may be recovered more 
easily in food systems than those under cell starvation or limited media conditions. 
Another possible explanation about no antibacterial activities by OSL and OSE in 
commercial hams could be distribution problem or dilution effect of ovotransferrin to the 
products, state of strains in inocula, or stability of ovotransferrin on the surface of meat 
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products. Generally, antimicrobial activity of ovotransferrin is dependent upon dose of 
ovotransferrin. In the present study, 1 ml of 20~ 30 mg/ml ovotransferrin was distributed on 
the surface of hams, and the concentration was likely to be diluted in certain part of the 
product so that low antibacterial effect against L. monocytogenes might be shown in the area. 
Also, ovotransferrin was spread manually, and thus it is difficult to distribute ovotransferrin 
uniformally or homogenously on whole products. Also, ovotransferrin incorporated could 
have been penetrated or absorbed inside the product so that it could not be involved in 
antimicrobial activities. Stiles (1996) demonstrated that even though antimicrobials such as 
bacteriocins are effective in inhibiting pathogens including L. monocytogenes and other 
spoilage microorganisms in model systems, high population of survivors or recovering 
features is often observed in food systems. This study showed that there are many limitations 
in applying ovotransferrin as antimicrobial agent in food systems at this point. 
 
Conclusion 
Lysozyme at 2 mg/ml in BHI media delayed the growth of L. monocytogenes for 24 
hrs at 35oC, but it started to adapt new environment. OL2 appeared to be bacteriostatic 
activity and OSL2 indicated to have bactericidal effect against L. monocytogenes in vitro test. 
Also, 100 mM sodium bicarbonate was found to enhanc the antimicrobial activity of OL 
against L. monocytogenes, while lysozyme at 2.0, 2.5, or 3.0 mg/ml did not show significant 
effect on antibacterial activity of OS toward L. monocytogenes. EDTA alone at 1 mg/ml was 
bacteriostatic against L. monocytogenes and OSE1 was bactericidal. However, it was difficult 
to determine whether EDTA has synergistic effect on ovotransferrin since EDTA itself had a 
significant antibacterial activity against L. monocytogenes in BHI broth culture. The initial 
cell number of cells in media affected the antibacterial activity of OSE or OSL toward L. 
monocytogenes, but the effect of cell population on antimicrobial action of ovotransferrin 
was not significant. Contrary to in vitro test, OSL, OSEL, L, and LE did not show any 
antimicrobial activities in commercial hams during incubation at 10oC for 29 days. There was 
apparent difference in antibacterial activities of ovotransferrin between model systems and 
real products. This study suggested that OSL2 had a great potential as a natural antimicrobial 
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agents to control L. monocytogenes in vitro, but further studies are needed to improve the 
antimicrobial activity of ovotransferrin in food products.  
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Table 1. Effect of ovotransferrin combined with NaHCO3 and EDTA or NaHCO3 and 
lysozyme on clear zone formation on BHI agar media plates inoculated with L. 
monocytogenes during 35o C incubation for 24 ~ 48 hrs 
                                                           
Treatment    Conc. (mg/ml)    Control           OTF a       OTF + NaHCO3b        
                                                                  
        0                         -*                   -                       -/+ 
                                1.0                -                    -                        - 
                         1.5                   -                   +/-                      - 
   Lysozyme            2.0                  ++                 ++                     +/- 
                                2.5                       ++                ++                     ++     
                                3.0                       ++                +++                   ++   
                           
                               1.0                     -                     -               - 
EDTA              1.5                   ++           +**              + 
                         2.0                    ++                   +                     ++                   
                                                                  
P
P
P
P
   a20 mg/ml ovotransferrin 
    b100 mM NaHCO  was used at this study. 3
   *No clear zone formed on BHI agar media plate. 
  **Formation of clear zone: the strength of clear zone was described as + (weak), ++ (middle), 
and +++ (strong) by its size or clarity on the BHI agar. (n = 3) 
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Table 2. Viable cells of L. monocytogenes on commercial hams treated with or without ovotransferrin in 100 mM  
  NaHCO3 (OS) plus or/and lysozyme (2 mg/ml) and/or EDTA (1 mg/ml) during 10oC storage 
                                                                                                      
           Treatments                                                                                Storage period (days)     
        0                  2                  5          10              15                     22                 29        
                                       -----------------------------   Number of viable cells (log 10 CFU/ml)  ------------------------                         
           Control        4.5a ± 0.0*     4.6 a ± 0.2      5.0 a ± 0.0      5.3 a ± 0.4      5.8 a ± 0.0      5.4 a ± 0.2       5.3 a ± 0.4 
           1OSL     4.3 a ± 0.1     4.7 a ± 0.1      5.1 a ± 0.1      5.5 a ± 0.1  5.6 a ± 0.4      5.5 a ± 0.9       5.2 a ± 0.3 
           1OSLE    4.4 a ± 0.1     4.6 a ± 0.0      5.0 a ± 0.1      5.1 a ± 0.2  5.9 a ± 0.3      5.6 a ± 0.2       6.0 a ± 0.4 
           2OSL     4.4 a ± 0.0     4.6 a ± 0.0      5.0 a ± 0.1      5.2 a ± 0.2  5.2 a ± 0.1      5.5 a ± 0.0       5.4 a ± 0.6 
           2OSLE t  4.3 a ± 0.1     4.6 a ± 0.1      4.9 a ± 0.2      5.1 a ± 0.1  5.6 a ± 0.2      5.7 a ± 0.3       5.4 a ± 0.2 
               L        4.3 a ± 0.0     4.5 a ± 0.1     4.9 a ± 0.1       4.9 a ± 0.3  5.4 a ± 0.3      5.0 a ± 1.0       5.4 a ± 0.5 
         LE       4.4 a ± 0.2     4.5 a ± 0.1      5.0 a ± 0.1      5.1 a ± 0.1  5.5 a ± 0.5      5.6 a ± 0.3       6.2 a ± 0.6             
aMeans within a column with no common superscript differ (P < 0.05, n = 4). 
Control: only L. monocytogenes inoculated. *Mean ± standard deviation.  
1OSL: 20 mg/ml ovotransferrin + 100 mM NaHCO3 + 2 mg/ml lysozyme  
1OSLE: 1OSL + 1 mg/ml EDTA ,   2OSL: 30 mg/ml ovotransferrin + 100 mM NaHCO3 + 2 mg/ml lysozyme  
1OSLE: 2OSL + 1 mg/ml EDTA,    L: 2 mg/ml lysozyme  
LE: 2 mg/ml lysozyme + 1 mg/ml EDTA   
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Fig.1. Turbidity of BHI broth cultures inoculated L. monocytogenes and ovotransferrin (20 
mg/ml) combined with NaHCO3 or/and EDTA during 35oC incubation  
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C: control, 104 CFU/ml of L. monocytogenes 
L2: 2 mg/ml Lysozyme 
L2.5: 2.5 mg/ml Lysozyme 
L3: 3.0 mg/ml Lysozyme 
OS: 20 mg/ml ovotransferrin + 100 mM-NaHCO3 
OL2: 20 mg/ml ovotransferrin + L2  
OL2.5: 20 mg/ml ovotransferrin + L 2.5  
OL3: 20 mg/ml ovotransferrin + L 3.0  
OSL2: OS + 2 mg/ml lysozyme 
OSL2.5: OS + 2.5 mg/ml lysozyme 
OSL3: OS+ 3.0 mg/ml lysozyme 
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Fig 2. Antibacterial activity of ovotransferrin (20 mg/ml) combined with 100 mM NaHCO3 
and/or lysozyme against the growth of L. monocytogenes on BHI broth culture during 35oC 
incubation for 24 ~ 36 hr   
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                            a-d Bars with different letters indicate significantly different values (P < 0.05. n=4). 
C: control, only 104 CFU of L. monocytogenes 
L2: 2 mg/ml Lysozyme 
L2.5: 2.5 mg/ml Lysozyme 
L3: 3.0 mg/ml Lysozyme 
OL2: 20mg/ml ovotransferrin + L2 
OL2.5: 20mg/ml ovotransferrin + L2.5  
OL3: 20mg/ml ovotransferrin + L 3.0  
OS: 20 mg/ml ovotransferrin + 100 mM-NaHCO3 
OSL2: OS + 2 mg/ml lysozyme 
OSL2.5: OS + 2.5 mg/ml lysozyme 
OSL3: OS+ 3.0 mg/ml lysozyme 
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Fig 3. Turbidity of BHI broth cultures inoculated L. monocytogenes and ovotransferrin (20 
mg/ml) combined with NaHCO3 or/and EDTA during 35oC incubation  
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C: control, only 104 CFU / ml of L. monocytogenes 
E1: 1 mg/ml EDTA 
E1.5: 1.5 mg/ml EDTA 
E2: 2.0 mg/ml EDTA 
OS: 20 mg/ml ovotransferrin + 100 mM NaHCO3 
OE1: 20 mg/ml ovotransferrin + E1 
OE1.5: 20 mg/ml ovotransferrin + E2 
OE2: 20 mg/ml ovotransferrin + E3 
OSE1: OS + E1 
OSE1.5: OS + E1.5 
OSE2: OS+ E2 
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Fig 4. Antibacterial activity of ovotransferrin (20 mg/ml) combined with 100 mM NaHCO3 
and/or EDTA (1 mg/ml) against the growth of L. monocytogenes in BHI broth culture during 
35oC incubation for 48 hr  
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                            a-d Bars with different letters indicate significantly different values (P < 0.05. n=4). 
C: control, only 104 cells of L. monocytogenes 
E1: 1 mg/ml EDTA 
E2: 2.0 mg/ml EDTA 
OS: 20 mg/ml ovotransferrin + 100 mM NaHCO3 
OSE1: OS + E1 
OSE2: OS + E2 
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Fig 5. Effect of initial cell population on the antibacterial activity of ovotransferrin (20 
mg/ml) solution combined with 100 mM NaHCO3 and EDTA (2 mg/ml) or lysozyme (1 
mg/ml) against L. monocytogenes in BHI broth culture during 35oC incubation for 48 hr  
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                        a-d Bars with different letters indicate significantly different values (P < 0.05. n=4). 
A: 104 CFU/ ml BHI broth 
B: 105 CFU/ ml BHI broth 
C: 106 CFU/ ml BHI broth   
OS: 20 mg/ml ovotransferrin + 100 mM NaHCO3  
OSL2: OS + 2 mg/ml lysozyme 
OSE1: OS + 2 mg/ml lysozyme + 1 mg/ml of EDTA 
 
 
 
 
 
 
 
 196
CHAPTER 8. GENERAL CONCLUSIONS 
 
 Foodborne illnesses are a significant problem and a major public health concern. A 
number of methods including the use of synthetic and natural antimicrobial agents have been 
developed to control the growth of pathogens in foods, but there are growing consumer 
demands for ‘natural’ antimicrobials or methods, which are environmentally friendly, 
medically acceptable, highly effective, and economical to manufacture.  
 Egg contains various antimicrobial proteins including lysozyme, egg yolk antibody 
(IgY), and ovotransferrin. As IgY has a great potential for use as a natural antimicrobial 
agent, this study developed a novel protocol for a large-scale production of IgY from egg 
yolk. The new protocol used 0.01 % charcoal to remove lipoproteins, ultrafiltration to 
concentrate IgY solution, and 40% ammonium sulfate to precipitate IgY. The recovery of 
IgY produced by the protocol was around 70 ~ 80% and its purity were much higher than 
that of IgY obtained by anion exchange chromatography. As ammonium sulfate precipitation 
method could handle a large volume of IgY solution at a time, the new procedure was 
suitable for a large-scale purification of IgY from egg yolk. 
 Ovotransferrin that has a high potential as a natural antimicrobial agent was separated 
from egg white using developed protocol. That is, apo-ovotransferrin in egg white was 
saturated with iron to prevent its denaturation during ethanol treatment. Holo-ovotransferrin 
was extracted by 43% ethanol and precipitated by 59% ethanol from iron-saturated egg white 
solution. After dissolving precipitated holo-ovotransferrin with distilled water, the iron bound 
to holo-ovotransferrin was removed using AG ®1-X2 ion exchange resins so that apo-
ovotransferrin was obtained. The recovery rate of apo-ovotransferrin was around 94%, 
whereas the purity was greater than 80%. The developed method was simple and economical 
for a large-scale production of ovotransferrin because the protocol used only ethanol and AG 
®1-X2 ion exchange resins and they can be recovered and reused. In addition, the 
ovotransferrin obtained from this protocol can be easily applied of food products because 
only ethanol was used as a solvent for separation of apo-ovotransferrin.  
Ovotransferrin was originally thought to inhibit microbial growth by limiting iron from 
the environment. However, the precise mechanism of antibacterial action of ovotransferrin 
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was not defined clearly. This study investigated the effect of citric acid, NaHCO3 on the 
antibacterial activity of ovotransferrin against E. coli O157:H7 and L. monocytogenes to 
understand the antimicrobial action of ovotransferrin. The antibacterial activities of Apo-, 
Zn-, and Fe-bound ovotransferrin against E. coli O157:H7 and L. monocytogenes were also 
investigated. The antibacterial activity of natural apo-ovotransferrin against E. coli O157:H7 
and L. monocytogenes in model systems increased as the concentration of sodium 
bicarbonate increased. Ovotransferrin combined with 100 mM-NaHCO3 (OS) resulted in 
marked increase in antibacterial activity against the two pathogens. Iron binding capacity of 
ovotransferrin was generally decreased under acidic pH. Also, the antibacterial activity of 
ovotransferrin against E. coli O157:H7 increased when ovotransferrin was combined with 
0.5% citric acid even though the pH of media decreased to pH 4 ~ 5 by citric acid. The 
growth of L. monocytogenes was prevented by Zn-saturated ovotransferrin, but E. coli 
O157:H7 was not. These results suggested that iron binding capacity was not the major 
antimicrobial mechanism of ovotransferrin because acidic condition formed by addition of 
citric acid improved antibacterial acticity of ovotransferrin against E. coliO157:H7. Instead, 
ovotransferrin was likely to interact directly with bacterial membrane and induced a variety 
of physicochemical changes, which affected the survival of microorganisms.   
Ovotransferrin alone and OS showed limited antibacterial effect on the growth of E. 
coli O157:H7 and L. monocytogenes, but addition of EDTA improved the antibacterial 
activity of ovotransferrin or OS against two pathogens. EDTA (2 mg/ml) plus OS (OSE) 
caused 3 ~ 4 log reduction in E. coli O157:H7, while EDTA (1mg/ml) plus OS resulted in 
around 1 log reduction of L. monoyctogenes during after 36 hr incubation at 35oC. But it was 
difficult to determine whether EDTA has a synergistic effect with ovotransferrin since EDTA 
itself showed bacteriostatic property against L. monocytogenes. Through this study, use of 
OSE seemed to be an effective approach to control E. coli O157:H7. Also, the effect of 
lysozyme on antibacterial activity of OS against E. coliO157:H7 and L. monocytogenes was 
not clearly found in the present study. However when lysozyme at 2.5 or 3.0  mg/ml 
lysozyme was combined with OS, the combinations showed to have bactericidal activity 
against L. monocytogenes, resulting in 1 log reduction of initial cell number in vitro test.  
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 Contrary to the results obtained in model systems using BHI media, ovotransferrin 
plus 100 mM NaHCO3 or 0.5% citric acid and ovotransferrin plus EDTA or/and lysozyme 
(OSE or OSL) did not show significant antibacterial activity against E. coli O157:H7 and L. 
monocytogenes in pork chops and hams. Such differences in antibacterial activity of 
ovotransferrin combined with other antimicrobials between model systems and real products 
seemed to be ascribed to different media compositions such as the presence of many divalent 
cations, distribution problems, and low stability of unbound ovotransferrin on the surface of 
meat products.  
In conclusion, this study suggested that there is high possibility of using ovotransferrin 
and its combinations with NaHCO3, EDTA, or lysozyme as natural antimicrobial agents to 
control E. coli O157:H7 and L. monocytogenes in foods. However, elucidation of the precise 
antibacterial mechanisms of ovotransferrin and improvements in antibacterial property of 
ovotransferrin and its combinations with other agents is needed for their use in food systems.  
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